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ABSTRACT 
 
An association between methamphetamine dependence and neurocognitive impairment has long 
been established. However, there are a number of research gaps. First, while evidence suggests 
that the primary cognitive domains affected in methamphetamine dependence are executive 
functions; previous research fails to employ a comprehensive battery of executive functioning 
tests. Second, there is little research investigating the specific neuropsychological impairments 
associated with methamphetamine psychosis in particular. Third, ADHD is highly co-morbid with 
substance dependence. Symptoms of ADHD were therefore investigated as possible confounders 
in this study. Fourth, few studies of methamphetamine dependence have explored relationships 
between neuropsychological data and cortical thickness data; the current study therefore 
investigated this further. The current study employed a neuropsychological test battery to 
compare executive functioning across three groups; a methamphetamine dependent group 
without psychosis (n = 20), a methamphetamine dependent group with psychosis (n =19) and a 
healthy control group (n = 20); demographically matched. Brain images were acquired using a 
Siemens Magnetom Allegra 3T system with a high-resolution, T1-weighted, 3D-multiecho 
MPRAGE sequence with the following scan parameters: TR=2530ms; graded TE=1.53, 3.21, 4.89, 
6.57ms; flip angle=7°; FOV=256mm; slice thickness=1mm; 160 slices; and acquisition duration of 
10.49 min. Cortical thickness was assessed employing a surface-based cortical reconstruction and 
automatic labelling tool in the FreeSurfer software package. Four executive domains were 
identified and evaluated, namely decision making and impulsivity; inhibitory control and set-
shifting; attention and working memory; and verbal fluency. One-way ANOVAs were conducted in 
order to assess differences between groups. Analyses indicated significant between group 
differences on most tasks of executive functioning. Overall the methamphetamine psychosis 
(MA+) group performed more poorly than the methamphetamine non-psychosis (MA-) group and 
the controls (NC). Statistically significant between-group differences were observed on inhibitory 
control and set-shifting (p < .001), attention and working memory (p = .006), and on tasks of 
generativity (p < .001). Spearman’s correlational analyses revealed that in general, executive 
impairment was associated with cortical thinning of frontal regions in the MA+ group and cortical 
thickening of frontal regions in the MA- group. This may be reflective of a compensatory response 
to methamphetamine toxicity in the MA- group. In conclusion, executive functioning was 
significantly impaired in the MA- group and even more so in the MA+ group. Symptoms of ADHD 
were not found to be significantly correlated with executive functioning data. Therefore 
executive dysfunction is more likely the result of MA toxicity than a pre-existing ADHD disorder. 
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An improved understanding of the neuropsychology and neuroanatomy of methamphetamine 
dependence may ultimately contribute to the clinical management of these individuals. 
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CHAPTER ONE: INTRODUCTION 
 
The current study aims to address four gaps that have been identified in the existing research 
conducted on the neuropsychological sequelae of methamphetamine (MA), and particularly of 
methamphetamine-induced psychosis. Here we introduce these gaps before moving to review the 
literature. First, I introduce the lack of comprehensive data available on executive functioning (EF) in 
MA. Second, given the association between MA and substance-induced psychotic disorder, I then 
identify the dearth of research available comparing individuals who develop psychosis to those who 
do not develop psychosis on neuropsychological task performance, particularly in the South African 
context. Third, I discuss the co-morbidity of ADHD and MA-dependence and the relationship 
between these two disorders in terms of EFs as ADHD is a potential confounder in my data. Finally, I 
discuss the prefrontal brain regions that mediate these EFs and the value that the current research 
will add to existing knowledge on this topic. 
 
An association between methamphetamine dependence and neurocognitive impairment has long 
been established. A meta-analysis of the neuropsychological consequences associated with MA-
dependence found that these involve a variety of cognitive domains, including executive functions, 
memory, motor skills, language and information processing speed, and visuo-constructional abilities 
(Scott et al., 2007). Executive functions involve the management of cognitive process and include 
reasoning, planning and problem solving; memory is the ability to store and remember information; 
motor skills refer to the ability to perform a sequence of movements; language refers to the ability 
to communicate, both verbally and written; Information processing refers to the ability to interpret 
incoming information; visuo constructional abilities involve the coordination of fine motor skills with 
visuospatial abilities. The largest impairments in MA have been found on tasks of executive 
functions, (Scott et al., 2007). However, many studies test “executive functions” by means of either a 
single task of response inhibition (Salo et al., 2007), two tasks of response inhibition (McCann et al., 
2008) or simply one task of working memory and one task of decision making (Gonzalez, Bechara & 
Martin, 2007). Thus detailed research on the specific domains of executive functions (EF) such as 
attention and working memory, decision making and impulsivity, inhibition and mental flexibility, is 
lacking. The current study attempts to address this gap by employing a comprehensive battery of EF 
tasks, focusing in particular on the executive domains of decision making and impulsivity, inhibition 
and set shifting, attention and working memory, as well as verbal fluency. 
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Of further importance, is the substance-induced psychotic disorder (SIPD) resulting from MA use. 
This psychotic state experienced by MA-dependent individuals is characterized by auditory, visual 
and/or tactile hallucinations and persecutory ideation (McKetin, McLaren, Lubman & Hides, 2006; 
Srisurapanont et al., 2003). Relatively little research to-date has been conducted on 
methamphetamine-induced psychotic disorder and particularly little research has been conducted 
on the neuropsychological deficits associated with MA psychosis, particularly in comparison with MA 
dependent individuals without a history of psychosis, and particularly in the South African context. 
The current study attempts to address this gap in the literature by comparing neuropsychological 
functioning, specifically executive functioning, in MA-dependent individuals with and without 
psychosis. 
 
MA dependence and attention-deficit/hyperactivity disorder (ADHD) are commonly comorbid 
conditions. It is notable that similar executive dysfunction to that seen in MA dependence is seen in 
ADHD. Certainly, ADHD is a risk factor for substance abuse and the progression to dependence is 
quicker in individuals with ADHD than those without ADHD (Jaffe et al., 2005). In particular, ADHD 
individuals use MA more frequently than those without ADHD (Jaffe et al., 2005). Whether this is 
due to the “self medication hypothesis” is not entirely evident. Nevertheless, it is also possible that 
MA may lead directly to impairments in executive function (Jaffe et al., 2005; Matsumoto, Kamijo, 
Yamaguchi, Iseki, & Hirayasu, 2005). ADHD is therefore a confounding factor when investigating 
executive functioning in substance use disorders. There is, however, relatively little data 
investigating whether the executive impairments observed in MA may be due to a pre-existing 
disorder such as ADHD, or due to the neurotoxic effects of the drug. While establishing causality is 
not the aim of this cross-sectional study, I do aim to investigate the relationship between ADHD and 
executive impairment in our MA dependent sample. 
 
Previous research investigating methamphetamine dependece, neuropsychological functioning, and 
brain imaging has examined either regional cerebral blood flow (Chang et al. 2002), morphometric 
changes (Chang et al. 2005) or conducted fMRI studies investigating performance of single cognitive 
tasks (Monterosso et al. 2007; Paulus et al. 2002, 2003). Thompson et al. (2004) mapped regional 
brain abnormalities and correlated this data with memory performance. However, there are few 
studies that have performed such correlational analyses between MRI and neuropsychological data. 
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No such studies, to my knowledge have correlated executive functioning data with cortical thickness 
data in methamphetamine dependence, and particularly methamphetamine psychosis. I therefore 
aim to address this gap. 
 
In particular, I aim to correlate executive functioning data with cortical thickness data of the frontal 
cortex as EFs are mediated by the prefrontal cortex (PFC). Three main areas of the PFC have been 
identified; namely the orbitofrontal cortex (OFC) the dorsolateral prefrontal cortex (DLPFC), and the 
anterior cingulate cortex (ACC), mediate decision making and emotion regulation, working memory 
and mental flexibility, and response inhibition, respectively (Verdejo-Garcia, Bechara & Recknor, 
2006). Figure 1 below is a diagrammatic representation of how the frontal regions and associated 
executive functions have been divided in this thesis. Given that response inhibition and impulsivity 
are closely linked, as are response inhibition and attention; this schematic is intended as an initial 
heuristic. I discuss this further in the following literature review  
 
Figure 1. Diagramatic Representation of the relationship between executive functions and the 
prefrontal cortex 
 
 
In summary, this study will focus on addressing these key gaps in existing research. Firstly we will 
investigate executive functioning of individuals who are dependent on MA. We will be using a 
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comprehensive battery of tests investigating four executive functioning domains, namely, decision 
making and impulsivity, attention and working memory, inhibition and set-shifting, and verbal 
fluency. Secondly, we will be comparing those individuals who are dependent on MA and do not 
develop MA psychosis to those who do develop MA psychosis. Thirdly, we will be investigating the 
co-morbidity of ADHD and MA in our sample. And finally, we will investigate the frontal brain regions 
that mediate executive functioning in our sample of MA dependent individuals. The literature 
investigating these four core components will now be reviewed in order to provide background 
regarding previous research findings. 
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CHAPTER TWO: LITERATURE REVIEW 
 
This chapter begins with a brief background and history of MA, before discussing some statistics 
specific to South Africa. While this is not an epidemiological study and therefore details of previous 
research conducted is not provided here, the background and history provide a rationale for 
investigating MA further in the South African context. The literature relevant to the four core 
components of the current study will then be discussed in more detail. First, we will discuss the 
neuropsychological effects of MA, particularly executive functions. Second, we discuss the frontal 
cortex sub-regions that mediate EFs. Third we briefly discuss the co-morbidity between ADHD and 
MA. Lastly, we review the literature relevant to methamphetamine-induced psychosis. The following 
methods have been used to identify relevant literature for this chapter: (1) searching the MEDLINE, 
PUBMED, PSYCHARTICLES and PSYCHINFO databases; (2) exploring the reference list of peer-
reviewed journal articles already located; and (3) following up suggestions from colleagues working 
in this field. The literature search was confined to English publications in peer-reviewed journals. 
Where unpublished works were encountered such as interviews and unpublished reports, these 
have also been included. This chapter will then conclude with the specific aims and hypotheses of 
the current study. 
  
METHAMPHETAMINE: BACKGROUND 
 
A Brief History of Methamphetamine 
 
MA is sometimes referred to as “Hitler’s Drug” (Leggett, 2003: p. 34) as it was allegedly used by the 
Nazis as a means of assisting soldiers in combat. Although MA was first synthesized in Japan in the 
late 1800s, it was not widely used until World War II (Leggett, 2003) where German military 
personnel used it in order to combat fatigue and increase alertness (Scott et al. 2007). It was also 
given to Japanese civilian factory workers in military support industries to increase productivity 
(Anglin et al., 2000). After the war, the first epidemic of widespread abuse occurred between 1945 
and 1957 where a surplus of Army stock flooded the market. In 1954 the number of MA abusers in 
Japan was estimated at 550 000 people, 10% of whom reported symptoms of MA-induced psychosis. 
MA use then subsided for a while as new laws were introduced in response to the increase in crime 
and homicides linked to MA. MA use then later spread among blue collar workers, students, 
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housewives and office workers, leading to the second epidemic which began in 1970 to the present 
day (Anglin et al., 2000).  
 
In South Africa, the first methamphetamine (or ‘tik” as it is locally known) manufacturing operation 
was discovered by the police in 1998. No other such operations were found until 2001 when 10 MA 
laboratories were discovered, nine in Gauteng and one in Woodstock in Cape Town. In 2003 a shift 
was seen where the majority of cases were then found in the Western Cape, including multiple 
seizures in Mitchell’s Plain and other areas on the Cape Flats; most of which involved pure 
methamphetamine powder (Leggett, 2003).  
 
Methamphetamine Use in South Africa 
 
According to SACENDU (as cited by Leggett, 2003), treatment demand for MA addiction also 
increased during that time. In the first half of 2002, there were only three patients in treatment for 
MA dependence in Cape Town out of a total 1600 patients in rehab for drug addiction. This 
increased to 13 in the second half of 2002 and to 35 in the first half of 2003 (Leggett, 2003).  
 
MA use in South Africa has significantly increased in the last decade, particularly in areas on the 
Cape Flats, such as Mitchell’s Plain in the Western Cape Province (Kapp, 2008; Leggett, 2003; 
Plüddemann, Myers & Parry, 2007; Simbayi et al., 2006), with 42% of drug abusers in Cape Town in 
2006 using methamphetamine as their primary drug of choice (Pluddemann, Myers & Parry, 2007). A 
report compiled by the Medical Research Council of South Africa (MRC; Pluddemann, Myers & Parry, 
2007), indicated that the number of patients with MA as their primary or secondary substance of 
abuse increased dramatically from 2003 to 2006. The authors of that report found that out of the 
total number of patients treated at over 25 specialist treatment centres for any substance (including 
alcohol, cannabis, mandrax, heroin or cocaine), 6 % of them were MA users in 2003. This number 
increased to 49% in 2006 (Pluddemann, Myers and Parry, 2007).  
 
In a more recent report by SACENDU (South African Community Epidemiology Network on Drug Use; 
Dada et al., 2012), data were collected across 23 specialist treatment centres in Cape Town and it 
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was found that methamphetamine remains the most common primary substance of abuse. The 
drastic increase in MA use that was seen between 2003 and 2006 is not reflected over the period 
2007 – 2012. In the first half of 2007, 41% of patients used MA as their primary substance of abuse. 
This decreased to 36% in the second half of 2007. In the first half of 2011, 35% of patients used MA 
as their primary substance of abuse. This increased to 39% in the second half of 2011. Moreover, 
Plüddemann, Dada and Parry (2013) observed a significant decline in the number of adolescent 
patients reporting methamphetamine as their primary substance of abuse between 2006 and 2011. 
However, a similar trend was not observed in adults. Over the same period, a gradual but significant 
increase was observed regarding the number of adults reporting methamphetamine as their primary 
substance of abuse (Plüddemann, Dada & Parry, 2013). This indicates that the plateau of numbers 
could be due to the decrease in number of adolescent users; however, the number of adult users 
continues to increase. 
 
Despite this apparent plateau, MA is still the most common substance of abuse, with numbers far 
exceeding those for heroin, cocaine, ecstasy, dagga, mandrax and even alcohol (Dada et al., 2012). 
Drug abuse is currently thought to cost South Africa R20-billion per year (Benadie, 2012; in press). 
These statistics are alarming given the highly addictive nature of MA and its devastating 
consequences. Long term MA abuse or dependence can result in a variety of medical and psychiatric 
sequelae, impairment in occupation and social functioning, and particularly neuropsychological 
impairment (Scott et al., 2007). 
 
Clinical Effects of Methamphetamine 
 
Methamphetamine (MA) is a highly addictive psycho-stimulant drug that acts on the central nervous 
system (CNS) and results in the release of monoamine neurotransmitters, which includes dopamine, 
norepinephrine and serotonin. The marked increase in dopamine levels result in the “high” 
experienced by individuals who use the substance (Ernst, Chang, Leonido-Yee & Speck, 2000). In 
order to reproduce the same intense feeling of pleasure, after dopamine stores have been depleted, 
a higher dose of MA is required. Long term high dose use of MA results in a severe depletion of 
dopamine, leading to depression, fatigue, and anhedonia. MA is then needed in order for the brain 
to produce enough dopamine for the individual to feel normal; hence, the highly addictive nature of 
the drug (Barr et al., 2006).  
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In addition, MA has a substantially greater elimination half-life than other psycho-stimulant drugs, 
such as cocaine. This leads to behavioural and psychological effects that last significantly longer than 
other drugs (8-13 hrs for MA v. 1-3 hrs for cocaine; Barr et al., 2006; Scott et al., 2007). The effects 
from smoking MA are instantaneous and result in a number of acute effects on the sympathetic 
branch of the autonomic nervous system, including hypertension, tachycardia, hyperthermia, 
increased breathing rate, and constriction of blood vessels. Scott et al. (2007) adds to these acute 
effects feelings of euphoria and alertness, increased libido and a decrease in appetite. These acute 
effects can last anything between 4 and 24 hours (Ernst et al., 2000). Chronic use, which involves 
binge use where the drug is administered repeatedly over a few hours or even days, can lead to 
highly elevated blood concentrations of the drug (Scott et al., 2007). Moreover, due to the relatively 
high lipid solubility of MA, the drug is transferred rapidly across the blood-brain barrier (Barr et al., 
2006). As a result, long term exposure to MA may result in profound impairments in both the 
neurobiology and structure of the brain, leading to both psychiatric and neuropsychological 
consequences (Scott et al. 2007). While “the mechanisms responsible for amphetamine-induced 
neurotoxicity have not been fully identified” (Berman, O’Neill, Fears, Bartzokis, & London, 2008: p. 
196), it is accepted that this neurotoxicity has been associated with various neuropsychological 
deficits (Nordahl, Salo, & Leamon, 2003) as well as particular abnormal behaviours such as 
psychoses, amongst others (Chang, Alicata, Ernst & Volkow, 2007; Ernst, Chang, Leonido-Yee, & 
Speck, 2000; Jacobs, Fujii, Schiffman & Bello, 2008). 
 
In summary, a brief background of MA has been provided. We now move to review the literature on 
the four core components of the current study in more detail. We start by reviewing the literature 
on the neuropsychological effects of MA and we specifically include an extensive section reviewing 
the literature on executive functioning. Included in this section is a discussion of the frontal cortex 
sub-regions mediating executive functioning. We then review the literature on the psychiatric 
associations with MA. The co-morbidity between MA and ADHD will also be discussed. 
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THE NEUROPSYCHOLOGICAL DEFICITS ASSOCIATED WITH METHAMPHETAMINE AND OTHER 
STIMULANTS 
 
Methamphetamine, cocaine, and other drugs that alter the monoaminergic system, can have a 
significant effect on behavioural and cognitive processes even in the absence of psychosis 
(Fernández-Serrano, Pérez-García, & Verdejo-García, 2011; Nordahl, Salo & Leamon, 2003). 
Specifically psychoactive substance use is associated with neuropsychological deficits in certain 
cognitive domains. Moreover, stimulant dependence (cocaine, methamphetamine, ecstasy, and to a 
lesser extent nicotine and caffeine) is associated with greater neuropsychological impairment than 
alcohol, cannabis or opioid dependence (see van Holst & Schilt (2011) for a review). Some of these 
associations are clearer than others. A number of review articles investigating the neurocognitive 
effects of various substances are discussed below. These articles shed light on what is currently 
known and what needs further investigation.  
 
Spronk, van Wel, Ramaekers & Verkes, (2013) conducted a systematic review of studies on the acute 
and long-term effects of cocaine on cognitive functioning. These authors also performed several 
meta-analyses to compare the magnitude of cognitive effects across different domains. All studies 
published after 2003 were included in the review with a total of 14 acute studies and 63 long-term 
studies. The following cognitive domains were investigated; attention, response inhibition, memory, 
learning, psychomotor performance, cognitive flexibility and decision making. Results from the acute 
studies indicated that cocaine intoxication is associated with improved functioning in response 
inhibition as well as functions that involved a speed component in psychomotor tasks. Long-term 
cocaine use, however, was associated with impairments in most cognitive domains. The most 
significant impairments were found on tasks of sustained attention, response inhibition, memory, 
reward-based decision making and psychomotor performance (Spronk et al., 2013).  
 
The neuropsychological profiles of MA and cocaine are similar (Spronk et al., 2013). While the acute 
effects of single low doses of MA may include improved cognition, long term exposure to MA may 
lead to neuropsychological deficits across several domains (Barr et al., 2006). Fernández-Serrano et 
al. (2011) conducted a systematic review of the literature examining specific versus generalized 
effects of a number of drugs of abuse and their associated neuropsychological effects. Articles 
published between 1999 and 2009 were included in their review. Since most drug users are 
polysubstance users, few studies were reviewed investigating ‘pure’ samples where participants 
used mostly one substance. No studies of ‘pure’ cocaine users were found to meet their inclusion 
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criteria. Three studies investigating the neuropsychological effects of MA were included. These three 
studies are discussed below. 
 
Volkow et al. (2001; as cited in Fernández-Serrano et al., 2011) conducted a PET imaging study 
investigating dopamine-transporter-binding and neuropsychological impairment in 5 MA abusers 
before and after a 12 – 17 month period of abstinence. Retest of cognitive functions showed mild, 
but non-significant improvements in gross motor skills and episodic memory, but persistent 
impairments on fine-grained psychomotor function and executive-based interference during 
memory encoding. Moon et al. (2007; as cited in Fernández-Serrano et al., 2011) investigated verbal 
and visual episodic memory in 19 MA dependent participants with a mean abstinence of 1.79 years 
and 18 non-drug using control participants. It was found that long term abstinent MA users showed 
no impairments on tests of verbal memory, but impairments were observed on tests of visual 
memory. In a more recent study, Salo et al. (2009; as cited in Fernández-Serrano et al., 2011) 
investigated differences in performance on the Stroop task between three participant groups; a 
recently abstinent group (mean abstinence of 2.6 months), a long-term abstinent group (mean 
abstinence 31.5 months) and a non-drug using control group. Results indicated that recently 
abstinent participants showed greater impairments in response inhibition when compared to both 
long-term abstinent participants and non-drug using controls. This indicates that response inhibition 
skills may be recovered with increased duration of abstinence.  
  
Similar results were observed by Johanson et al. (2006). The authors investigated brain function in 
abstinent MA users using neuroimaging and cognitive assessment. Cognitive functions of 16 MA 
users were compared to those of 18 healthy controls. These cognitive functions were assessed using 
a variety of tasks. Estimates of IQ were obtained using the vocabulary and block design subtests of 
the Wechsler Adult Intelligence Scale (WAIS) III (Wechsler, 1997).  Motor performance was 
measured using the finger tapping task, the grooved pegboard and the Digital Symbol Substitution 
Test (DSST; (Wechsler, 1997). The California Verbal Learning Test (CVLT; Delis et al., 1987) and the 
Paired Associates Learning (PAL) task from Cambridge Automated Neuropsychological Assessment 
Battery (CANTAB) were used to assess explicit memory. Working memory was evaluated using 3 
subtests of the CANTAB: the Spatial Working Memory (SWM) task, the Delayed Match to Sample 
(DMS) task and the Rapid Visual Information Processing (RVIP) task. The standard Trail Making Tests 
(parts A and B; Reitan, 1958) as well as two word generation lists were used to assess executive 
function. Two executive function tasks from the CANTAB were also used: the 
Intradimensional/Extradimensional shift task which is a measure of an individual’s ability to attend 
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to specific attributes of compound stimuli and to shift that attention when required, and the 
Stockings of Cambridge task which is a test of spatial planning. MA users had to meet the criteria for 
amphetamine dependence in the past, but had to be in at least early partial remission, with no 
methamphetamine use for at least 3 months.  The authors failed to find significant differences on 
several neuropsychological domains. No differences were observed with regards to motor function, 
one of the two measures of explicit memory, executive functions or working memory. The authors 
suggested that this was partially due to the length of abstinence; that ranging between 3 months 
and 10 years, with an average of 3 years. Length of abstinence should therefore be minimized in 
order to identify neuropsychological deficits (Johanson et al., 2006).  
 
Importantly, however, a meta-analysis examining the neuropsychological domains affected by MA 
use noted significant impairments (Scott et al. 2007). The meta-analysis analyzed 18 studies all 
published prior to January 2007, including 487 participants with methamphetamine 
abuse/dependence and 464 normal control participants. The authors identified contradictory results 
when investigating the acute effects of MA. While some studies found that MA enhanced cognitive 
functioning, other studies reported cognitive deficits associated with acute administration. In terms 
of the long term effects of MA, however, the authors found significant deficits regarding several 
different cognitive processes, including episodic memory, executive functions (e.g., response 
inhibition, novel problem solving), complex information processing speed, and psychomotor 
functions.  These dysfunctions likely reflect alterations in frontostriatal and limbic circuits. Smaller 
effects were evident in attention, working memory, language, and visuoconstruction.  
 
A number of single studies investigating the neuropsychological effects of MA have also emphasized 
inconsistencies (see Simon 2000; Chang, 2002; Gonzalez, 2004; Johanson et al., 2006); and discussed 
the various methodological factors which may contribute to these. Firstly, limited studies have used 
a comprehensive neuropsychological battery in order to assess functioning across a number of 
neuropsychological domains. Moreover, many of these limited studies make use of a variety of 
divergent tests within their batteries and this may have contributed to inconsistent results. 
Secondly, the studies have varied in terms of their sample demographics and the drug use 
characteristics of their participants. While some studies include treatment-seeking participants 
where the range of length of abstinence is wide (see Johanson et al., 2006), other studies include 
participants who are currently using the drug (see Simon et al., 2000).  Results are also confounded 
by numerous common psychiatric (ADHD and depression) conditions (Scott et al., 2007) and various 
other comorbidity profiles. In particular, comorbid ADHD is not well characterized.  
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In addition, further research is required particularly in the area of impulsivity and decision making 
within the MA-dependent population (Scott et al., 2007).  This population has a tendency to display 
risky decision-making and impulsivity. Therefore Scott et al. (2007) suggests a relationship between 
decision-making and executive aspects of working memory deficits. Further suggestion is made that 
the combined deficits of working memory and decision-making may predispose MA users toward 
further risky behaviours such as needle-sharing and unprotected sex. This highlights the importance 
of examining such deficits in future studies (Scott et al., 2007).  
 
In summary, a wide range of neuropsychological domains may be impaired in MA, the most severe 
of those being executive functions. However, no research to-date has investigated executive 
functions comprehensively. The current study therefore aims to address this short-coming, by 
examining deficits in not only working memory or decision-making, but a comprehensive list of 
executive domains. Executive functioning in MA will now be discussed in detail together with the 
frontal cortex sub-regions that mediate these functions. 
 
Executive Functions and Related Brain Regions 
 
“The executive functions of human cognition are among the most interesting processes” (Stuss & 
Alexander, 2000, p. 289), and may be what defines us as uniquely human (Stuss & Levine, 2002). 
Executive functions include all processes of cognitive control; they are attentionally demanding and 
are involved in goal-directed behavior (Garavan & Hester, 2007). Executive functions can be divided 
into inhibition and set-shifting, due to their reliance on attentional processes (Stuss & Levine, 2002) 
attention and working memory (Awh, Vogel & Oh, 2005), and impulsivity and decision-making 
(Monterosso & Ainslie, 1999). Certainly, these domains are interrelated; inhibition and set-shifting 
both require aspects of attention (Stuss & Levine, 2002) and working memory (Chambers, Garavan & 
Bellgrove, 2009), and poor decision-making has been associated with working memory deficits 
(Bechara & Martin, 2004). However, all these processes involve the frontal lobes, particularly, the 
prefrontal cortex (PFC). Disruptions to the prefrontal cortex can lead to a number of pathological 
conditions with cognitive, emotional, behavioural or affective manifestations such as addiction 
(Goldstein, Volkow, Wang, Fowler, & Rajaram, 2001) or ADHD or even schizophrenia (Fuster, 2008). 
The relationship between executive function domains and addiction is complex. Cognitive process 
such as inhibitory and attentional control, behavior monitoring and memory play a significant role in 
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dependence risk (Garavan & Hester 2007), as does decision making (Noël, Bechara, Dan, Hanak, & 
Verbanck, 2007).  
 
Substance dependence is therefore often associated with impairment on tasks of executive 
functions, particularly those relying on different systems within the prefrontal cortex (PFC; Verdejo-
García, Bechara, Recknor & Pérez-García, 2005; Verdejo-García, Rivas-Pérez, López-Torrecillas & 
Pérez-García, 2006), such as decision making and working memory (Gonzalez, Bechara & Martin, 
2007). Moreover, evidence suggests that MA can result in impairments in executive functions. Barr 
et al. (2006, p. 306) suggests that the “most consistent and severe changes (in MA abusing 
individuals) include specific impairments in working memory, attention, and executive functions”. It 
has been hypothesized that these specific impairments were found “due to the denser dopaminergic 
innervation of neural circuits that sub-serve these cognitive processes, including dopamine-rich 
fronto-striatal thalamo-cortical pathways” (Woods, Rippeth, Conover et al., 2005; as cited in Barr et 
al., 2006, p. 306). These impairments differ depending on which one of three systems of the PFC 
have been affected; the dorsolateral prefrontal cortex (DLPFC; Bechara, H. Damasio, and A. Damasio, 
2000; Verdejo-García, Bechara, Recknor & Pérez-García, 2006; Verdejo-García, Rivas-Pérez, López-
Torrecillas & Pérez-García, 2006); the orbitofrontal cortex (OFC; Bechara, H. Damasio, and A. 
Damasio, 2000; Verdejo-García, Bechara, Recknor & Pérez-García, 2005; Verdejo-García, Rivas-Pérez, 
López-Torrecillas & Pérez-García, 2006); or the anterior cingulate cortex (ACC; Verdejo-García, 
Bechara, Recknor & Pérez-García, 2005; Verdejo-García, Rivas-Pérez, López-Torrecillas & Pérez-
García, 2006). These three systems of the PFC in relation to the four domains of executive 
functioning, including verbal fluency, and substance dependence will now be discussed.  
 
Verbal Fluency 
Our study combines verbal fluency with executive functions due to the fact that verbal fluency is 
negatively affected by a lack of cognitive control and has been associated with damage to the left 
frontoparietal cortices, anterior PFC, and insula (Gläscher et al., 2012).Verbal fluency or generativity 
consists of both category or semantic fluency and letter or phonemic fluency and is generally 
considered a measure of language production. While verbal fluency is not commonly considered an 
executive function it has been suggested that phonemic fluency is reliant on executive functions 
(Spreen & Straus, 2008; as cited in Neill, Garvich & Rossell, 2013) and therefore more difficult than 
semantic fluency due to the fact that  it requires a higher level of skill (Neill, Garvich & Rossell, 2013). 
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It has further been suggested that performance on a semantic fluency task requires intact executive 
functions, including task maintenance, working memory, monitoring and inhibition (Lezak et al., 
2004; as cited in Neill, Garvich & Rossell, 2013). There has been much debate in the literature about 
the possibility that semantic fluency is dependent more on executive than semantic skills (Doughty 
and Done, 2009; Neill, Garvich & Rossell, 2013).  
 
Doughty and Done (2009) conducted a systematic review and a series of meta-analyses examining 
semantic memory in schizophrenia. The authors collected 91 articles published prior to October 
2007 that investigated semantic memory in schizophrenia patients using a variety of semantic 
memory tasks such as naming, word-picture matching, verbal fluency, associations, priming and 
categorization. Their results indicated that semantic memory was affected in schizophrenia. They 
further noted that the decline in semantic knowledge in schizophrenia may not explain the semantic 
memory impairment adequately. The authors suggest that this may be due to the executive 
dysfunction that accompanies schizophrenia. Specifically, the meta-analysis that investigated verbal 
fluency measures supported the position that there is a primary executive impairment in 
schizophrenia which is responsible for the poor verbal fluency performance. Since the impairments 
on semantic fluency were similar to those observed on phonemic fluency and category switching, 
the authors suggest executive dysfunction which translates to problems with retrieval as well as a 
reduced store of semantic knowledge (Doughty & Done, 2009).  
 
Verbal fluency impairments have been identified in MA dependence (see for example Kalechstein et 
al., 2003; Simon et al., 2007; Weber et al., 2012). Scott et al. (2007), in their meta-analysis, identified 
moderate language impairments associated with MA users. The authors suggest that this could be 
due to the executive deficits observed earlier in the paper. Verbal fluency requires “rule-guided 
generation of words under time constraints” (Scott et al. 2007, p. 288). Verbal fluency therefore 
requires intact executive functions and any impairment in verbal fluency could be attributed to 
problems with executive or cognitive control of search and retrieval strategies and/or reduced 
processing speeds (Scott et al., 2007).  
 
In an earlier study, Kalechstein et al. (2003) investigated neurocognitive impairment in the initial 
phases of abstinence in MA dependence. The study included 27 MA dependent participants and 18 
normal controls. Participants were tested on a wide range of neurocognitive measures, including 
15 
 
 
executive functions and fluency, attention and psychomotor speed, learning and memory, and 
visuospatial skills. The authors found significant impairments on the majority of neurocognitive 
domains, and of particular interest for our research, verbal fluency in the MA dependent group 
when compared to the normal control group. 
 
More recently, Simon et al. (2010) evaluated the change in cognitive performance over a one month 
period during early abstinence from MA use. A group of 27 MA users were compared to 28 normal 
controls on neurocognitive tests measuring attention and processing speed, learning and memory, 
working memory, timed tasks of executive functions and untimed tasks of executive functions. A 
subsample from each group was tested one month later. A group of MA users who maintained 
abstinence for one month (n = 18) were compared to a group of normal controls (n = 21). Significant 
differences were found at both points of comparison, indicating no significant improvements in 
cognition in the first month of abstinence. Particularly, MA users performed worse than normal 
controls on tasks of verbal fluency. 
 
Verbal fluency has also been associated with a number of psychotic symptoms and has been 
specifically identified as a predictor of psychosis in high risk patients (Becker et al., 2010). Becker et 
al. (2010) investigated verbal fluency in patients at high risk of developing psychosis compared to 
first-episode schizophrenia patients. High risk patients are those who have a history of psychotic-like 
symptoms or have had a psychotic period that spontaneously subsided in less than a week, a family 
member with a first degree psychotic disorder, or the presence of a schizotypal personality disorder. 
The authors found no statistically significant difference between the high risk group and the 
schizophrenia group patient on verbal fluency (specifically, semantic fluency). However, within the 
high risk group statistically significant differences were observed between those who did develop 
psychosis and those who did not develop psychosis. Those who developed psychosis performed 
worse than those who didn’t.  Both groups differed significantly from controls. The authors 
concluded that verbal fluency is impaired before the development of psychosis. It is suggested that 
verbal fluency is a good predictor of the future development of psychosis in patients who are at high 
risk (Becker et al., 2010).  
 
In an earlier study, Riley et al. (2000) investigated neuropsychological functioning in a group of first 
episode schizophrenia patients. The authors compared 40 patients at first presentation of psychotic 
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symptoms to 22 matched controls on a neuropsychological test battery assessing attention, verbal 
learning and memory, spatial ability, psychomotor speed, and executive functions. Verbal fluency 
was included in the executive functions in order to provide a measure of left frontal lobe 
functioning. Significant differences were observed on some tasks of executive functioning, including 
verbal fluency (phonemic and semantic) as well as on verbal learning and memory. Specifically, the 
largest impairments were observed on verbal fluency, particularly semantic fluency. 
 
In summary, there is a strong argument for the approach taken in this thesis, which is to consider 
verbal fluency an executive function (see for e.g. Becker et al., 2010; Kalechstein et al., 2003; Riley et 
al., 2000). As emphasized, verbal fluency is negatively affected by poor cognitive control (Gläscher et 
al., 2012; Scott et al., 2007), an executive function comprising response inhibition and set-shifting. 
These two components of executive functioning are discussed below.  
 
Response Inhibition and Set-Shifting 
Impairment on tasks of response inhibition has been noted in MA (Scott et al. 2007). Inhibition refers 
to the ability to inhibit a thought, feeling or action and is typically assessed using a Stop Signal task, a 
Go/No Go task (Chambers, Garavan & Bellgrove, 2009; Leland, Arce, Miller & Paulus, 2008; Tekin & 
Cummings, 2002) or a Stroop task (Chambers, Garavan & Bellgrove, 2009; Garavan & Hester, 2007) 
or a card-sorting task (Stuss & Levine, 2002), and also draws on working memory (Gläscher et al., 
2012). Both response inhibition and set-shifting rely heavily on attentional processes (Stuss & Levine, 
2002) and have been associated mainly with the DLPFC and the ACC (Gläscher et al., 2012).  
 
Stop Signal Tasks are widely used to measure response inhibition in clinical populations (Chambers 
et al., 2009; Padmala & Pessoa, 2010; Sharp et al., 2010). Delays in stop signal reaction times (SSRTs) 
have been associated with individuals with damage to the right inferior frontal gyrus (IFG), 
particularly the pars opercularis when compared to a normal control group as well as individuals 
with left frontal damage (Aron et al., 2003; as cited in Chambers et al., 2009).  
 
However, other studies indicate that impairments on tasks of response inhibition are associated with 
medial rather than ventral PFC (Dècary & Richer, 1995; Floden & Stuss, 2006; Picton et al., 2007; as 
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cited in Chambers et al., 2009). Impairments on the Go/No Go task have been associated with 
excision of the dorsomedial PFC, including the ACC and the supplementary motor area (SMA; Dècary 
& Richer, 1995; as cited in Chambers et al., 2009). Tekin and Cummings (2002) also suggest that 
dysfunction in the ACC circuitry results in decreased motivation and response inhibition, particularly 
on the Go/No Go task. 
 
Stroop tasks are also widely used to measure response inhibition in clinical populations, including 
drug dependent populations (see Salo, Ursu, Buonocore, Leamon & Carter, 2009). This task 
essentially requires the individual to ignore irrelevant, distracting information; resulting in slower 
responses and reduced accuracy (Garavan & Hester, 2007). It therefore relies on selective attention 
in order to ignore distracting stimuli (Stuss & Levine, 2002). Literature suggests two brain regions 
associated with impairment on the Stroop Task; the ACC (Bench et al. 1993, Pardo et al. 1990; as 
cited in Stuss & Levine, 2002) and the DLPFC (Stuss et al. 2001; as cited in Stuss & Levine, 2002).  
 
The WCST also measures aspects of response inhibition. This task relies on attentional switching or 
set-shifting in order to inhibit perseverative responses. The shifting of responses necessary to 
succeed on the WCST are regarded as extra-dimensional (i.e. across perceptual dimensions, e.g. 
from colour to shape) as opposed to intra-dimensional (i.e. shifting within a perceptual dimension, 
e.g. from red to blue). Extra-dimensional shifting has been associated with the DLPFC (Stuss & Levine 
2002). 
 
The Stroop Task and the WCST were also used to investigate cognitive control by Gläscher et al. 
(2012). Poor performances on response switching and set switching were associated with damage to 
the ACC. Poor performances on the Stroop Task were associated with damage to the left DLPFC. 
 
In addition, Tekin and Cummings (2002) also suggest that the DLPFC is also involved in problem set 
shifting and mental flexibility as well as planning behaviour and problem solving. The authors 
suggest that dysfunction in this circuitry results in an individual unable to direct their attention 
meaningfully and is easily distracted. These individuals often perform poorly on the WCST which 
requires set shifting and strategy generation. They also perform poorly on generativity tasks such as 
verbal and design fluency tasks.  
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There is evidence that response inhibition is impaired in MA-dependence. Scott et al. (2007) 
conducted a meta-analysis of the cognitive functions associated with MA and noted significant 
executive dysfunction, particularly on tasks of response inhibition and set-shifting, specifically the 
Stroop Task and the WCST. A number of single studies have also identified impaired response 
inhibition in MA (Kim et al., 2006; Leland et al., 2008; Monterosso, Aron, Cordova, Xu & London, 
2005; Salo et al., 2002). For example, Salo et al. (2002) hypothesized in their study that MA-
dependent individuals lack the ability to ignore distracting information. The authors used a 
computerized version of the Stroop Task on a group of MA-dependent individuals (n = 8) as well as a 
control group (n = 13) in order to test their hypothesis. Although their sample sizes were small, their 
participants were recruited according to stringent exclusion criteria, thereby minimizing the effects 
of co-morbid psychiatric conditions or other substances on results.  The authors found that MA-
dependent individuals showed slower reaction times than normal controls on interference trials, but 
not on non-interference trials, indicating a response-selection deficit as a result of an impaired 
ability to ignore irrelevant information (Salo et al., 2002).  
 
Similarly, Monterosso, Aron, Cordova, Xu & London (2005) measured response inhibition in MA-
dependence using a Stop Signal task. The authors had 3 groups of participants; a group of MA-
dependent individuals (n = 11) who were abstinent for between 5 and 7 days; and two control 
groups (one smokers (n = 14) and one non-smokers (n = 29)). Stop Signal reaction times (SSRTs) were 
significantly slower for the MA-dependent group than the other two control groups. However 
reaction times for Go trials indicated no statistically significant between group differences, thus 
indicating no impairment in motor speed. In addition, no significant differences were observed with 
discrimination errors, indicating no impairment in decision processes. The authors conclude that a 
specific deficit in inhibition is associated with MA-dependence (Monterosso et al., 2005).  
 
Furthermore, Kim, S. J. et al. (2006) investigated grey matter density changes and performance on 
the WCST in 29 MA dependent participants and compared this to 20 control participants. The 
authors found lower grey-matter density in the right middle frontal cortex and more total errors in 
the WCST in MA abusers compared to controls. A correlation was observed between decreased 
grey-matter density in the right middle frontal cortex and total errors on the WCST. It was also found 
that long-term abstinent MA abusers showed less decrease on grey-matter density and fewer errors 
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than short-term abstinent abusers, indicating that this impairment may be recovered with increased 
duration of abstinence.  
 
More recently, Kim, Y. T. et al. (2009) conducted a study examining whether MA abusers have 
cerebral metabolic abnormalities and executive dysfunction. The authors investigated executive 
functions using the WCST task. Their participants included 24 MA dependent participants and 21 
age-matched control participants. All participants underwent resting-state PET imaging and 
completed a computerized version of the WCST. The authors found that MA dependent participants 
completed fewer categories and made more Perseverative Errors and Total Errors than normal 
control participants. Their data suggest that MA participants have dose-dependent frontal 
hypometabolism and frontal executive dysfunction (Kim, Y. T. et al., 2009).  
 
In addition, Leland et al. (2008) investigated the benefits of predictive cueing on response inhibition 
in MA-dependence. The authors suggested that an inhibitory response is often preceded by a cue 
that doesn’t necessarily require immediate inhibition. To illustrate this point one could think about 
the orange traffic light that precedes a red traffic light, warning one to slow down and stop; or a 
yield sign indicating a potential stop. Cued Go/No Go tasks present stimuli that predict the need to 
inhibit a response before the Go/No Go stimuli are presented. Both response times and response 
accuracy are improved on such cued tasks. The authors wanted to determine whether these cues 
would activate the ACC and therefore result in improved inhibition in MA-dependence. They used a 
cued Go/No Go task, paired with fMRI, with a group of MA-dependent individuals (n = 17) and a 
normal control group (n = 16). All participants were male and were all abstinent at the time of 
scanning. Results indicated two interesting findings. Firstly, MA-dependent individuals showed ACC 
activation in response to the presented cues predicting the need to inhibit a particular response. 
Secondly, it was found that the greater the activation of the ACC, the better their inhibitory 
performance on the trials following the cues. Such results were not observed with the normal 
control group, indicating that cues did not affect their performance (Leland et al. 2008). This cue-
based ACC activation is similar to the error-likelihood hypothesis of Brown and Braver (2005) as 
participants realized the potential for error in the form of inhibitory failure. This activation is also 
consistent with the response-conflict hypothesis of Botvinick et al. (2004), given the cues’ dual role 
of either a “Go” stimulus or a “Cue” stimulus, indicating the likelihood of the following trial being a 
“No Go” trial. 
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In summary, the ability to inhibit a particular response is impaired in MA dependence. It is evident 
that the anterior cingulate cortex plays an important role in this ability (Brown & Braver, 2005; 
Botvinick, Cohen & Carter, 2000; Bush, Luu & Posner, 2000; Gläscher et al., 2012). Therefore any 
disruptions to this frontal sub-region may result in impairment of response inhibition. However, in 
tasks where working memory load is increased, greater dorsolateral prefrontal cortex (DLPFC) 
activation is observed (Hester et al., 2004 as cited in Garavan & Hester, 2007; Tekin & Cummings, 
2002). Working memory and particularly attentional control are particularly important in response 
inhibition and set shifting (Stuss & Levine, 2002). The processes of attention and working memory 
will now be discussed.  
 
Attention and Working memory 
Attention and working memory (WM) seems to be impacted in MA (Scott et al. 2007). The processes 
of attention and working memory are clearly intertwined; however, exactly how these processes 
interact with each other has been the focus of much research in the field of cognitive neuroscience 
(Awh, Vogel & Oh, 2005). Selective attention refers to “goal directed focus on one aspect of the 
environment, while ignoring irrelevant aspects” (Gazzaley & Nobre, 2012, p. 129). Working memory 
on the other hand refers to “maintenance and/or manipulation of task relevant information in mind 
for brief periods of time to guide subsequent behaviour” (Gazzaley & Nobre, 2012, p. 129). Awh et 
al. (2005) suggest that the role of attention is a sort of a “gatekeeper”, determining which items will 
occupy the limited capacity of working memory. The DLPFC plays a significant role in the ability to 
remember facts over short periods of time i.e. working memory (Bechara et al., 2000). The ACC is 
also suggested to play a role in working memory processes (Cazalis et al., 2011; Lenartowicz & 
McIntosh, 2005). 
 
Numerous studies have found WM deficits in MA dependent individuals (Gonzalez, Bechara and 
Martin, 2007; Chang et al., 2002). For example, Chang et al. (2002) conducted a study investigating 
the persistent abnormalities in regional cerebral blood flow and cognitive functions in abstinent 
methamphetamine users. Twenty MA-dependent participants were compared to 20 healthy control 
participants on tests of neuropsychological functioning. Participants were tested on a computerized 
battery of focused and sustained attention as well as tests of psychomotor speed, gross motor 
functioning, verbal memory, and executive functioning. Results indicated that MA-dependent 
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individuals performed similarly to healthy controls, except on tasks of reaction time that required 
working memory (WM). Considering that WM has been shown to involve activation of D1 family 
dopamine receptors (Muly et al., 1998 as cited in Chang et al., 2002), it follows that MA related 
damage to the dopaminergic neurons may affect WM function (Chang et al., 2002).  
 
More recently, Gonzalez, Bechara and Martin (2007) investigated executive functions of individuals 
with different self reported “drugs of choice”; including either methamphetamine or alcohol.  
Seventeen participants identified alcohol as their drug of choice and 16 identified 
methamphetamine as their drug of choice. These two groups were compared to 19 healthy controls 
on two tasks; one testing decision making (Iowa Gambling Task) and one testing WM (a delayed non-
match to sample task). Results showed that the MA users performed significantly poorer than the 
alcohol users and healthy controls on the WM task. However, the gambling task did not yield any 
significant results, except for during the later trials of the task. On analyzing the final few trials, it 
was found that the MA dependent group and the alcohol users made more bad choices when 
compared to healthy controls (Gonzalez, Bechara & Martin, 2007). Working memory of MA users, 
therefore, was more impaired than decision making. 
 
A relationship between working memory and decision making exists. Bechara et al. (2000) saw value 
in investigating whether the cognitive functions relating to WM were different from those relating to 
decision making. The authors found that WM was not dependent on intact decision making abilities, 
but rather, a different relationship was observed. While it is possible to have intact WM in the 
presence or absence of intact decision making, impairments in WM resulted in impairments in 
decision making, revealing an “asymmetrically dependent” relationship (Bechara et al., 2000: p. 
301).  
 
There is literature suggesting that WM is mediated by the DLPFC (Bechara et al., 2000; Tekin & 
Cummings, 2002) and the ACC (Lenartowicz & McIntosh, 2005). Certainly patients with damage to 
the DLPFC have demonstrated working memory impairments.  However, few studies have explored 
the relationship between WM dysfunction and PFC damage in MA dependence. Therefore the 
current study aims to explore this in further depth. 
 
In summary, attention and working memory deficits have been identified in MA dependence, 
however, the majority of studies make this conclusion based on single tasks. Furthermore, working 
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memory seems to be mediated by the DLPFC and possibly the ACC, however, evidence for this 
relationship in MA is lacking in the literature. The current study aims to address these gaps. Decision 
making and impulsivity will now be discussed in more detail. 
 
Decision-Making and Impulsivity 
It has long been established that addiction to substances is associated with impairments in decision-
making (Bechara et al., 2001). Decision-making is a complex process that requires consideration of 
numerous variables (Kennerley & Walton, 2011). A simple decision of where to shop, for example, 
may require an individual to consider multiple variables before making a decision. The decision is 
likely to be influenced by a number of factors such as dietary requirements (vegetarian, halaal), 
dietary goals (saving money, health), food preferences, accessibility etc. It is also likely that the 
decision you make today is different to the one you made yesterday, or will make tomorrow, 
depending on your needs and goals. Therefore there is a valuation process that takes place 
(Kennerley & Walton, 2011). This valuation process needs to be deconstructed in order to measure 
the constructs of decision-making. 
 
Monterosso, Ehrman, Napier, O’brien & Childress (2001) suggest that there are two main variables 
that need to be considered when making a decision; delay and risk. The authors investigated three 
decision making tasks of delay and risk in order to establish whether they examine the same 
construct. They compared a delay discounting task, a gambling task and the Roger’s decision-making 
task. The authors administered these tasks to 32 cocaine-dependent participants. It was found that 
performance on the delay discounting task correlated with performance on the gambling task, 
indicating that these two tasks measure the same construct.  
 
Delay and risk have been consistently associated with frontal brain regions. Specifically, it was 
suggested by Kennerley and Walton (2011) that people with damage to the ventromedial and 
orbitofrontal PFC (VMPFC and OFC, respectively) consistently make poor choices such as investing 
money in risky business ventures. It was further suggested that the ACC also plays a role. While the 
VMPFC and OFC are involved in determining the incentive value of the decision outcome, the ACC 
seems to be involved in tracking the history of choices and integrating this with information 
regarding the current value of the choice. This suggests that the ACC may be necessary for adaptive 
decision-making.  
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Relatively recently, Gläscher et al. (2012) conducted a study investigating cognitive functions 
associated with the PFC, namely cognitive control and decision-making. The authors used voxel-
based lesion-symptom mapping in 344 individuals; 165 of which had lesions to the PFC. These 
individuals were tested on a comprehensive neuropsychological test battery. Four tasks were used 
measuring cognitive control and one task measuring decision-making was used. The results 
pertaining to cognitive control were mentioned above. Value-based decision-making and reward 
learning was measured using the Iowa Gambling Task (IGT). Poor performance on the IGT was 
associated with damage to the ventral sectors of the medial PFC, lateralized to the left. Performance 
on this task was also associated with dorsal sectors of the anterior PFC on the right and with the 
ACC, frontal pole, and the superior and middle frontal gyri, both medially and laterally.  
 
Evidence suggests that stimulant-dependent individuals are less efficient in making-decisions 
because they do not adequately evaluate the potential consequences of the decision (Paulus, 
Hozack, Frank, Brown & Schuckit, 2003). However, the precise nature of decision-making deficits in 
substance abusing populations remains an area of debate (Paulus, Hozack, Frank, Brown & Schuckit, 
2003). While some authors argue that substance abusing individuals show an exaggerated response 
to success (Bechara et al., 2001), others argue that these individuals are less sensitive to negative 
consequences (Lane and Cherek, 2000). In terms of reward and punishment, it seems as though 
these constructs are more effective when they are immediate rather than delayed. 
 
In MA, impairments in decision-making have been noted. Gonzalez, Bechara and Martin (2007) 
investigated working memory and decision making in 33 drug (48%) or alcohol (52%) dependent 
individuals, and 19 controls. The drug of choice was methamphetamine and participants were at 
least 14 days abstinent. Decision-making was measured using the Iowa Gambling Task (IGT). Results 
indicated that MA dependent participants were impaired on both working memory and decision-
making tasks and that both impairments were significantly different from alcohol dependent 
participants and controls. 
 
In a meta-analysis conducted by Scott et al. (2007), mentioned early in this literature review, it was 
found that few studies included a comprehensive neuropsychological test battery and for this 
reason, decision-making and impulsivity were not reviewed in their paper. Based on the evidence for 
such deficits associated with MA (Semple et al., 2005; Hoffman et al., 2006; Gonzalez et al., 2007; 
Monterosso et al., 2007) the authors suggest that any future studies investigating executive brain 
functions should specifically include tasks measuring these two constructs (Scott et al., 2007).  
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Salo (2009; in press) stated, in terms of MA dependence and decision-making, that “impairments in 
this decision-making ability might make them (MA-dependent individuals) more likely to spend a 
paycheck on the immediate satisfaction of getting high rather than on the longer-term satisfaction 
gained by paying rent or buying groceries". This inability to make an informed decision, involving 
adequate premeditation of the consequences associated with that decision is typical in substance 
abusing populations. Both economists and psychologists have an active interest in this particular line 
of research. The general consensus, in terms of decision-making amongst consumers, is that while 
they may act impatiently today, they prefer, or rather plan, to act patiently in the future. For 
example, when an individual is given a choice between R10 today or R11 tomorrow, they may 
choose the smaller immediate amount. However when asked to choose between R10 in a year and 
R11 in a year and one day, they may choose the larger, slightly delayed amount (McClure, Laibson, 
Loewenstein, & Cohen, 2004). A similar pattern of behaviour is present in MA users and is referred 
to as “delay discounting” in the literature. “Delay discounting” refers to a relationship between the 
delay and the value of the reinforcer.  
 
McClure et al. (2004; p. 504) suggests that the “discrepancy between short-run and long-run 
preferences (such as those in delay discounting) reflects the differential activation of distinguishable 
neural systems”. The authors hypothesized that short-run impatience is controlled by the limbic 
system. Long-run patience on the other hand is controlled by the lateral prefrontal cortex and 
associated structures. The authors tested their hypothesis by measuring brain activity of normal 
participants during a task in which they had to make choices between early monetary rewards or 
delayed monetary rewards. The earlier option had a lower value than the delayed option. The 
authors assumed that the more difficult the decision, the greater activation of relevant areas of the 
brain. Their assumptions were confirmed when prefrontal and parietal cortex showed greater 
activation during difficult decisions than other regions of the brain. Furthermore, they found that 
limbic and paralimbic cortical structures were involved when making choices of early rewards, rather 
than delayed rewards. These structures have consistently been associated with impulsive behaviour 
as well as drug dependence where dopaminergic innervation has been disrupted. Impatient 
behaviour thus seems to be driven by the limbic system (McClure et al., 2004).  
 
In an earlier investigation of brain structures associated with delay discounting, Paulus et al. (2002) 
conducted a study examining prefrontal dysfunction in methamphetamine-dependent individuals. A 
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functional neuroimaging study was carried out in order to determine the relationship between 
decision-making dysfunction and neural activation in different prefrontal areas. The authors 
hypothesized that methamphetamine-dependent individuals in early sustained remission show 
decision making dysfunctions that are related to disrupted activation of the orbitofrontal and 
dorsolateral cortices. Participants in their study included a group of ten methamphetamine-
dependent (M-D) adult males as well as a group of control participants. A structured clinical 
interview for a DSM-IV diagnosis (American Psychiatric Association, 1994) and the anti social 
personality disorder (ASPD) segment of the SCID II for personality disorders were conducted on the 
MD group. Individuals with major depressive disorder, bipolar, schizophrenia, post-traumatic stress, 
panic, obsessive-compulsive disorder or ASPD as well as individuals exhibiting current signs of 
withdrawal as indicated by the presence of at least two DSM IV withdrawal signs were excluded 
from the study. Participants were abstinent from methamphetamine for an average of 22.4 days (+/- 
3.5 days), at the time of testing. A two-choice prediction task was administered to all participants to 
determine the response characteristics in decision-making situations with uncertain outcome as well 
as a two-choice response task. The main difference between these two tasks is that during the two-
choice prediction task, the participant does not know the correct response in advance. The only 
information that the participant may use to guide their current response is the sequence of previous 
responses and outcomes. In comparison, during the two-choice response task, the participant knows 
the correct answer before selecting a response. Magnetic resonance images were obtained from all 
participants.  
 
Results yielded five main results. Firstly, methamphetamine-dependent participants relative to 
controls relied more on an outcome-dependent strategy during the two-choice prediction task than 
the controls. This indicates that MD participants are more driven by the previous outcome of a 
response than normal control participants. Secondly, as duration of abstinence increased in the MD 
group, the degree of behavioural difference between these two groups diminished, indicating the 
possibility that this behaviour change could be temporary. Thirdly, the MD group similarly to 
controls exhibited task-related activation in bilateral prefrontal, parietal, and insula cortices. 
However, they showed less inferior prefrontal task-related activation. Fourth, MD participants did 
not show task-related activation in left prefrontal cortex, bilateral ventromedial prefrontal cortex or 
right orbitofrontal cortex. These results were expected given that these areas are critical for 
decision-making. Fifth, it was found that activation in the right orbitofrontal cortex was a good 
predictor of the duration of methamphetamine use (Paulus et al., 2002). However, given the small 
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sample sizes of this study (n = 10) and that the samples consisted only of males, the extent to which 
the results can be interpreted is limited. The authors conclude that immediate outcomes more often 
drive decision-making behaviour in MA-dependent individuals, relative to controls. MA-dependent 
individuals also show less task-related activation of the DLPFC and the OFC; this reduced activation 
was not related to length of abstinence. Therefore, chronic use of MA may lead to long-lasting 
effects on decision-making, consistent with changes in activity in the OFC (Paulus et al., 2002).  
 
Similarly, Monterosso et al. (2007), conducted research exploring the neuropsychological substrates 
that underlie performance on a delay discounting task. The clinical literature thus far suggests that 
the neural substrates that are most likely to play a role in the valuation of delayed rewards involve 
the ventromedial prefrontal cortex (VMPFC), including the orbitofrontal cortex (OFC). The authors 
therefore designed a study to investigate the neural basis of delay discounting in MA dependent 
individuals. The study involved two parts. Firstly the authors assessed delay discounting in a group of 
MA dependent participants and then compared these results to those of healthy control participants 
who were not drug-dependent or drug-abusing (with exception to light marijuana abuse). Secondly, 
the authors used a variant of the task used in the first part of the study for an fMRI component 
comparing MA-dependent participants (n=12) to the control participants (n=17). It was hypothesized 
that the MA-dependent group would show greater delay discounting than the control group and 
that this finding would be paired with “less task-related signal change in the prefrontal cortex in the 
MA-dependent group” (Monterosso et al. 2007; p. 385). Participants in the MA-dependent group 
had to meet the DSM IV criteria for MA dependence. Participants were excluded if they met the 
criteria for any other current axis I diagnoses, except nicotine dependence. Participants were also 
excluded if they tested positive for any drugs other than MA and marijuana.  
 
Participants performed a delay discounting task outside the scanner which was presented on a 
computer screen. The task required participants to choose between smaller immediate rewards and 
larger delayed rewards. Once participants had completed the pre-scanning DD task they then 
entered the scanner and completed an fMRI choice probe task. Results from the Monterosso et al. 
(2007) study indicated that MA abusers discounted more often than normal control participants. 
This difference was apparent even though the control group did not exclude cigarette smokers, a 
population that is known to exhibit considerably higher levels of delay discounting than non-smoking 
individuals.  
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In terms of neural recruitment patterns during the delay discounting task, Monterosso et al. (2007) 
found robust bilateral recruitment of the intraparietal sulcus (IPS). The authors suggested that this 
may be due to the fact that the task requires both a calculation component and a response selection 
component. Participants therefore need to combine the two types of information (delay and 
amount) and then compare the alternatives in order to make a decision. Lesion and imaging studies 
suggest that the IPS is involved in numerical calculations. This finding is consistent with McClure et 
al. (2004) who suggested frontoparietal cortex involvement in choices involving immediate 
alternatives. Furthermore, the authors also observed activation of the dorsolateral prefrontal cortex 
(DLPFC). This area of the brain is associated with working memory, a key component of delay 
discounting.  
 
However, when comparing the two participant groups the authors did not observe reduced task-
related activation of the frontoparietal network of MA abusers during the task, as would be 
expected. They did, however, observe between group differences regarding the hard-choice versus 
easy-choice paradigms. There were two clusters where these changes were evident; one in the left 
DLPFC and another in the right posterior parietal cortex. Although these were the only differences 
that were significant, a similar pattern of signal change was observed in all regions recruited by the 
task. This pattern of neural activation being greater in response to hard choices than easy choices 
was generally more robust in control participants than MA abusers. This result is similar to that 
found by McClure (2004). However, Monterosso et al. (2007) did not observe activation of the limbic 
and paralimbic systems, as did McClure (2004). A possible reason for this is that the choices used in 
the Monterosso et al. (2007) study were purely hypothetical and this could have minimized the 
limbic recruitment in such choices.  
 
The authors performed a correlational analysis between activation and delay discounting. Results 
did not reveal any relationship between either the hard-choice versus no-choice paradigm or the 
hard-choice versus easy-choice paradigm and individual level of delay discounting. The latter being 
of particular interest as this would suggest that the observed group differences in activation, 
associated with this paradigm, are not in fact related to behavioural group differences in delay 
discounting of MA abusers. This finding would therefore suggest that the apparent inefficiency in 
neural response observed in MA abusers is not related to the tendency toward greater delay 
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discounting (Monterosso et al., 2007). However the authors note that a larger sample size may 
reveal such a relationship. 
 
More recently, Hoffman et al. (2008) conducted a study investigating neural correlates of delay 
discounting (DD) in recently abstinent MA-dependent adults. The authors examined the cortical and 
sub-cortical activity associated with DD in patients recently (2-8 weeks) abstinent from MA and in a 
matched sample of healthy controls, using fMRI. The authors hypothesized that DD choices would 
activate the dorsolateral prefrontal cortex (DLPFC), the orbitofrontal cortex (OFC) and the posterior 
parietal cortex (PPC) more than control choices, in both groups. In addition to this they expected 
that choices of immediate vs. delayed rewards would activate ventral striatum and sub-genual 
anterior cingulate cortex (ACC). Finally, the authors “hypothesized that increased discounting in the 
MA group relative to the control group would be reflected in increased activity in the affective circuit 
due to overvaluation of immediate rewards and decreased activity in the cognitive circuit due to 
difficulty making comparisons” (Hoffman, 2008; p. 184). 
 
The Hoffman et al. (2008) study included two participant groups; an MA-dependent group (n=19), 
and a healthy control group (n=17). MA-dependent participants reported using at least 0.5g of MA 
per day over 5 days per week for the past year. Each participant was interviewed and diagnosed 
using the Structured Clinical Interview of the DSM-IV (APA, 2000) in order to establish a diagnosis for 
MA-dependence and confirm the absence of disqualifying psychiatric disorders. The DD task was 
performed in the fMRI scanner and took the form of a forced-choice block design task. The task 
consisted of eight DD blocks alternated with 8 magnitude-estimation (ME) control blocks. Each block 
contained 10 trials resulting in a total of 80 ME and 80 DD trials per run for two runs. DD trials 
presented the participants with two choices; a delayed reward and an immediate reward. The ME 
trials, which served as the control condition, consisted of two choices in which either the delay or 
the reward was held constant. Each participant was presented with 160 immediate and delayed 
reward pairs in pseudorandom sequence.  
 
Results from their study indicated that MA participants discounted more heavily than the non-drug 
addicted control participants. Greatest activation was associated with hard DD choices bilaterally in 
the middle cingulate, posterior parietal cortex (PPC), and the right rostral insula. Control participants 
displayed more activation than MA participants bilaterally in the precuneus and the right caudate 
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nucleus, anterior cingulate cortex (ACC), and the dorsolateral prefrontal cortex (DLPFC). Degree of 
discounting was correlated with the activity in the amygdale, DLPFC, posterior cingulate cortex and 
PPC. The authors concluded that MA addicted individuals who strongly prefer smaller immediate 
over larger delayed rewards, activate the dorsal cognitive control system in order to overcome their 
preference. Amygdala activation during choice of delayed reward was associated a greater degree of 
discounting. This suggests that heavily discounting MA-dependent individuals may be more 
responsive to the negative attributes of delayed rewards than non-drug addicted individuals 
(Hoffman et al., 2008). 
 
While it seems that the majority of studies have indicated that MA-dependent individuals discount 
more often than controls, the mechanism behind delay-discounting is an area of debate. While 
McClure et al. (2004) observed limbic and paralimbic activation, Monterosso et al. (2007) did not. 
While Monterosso et al. (2007) did not observe decreased activation of the fronto-parietal network 
as one would expect, Paulus et al. (2002) observed less inferior prefrontal task-related activation in 
MA-dependence. Therefore more clarity on the neural correlates associated with delay-discounting 
is required, particularly in MA-dependence. The present study aims to investigate the prefrontal 
brain regions that correlated with executive brain functions in methamphetamine dependence.  
 
It has been hypothesized that delay discounting forms the primary basis of impulsivity (Ainslie, 
1975). Impulsivity plays a significant role in both our understanding and the diagnosis of various 
forms of psychopathology. There is an entire section of the DSM-IV (American Psychiatric 
Association, 2000) dedicated to impulse-control disorders such as, intermittent explosive disorder, 
kleptomania and pyromania. Furthermore, impulsivity appears in the diagnostic criteria for a variety 
of psychiatric disorders such as, borderline personality disorder, antisocial personality disorder, 
attention deficit/hyperactivity disorder, mania, dementia, bulimia nervosa, and the paraphilias and, 
of particular importance to the current study, substance use disorders. Therefore research on 
substance use disorders must take into account the impact of impulsivity on neuropsychological 
functioning.  
 
Impulsivity is predominant among users of various substances, including alcohol, cocaine and 
amphetamines. Moreover, it is considered a risk factor for the development of alcohol and 
substance abuse and dependence and is also a predictor of poorer treatment results for substance-
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dependent individuals. Impulsivity is a personality trait that is clinically important in terms of both 
understanding and intervening with drug users (Semple, Zians, Grant, & Patterson, 2005) as it can 
lead to a number of maladaptive behaviours such as polysubstance use, binge drug use, unprotected 
sex, needle sharing and suicidal behaviour (Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia, 2007). 
 
Impulsivity is a multidimensional construct. Traditional personality theories view impulsivity as a 
thrill or sensation-seeking construct that involves a lack of planning, prompting an individual to act 
on feelings of the moment without regard for rules and regulations (Whiteside & Lynam, 2001). 
While Moeller et al. (2001, p. 1784) has provided an appropriate definition of impulsivity as “a 
predisposition toward rapid, unplanned reactions to internal or external stimuli without regard to 
the negative consequences of these reactions to themselves or to others”, there still remains little 
consensus among researchers regarding the definition and measurement of impulsivity (Semple et 
al., 2005).  
 
Semple et al. suggested that in 2005 there were few studies that examined the relationship between 
MA and impulsivity. The authors concluded that this relationship needed further investigation, given 
the clinical implications. They suggested that patient screening and assessment of impulsivity could 
identify patients who are at risk of developing a substance use disorder or are likely to engage in 
high risk sexual behaviour. This knowledge could also assist drug treatment or rehabilitation 
programs as well as intervention programs aimed at reducing high risk sexual behaviours. The 
authors therefore decided to explore this relationship further in a sample of 385 males and females 
currently using MA. They examine impulsivity in terms of personal and social resources, substance 
use, sexual risk behaviour, and psychiatric health. The authors hypothesized that participants who 
scored high on self-report measures of impulsivity would also have fewer personal and social 
resources, consume larger amounts of MA, exhibit high risk sexual behaviours and exhibit worse 
psychiatric health. Results showed that two background characteristics were shown to be associated 
with high levels of impulsivity namely, age and education. Younger participants and less educated 
participants were shown to have higher levels of impulsivity. A positive relationship was also 
observed between quantity of MA used and impulsivity. Higher doses of MA were associated with 
higher levels of impulsivity. The high impulsivity group also had significantly more sex partners and 
significantly more unprotected sex acts than the low impulsivity group. A strong positive correlation 
was also noted between depression and impulsivity. The authors proved that substance using 
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individuals show high levels of impulsivity that are linked with various other negative factors 
associated with substance use. The current study therefore aims to explore impulsivity further using 
a delay discounting task. 
 
In summary, there is evidence for an association between MA dependence and decision making 
deficits. However, Scott et al. (2007) suggests this relationship needs further investigation. There 
also exists debate around the exact nature of decision making deficits in MA and it is for these 
reasons that we will investigate this further. Decision-making has been assessed either using a 
gambling task or a delay discounting task. Our aim is to include a variety of tasks in our study in 
order to fully assess the nature of decision-making deficits in our sample. Furthermore, the OFC and 
ACC have been found to mediate decision-making. However, cortical thickness of these frontal sub-
regions has not been investigated in relation to executive functioning in MA dependence. The 
current study aims to address this gap. We now move to review, briefly, the literature on the 
relationship between impulsivity, ADHD and methamphetamine. 
 
THE RELATIONSHIP BETWEEN IMPULSIVITY, ADHD, AND METHAMPHETAMINE 
 
Impulsivity is one of three distinct characteristic of attention deficit/hyperactivity disorder (ADHD), 
together with hyperactivity and inattention. Individuals who are diagnosed with ADHD are at 
increased risk for substance use disorder (SUD; Biederman et al., 1998; Matsumoto et al., 2005; 
Wilens et al., 1997). Biederman et al. (1998) found that ADHD is associated with a twofold increased 
risk for SUD. This association has numerous clinical, scientific and public health implications (Wilens 
et al. 1997). Clinically, early detection of developing drug dependence in high risk ADHD adolescents 
could lead to effective early intervention strategies. Thus, preventive programs could be developed, 
aimed at adolescents with ADHD, years before the onset of SUD (Wilens et al. 1997). Treating 
adolescent ADHD can therefore help prevent the development of SUD (Wilson et al., 2005). 
Moreover, ADHD can play a pivotal role in the pathogenesis and maintenance of SUD (Wilson et al., 
2005) and evidence suggests high rates of comorbidity between ADHD and MA dependence, in 
particular (Duarte, Woods, Rooney, Atkinson & Grant, 2011; Jaffe at al., 2005; Obermeit et al., 2013).  
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The neuropathogenesis of ADHD is not well understood, however, it is presently conceptualized as a 
disorder resulting from hypoactivity in the dopaminergic systems and possibly an imbalance in the 
noradrenergic systems (Biederman, 2005; di Michele et al., 2005). Therefore, neuropsychological 
disturbances would be characteristic of an underlying fronto-striatal pathophysiology (Hervey et al., 
2004). Moreover, similar to MA, current pharmacologic treatments for ADHD target dopaminergic 
systems and block the reuptake of dopamine and norepinephrine. As a result, individuals with ADHD 
may experience more beneficial effects from initial MA use which may then lead to repeated use 
and thus dependence (Jaffe et al., 2005). It is therefore unknown whether MA use results in a similar 
symptom profile to ADHD, or whether individuals with these symptoms have a predisposition for MA 
dependence, due to its initial “self-medicating” effects. It has also been suggested that ADHD is a 
significant predictor of MA-induced psychosis (Fujii, 2002; Salo et al., 2013). The current study aims 
to investigate the co-morbidity of MA use and ADHD. We now move to review the literature on the 
psychiatric associations with MA. 
 
METHAMPHETAMINE-INDUCED PSYCHOTIC DISORDER 
 
Substance-induced psychotic disorder (SIPD) can be attributed to the use of a variety of legal and 
illegal substances such as alcohol, cannabis, cocaine, heroin and methamphetamine. SIPD as a result 
of methamphetamine is associated with chronic, high doses and/or continuous use (see Grant et al., 
(2011) for a review on MA Psychosis). Dependent methamphetamine users are at a particularly high 
risk of developing psychosis (McKetin et al., 2006). A study conducted by Srisurapanont et al. (2003) 
found both positive and (to a lesser extend) negative symptoms associated with MA psychosis. 
Positive symptoms include delusions, hallucinations and incoherent speech. Negative symptoms 
include poverty of speech, psychomotor retardation and flattened affect (Srisurapanont et al., 2003). 
Other psychiatric sequelae associated with MA psychosis include anxiety, paranoia, and delirium. 
Depression accompanies withdrawal when MA use ceases (Harris & Bakti, 2000 as cited in Scott et 
al., 2007).    
 
McKetin et al. (2006) examined the prevalence of psychotic symptoms among regular MA users in 
Australia. The authors found that 18% of their sample showed clinically significant symptoms of 
psychosis; excluding those with a history of schizophrenia or any other psychotic disorders. This 
indicates a high prevalence of psychotic symptoms among regular MA users. In addition it was found 
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that MA abusers were 13 times more likely to develop psychotic symptoms when compared to the 
general population (McKetin et al., 2006).  
 
Literature examining MA psychosis in South Africa is scarce (Vos, Cloete, Le Roux, Kidd, Jordaan, 
2010). The number of psychiatric admissions due to MA use in the Western Cape increased 
significantly between 2002 and 2006. Vos et al. (2010) completed a retrospective study investigating 
admission numbers of adult and adolescent substance users in the first half of 2002, compared to 
those in the first half of 2006. Results indicated zero psychiatric admissions due to MA use in 2002. 
This number increased in 2006, with a total of 37% of admissions due to MA use. Demographic 
information obtained from the sample in 2006 indicated that the majority of admissions were male 
(64%), single (100%), unemployed (93%) and the mean age at admission was 22 years. The authors 
concluded that MA-related psychiatric hospital admissions reflect an increasing trend; consistent 
with the reported increase in demand for treatment at community drug treatment centers in Cape 
Town (Vos et al., 2010). 
 
There are a number of risk factors that influence the development of a psychotic disorder secondary 
to methamphetamine abuse or dependence. In particular, individuals with a premorbid neurological 
condition may be at greater risk (Fujii, 2002; Salo et al., 2013). Fujii (2002) examined this hypothesis 
by reviewing 29 inpatients of Hawaii state hospital for history of traumatic brain injury, learning 
disabilities, birth complications, or soft neurological signs. It was found that 19 out of 29 inpatients 
demonstrated one or more of the above during childhood. In particular, a large number of these 
inpatients were diagnosed with ADHD. Similarly, in a more recent study, Salo et al. (2013) 
investigated the possibility ADHD-relevant childhood behaviours as a predictor of later MA psychosis 
in adulthood. The authors included a total of 190 MA using participants in their study; 145 of which 
reported symptoms associated with MA psychosis and 45 did not. All participants completed the 
Wender Utah Rating Scale (WURS) which retrospectively assesses ADHD-relevant childhood 
behaviours and symptoms in adults. The authors found a significant positive correlation between 
frequency of MA-related psychotic episodes and scores of the WURS (Salo et al., 2013). Previous 
neurological disorders such as ADHD, therefore, may be a risk factor for developing treatment-
resistant psychosis in MA abusers (Fujii, 2002; Salo et al., 2013).  
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Considering that MA psychosis is often resistant to treatment, patients with this disorder are often 
misdiagnosed as having schizophrenia (Fujii, 2002). This is because MA psychosis presents similarly 
to paranoid schizophrenia (Jacobs et al., 2008). These similarities are expected given the effect of 
MA on dopamine and the dopamine hypothesis of schizophrenia (Baumeister & Francis, 2002). The 
similarities between the neuropsychological profiles of both paranoid schizophrenia and MA 
psychosis were investigated by Jacobs et al. (2008), as compromised neurocognition is a core feature 
of both schizophrenia and MA psychosis (Mesholam-Gately, Giuliano, Goff, Faraone and Seidman, 
2009). The authors suggested that while both the literature on the neurocognition of schizophrenia 
and the literature on the neurocognition of MA dependence had been extensively studied, no 
studies had been conducted on MA psychosis at that time. The authors therefore compared a group 
of inpatients with paranoid schizophrenia at a state hospital in Hawaii (n = 19) to a group of 
inpatients with MA psychosis (n = 20) on a range of neuropsychological tasks including a number of 
tests of executive functioning, such as the Wisconsin Card Sorting Task, the DKEFS colour word 
interference subtest. This is the first such study comparing these two population groups. The 
authors found no significant differences between the two groups on any domains of executive 
functioning. The authors suggest that “the similarities in presentation between MA psychosis and 
paranoid schizophrenia extend to neurocognition and allude to a common underlying 
pathophysiology” (Jacobs et al., 2008: p. 102). Therefore the neurocognition of schizophrenia will 
now be discussed. Given the minimal number of studies investigating the neuropsychological deficits 
associated with MA psychosis, the evidence presented below may assist in identifying the nature of 
such deficits. 
 
Mesholam-Gately et al. (2009) conducted a meta-analysis of neurocognitive findings from 47 studies 
of first episode schizophrenia published from 1994 to 2008. The meta-analysis used 43 separate 
samples including 2204 first episode patients and 2775 largely age- and gender-matched control 
participants. Significant impairments across 10 neurocognitive domains were observed in the 
samples of first episode schizophrenics. Findings indicated that these impairments observed during 
first episodes, are similar to those observed in well established illness. The most severe impairments 
were observed in immediate verbal memory and processing speed. However, neurocognition 
seemed to be impaired across all 10 domains, indicating generalised neurocognitive impairment. 
Executive functions were assessed using only a few outcome measures of the Wisconsin Card Sorting 
Task. While significant impairments were observed, it is certainly challenging to draw conclusions 
based on evidence from just one task of executive functions and studies investigating executive 
functions using larger neuropsychological test batteries are required. It was noted that general 
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cognitive ability, as assessed by means of IQ scores, was found to be considerably worse in first 
episode schizophrenia, when compared to IQ observed before frank illness onset. This indicates a 
decline in cognition between the premorbid and first episode stages of schizophrenia (Mesholam-
Gately et al., 2009). Thus, similar trends may be observed in the onset of MA psychosis.  
 
Executive functioning impairments were also emphasized by Bilder et al. (2000) who conducted a 
study investigating the neuropsychology of first episode schizophrenia. The authors administered a 
comprehensive neuropsychological test battery to 94 individuals with first-episode schizophrenia as 
well as to a group of 36 healthy volunteers. The neuropsychological test battery evaluated the 
following domains:  language, memory, attentional, executive, motor, and visuospatial abilities. 
Results indicated a relatively non-specific deficit pattern, reflecting disturbances in key systems 
(mesencephalic, diencephalic, limbic or frontal functional systems). However, statistically significant 
impairments were found on memory and executive functions, when compared to other domains 
such as language and visuospatial abilities. Particularly, the most severe deficits were observed on 
tasks of attention and executive functions (Bilder et al., 2000).  
 
In summary, it has been observed that certain symptoms associated with MA are seen also in 
schizophrenia (e.g. paranoid delusions). This likely reflects an overlap in underlying mechanisms, and 
therefore in neuropsychology (Salo et al., 2002). Indeed, it has been observed that the 
neuropsychological profile of schizophrenia is similar to that observed in MA psychosis (Jacobs et al., 
2008). Given that the most severely affected domain in schizophrenia is that of executive functions 
(Bilder et al. 2000), it may therefore be hypothesized that the most severely affected domain in MA 
psychosis will also be executive functions. Given the evidence presented above it is also likely that a 
decline in cognition will be observed in MA psychosis, when compared to MA dependence. 
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SUMMARY 
 
The literature review has identified four key areas that need further investigation. These are listed 
and summarized below. A research question pertaining to each section is posed. Specific hypotheses 
are presented below. 
 
1. Methamphetamine and executive functions 
Chronic use of methamphetamine has been associated with neurotoxicity (Barr et al., 2006; Berman 
et al., 2008; Nordahl et al., 2003; Scott et al., 2007) and structural abnormalities in the brain 
(Hoffman, 2008; McClure et al., 2004; Monterosso et al., 2007; Paulus et al., 2002). These structural 
abnormalities result in various neuropsychological sequelae (Barr et al., 2006; Hoffman, 2008; 
McClure et al., 2004; Monterosso et al., 2007; Paulus et al., 2002; Nordahl, Salo & Leamon, 2003; 
Scott et al., 2007). Currently, research investigating these neuropsychological sequelae has provided 
inconsistent results. These studies state different findings with regards to the nature of the 
neuropsychological impairments. Therefore further research is needed in order to address this issue. 
Specifically, many studies suggest that executive functions are most often and most severely 
affected by MA (Barr et al., 2006; Bechara et al., 2001; Chang et al., 2002; Gonzalez, Bechara & 
Martin, 2007; Paulus, Hozack, Frank, Brown & Schuckit, 2003; Verdejo-García, Bechara, Recknor & 
Pérez-García, 2005).  However, previous studies have based their findings on only one or two tasks 
of executive functioning. No studies to date have comprehensively explored executive functions in 
MA dependence. The present study therefore aims to address this shortcoming by investigating 
executive functions by means of a comprehensive neuropsychological test battery, covering the 
domains of attention and working memory, decision making and impulsivity, response inhibition, 
and verbal fluency.  
 
Research Question: Are executive functions impaired in MA? And if so which of the four domains 
shows the most severe impairment? 
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2. Methamphetamine-induced psychotic disorder 
Moreover, substance-induced psychotic disorder as a result of MA abuse in an under-researched 
topic, particularly in South Africa, where prevalence rates and economic costs are high. Specifically, 
neuropsychological data on this population is South Africa is lacking. The present study aims to 
address this shortcoming in providing data on the neuropsychological sequelae associated with MA 
psychosis. Particularly, the study aims to draw on comparisons between MA dependence with a 
history of psychosis and MA dependence without a history of psychosis in an attempt to improve 
understanding of these populations from a neuropsychological point of view; thus potentially 
informing and improving behavioural therapies. 
 
Research Question: Are executive functions more severely impaired in MA Dependence with a 
history of psychosis compared to MA Dependence without a history of psychosis? 
 
 
 
3. Co-morbidity of ADHD in methamphetamine 
Furthermore, given the high comorbidity of ADHD and substance dependence (Biederman et al., 
1998; Jaffe et al., 2005; Matsumoto et al., 2005; Wilens et al., 1997; Wilson et al., 2005), the present 
study aims to investigate the relationship between symptoms of ADHD and executive functioning 
within MA dependence. ADHD is a potential risk factor for the development of a substance use 
disorder. Identifying risk factors can aid in identifying high risk groups, and therefore aid in the 
prevention of MA dependence in South Africa.  
 
Research Question: Are symptoms of ADHD found to be co-morbid in our MA groups and if so, how 
do these relate to any executive impairment found? 
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4. The correlation between executive functions and prefrontal cortex 
Finally, the present study also aims to correlate cortical thickness of frontal cortex sub-regions with 
neuropsychological deficits, specifically executive dysfunction. Previous research investigating 
methamphetamine dependence, neuropsychological functioning, and brain imaging has examined 
either regional cerebral blood flow (Chang et al. 2002), morphometric changes (Chang et al. 2005) or 
conducted fMRI studies investigating performance of single cognitive tasks (Monterosso et al. 2007; 
Paulus et al. 2002, 2003). Thompson et al. (2004) mapped regional brain abnormalities and 
correlated this data with memory performance. However, there are few studies that have 
performed such correlational analyses between MRI and neuropsychological data. No such studies, 
to my knowledge have correlated executive functioning data with cortical thickness data in 
methamphetamine dependence, and particularly methamphetamine psychosis. I therefore aim to 
address this gap. In addition, there are some inconsistencies in the literature regarding the exact 
brain structures associated with MA dependence and we aim to add insight here.  
 
Research Question: Is there a correlation between executive impairment and cortical thickness in 
our MA sample? 
 
 
The above research questions will be answered by investigating a number of specific hypotheses. 
These are outlined below. 
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HYPOTHESES 
 
1. Executive function impairments will be observed in the MA groups compared to healthy 
controls on the domains of response inhibition and set-shifting, attention and working 
memory, decision-making and impulsivity, and verbal fluency. 
2. The MA-psychosis group will perform worse than both MA-dependent and NC groups on 
tasks of executive functioning. 
3. Decision making and impulsivity are expected to be positively correlated with structural 
abnormalities in the OFC and the ACC, i.e. greater extent of structural damage in the OFC 
and the ACC will be associated with more severe impairments on tasks of decision making 
and impulsivity. 
4. Working memory is expected to be positively correlated with structural abnormalities in the 
DLPFC, i.e. greater extend of structural damage in the DLPFC will be associated with more 
severe impairments on tasks of WM. 
5. Response Inhibition is expected to be positively correlated with structural abnormalities in 
the ACC, i.e. larger amounts of structural damage in the ACC will be associated with more 
severe impairments on tasks of response inhibition. 
6. Verbal Fluency is expected to be positively correlated with structural abnormalities in the 
anterior PFC and insula, i.e. greater extend of structural damage in the anterior PFC and 
insula will be associated with more severe impairments on tasks of verbal fluency. 
7. Comorbid ADHD has a negative impact on executive functions in this methamphetamine-
dependent sample. 
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CHAPTER THREE: RESEARCH DESIGN AND METHODS 
 
STUDY DESIGN 
 
This empirical study employed a quasi-experimental, controlled design used in order to test specific 
hypotheses. Quasi-experimental designs are those which employ multiple measures or a control 
group without randomly assigning participants to groups. Since quasi-experiments are natural 
experiments, threats to external validity are minimized and generalisability is increased as compared 
to a laboratory setting (Mouton, 2001). The ability of these designs to establish a cause and effect 
relationship is dependent upon the degree to which the two groups in the study are equivalent. In 
this study, participants have been matched as closely as possible in terms of age, gender, level of 
education, employment status, ethnicity, and language. A battery of validated neuropsychological 
tests was administered to all participants as well as a number of questionnaires widely used in 
clinical settings. 
 
The independent variable in this study is related to methamphetamine and is a grouping variable 
that has three levels, namely, methamphetamine dependence with a history of psychosis  i.e., 
substance induced psychotic disorder (MA+), methamphetamine dependence without a history of 
psychosis (MA-) and no methamphetamine i.e. healthy control participants (NC) with no history of 
methamphetamine use. The dependent variables are related to executive functioning, and include 
measures of impulsivity and decision making, inhibition and set shifting, attention and working 
memory, and verbal fluency.  
 
Methamphetamine dependence is defined using the diagnostic criteria of the Diagnostic and 
Statistical Manual of Mental Disorders 4th edition (2000). The substance of choice is from the 
amphetamine class of substances, specifically methamphetamine. According to the DSM-IV-TR the 
criteria for substance dependence are as follows: 
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A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as 
manifested by three (or more) of the following, occurring at any time in the same 12-month period: 
(1) tolerance, as defined by either of the following: 
a. a need for markedly increased amounts of the substance to achieve intoxication or 
desired effect 
b. markedly diminished effect with continued use of the same amount of the substance 
(2) withdrawal, as manifested by either of the following: 
a. the characteristic withdrawal syndrome for the substance 
b. the same (or closely related) substance is taken to relieve or avoid withdrawal 
symptoms 
(3) the substance is taken in larger amounts or over a longer period than was intended 
(4) there is a persistent desire or unsuccessful efforts to cut down or control substance use 
(5) a great deal of time is spent in activities necessary to obtain the substance (e.g., visiting 
multiple doctors or driving long distances), use the substance (e.g., chain smoking), or 
recover from its effects 
(6) important social, occupational, or recreational activities are given up or reduced because of 
substance use 
(7) the substance use is continued despite knowledge of having a persistent or recurrent physical 
or psychological problem that is likely to have been caused or exacerbated by the substance 
  (American Psychiatric Association, 2000) 
 
 
Participants in the clinical groups (methamphetamine groups) had to meet these criteria in order to 
be eligible to take part in this study. Participants who did not meet these criteria and/or met these 
criteria for any other substances (with the exception of nicotine and cannabis) were excluded from 
participation.  
 
In addition, the Methamphetamine Psychosis group of participants had to be diagnosed with 
substance-induced psychotic disorder. The diagnostic criteria for substance induced psychotic 
disorder as set out by the Diagnostic and Statistical Manual of Mental Disorders (American 
Psychiatric Association, 2000) are as follows: 
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A. Prominent hallucinations or delusions 
B. There is evidence from the history, physical examination, or laboratory findings of either (1) 
or (2): 
(1) the symptoms in Criterion A developing during, or within a month of, substance 
intoxication or withdrawal 
(2) medication use is etiologically related to the disturbance 
C. The disturbance is not better accounted for by a Psychotic Disorder that is not substance 
induced. Evidence that the symptoms are better accounted for by a Psychotic Disorder that is 
not substance induced might include the following: the symptoms precede the onset of the 
substance use; the symptoms persist for  substantial period of time (e.g., about a month) 
after the cessation of acute withdrawal or severe intoxication, or are substantially in excess 
of what would be expected given the type or amount of the substance used or the duration 
of use; or there is other evidence that suggests the existence of an independent non-
substance-induced psychotic disorder (e.g., a history of recurrent non-substance-related 
episodes) 
D. The disturbance does not occur exclusively during the course of a delirium 
  (American Psychiatric Association, 2000) 
 
 
The dependent variable, executive functioning, has been operationally defined as those functions 
that are associated with the neural circuits of the prefrontal cortex (PFC). The PFC is strongly 
correlated with the formulation and monitoring of goal directed actions (Stuss & Knight, 2002; 
Roberts et al., 1998; as cited by Verdejo-Garcia, Bechara & Recknor, 2006). There are three 
functional circuits of the PFC, each arguably relevant to specific executive functions, specifically 
working memory and mental flexibility (dorsolateral prefrontal cortex), decision making and emotion 
regulation (orbitofrontal cortex) and response inhibition (anterior cingulate cortex; Verdejo-Garcia, 
Bechara & Recknor, 2006). We have also added verbal fluency to our battery, given its association 
with the frontal cortex (Doughty and Done, 2009; Neill, Garvich & Rossell, 2013).  
 
 
 
 
43 
 
 
PARTICIPANTS 
 
Three groups of participants were recruited to take part in this study: a methamphetamine 
dependent group with a history of psychosis (MA+), a methamphetamine dependent group without 
a history of psychosis (MA-) and a group of non-substance-dependent/abusing healthy control 
participants (NC). A total of 175 participants were recruited for this study; approximately 70 
participants were judged as eligible to take part; out of which 59 took part. The MA+ and control 
groups each contained 20 participants and the MA- group contained 19 participants. The remaining 
116 participants were either not eligible for the study or chose not to complete participation. 
Ineligibility resulted from a number of factors including drug dependence other than 
methamphetamine, co-morbid psychiatric disorders or lack of English proficiency.  
 
Recruitment was carried out through usual clinical activities. Three groups were recruited. First, the 
methamphetamine dependent group with a history of psychosis (particularly first episode) was 
recruited from psychiatric in-patient wards at Groote Schuur Hospital, Valkenberg Psychiatric 
Hospital, Victoria Hospital and Somerset Hospital in Cape Town. These participants met the criteria 
for an Axis I diagnosis of substance induced psychotic disorder (SIPD) according to the structured 
clinical interview for DSM-IV (SCID-IV) as well as the DSM-IV criteria for methamphetamine 
dependence. Their treatment with neuroleptics had not extended past three months at the time of 
testing. Second, non-psychotic methamphetamine dependent participants were recruited from the 
Cape Town Drug Counseling Centre and various other drug counseling centers within the Cape Town 
area that were willing to participate in the study. This sample met the DSM-IV criteria for 
methamphetamine dependence through use of a SCID-IV. These participants did not, however, meet 
the criteria for SIPD according to the SCID-IV. Third the healthy control participants were recruited 
through word of mouth and flyers requesting voluntary participation. These participants did not 
meet the DSM-IV criteria for methamphetamine dependence or SIPD nor any other psychiatric 
disorder.  
 
Testing after a period of drug abstinence also decreases the likelihood that the observed cognitive 
impairment is due to residual drug or withdrawal effects. Since many of our participants were in 
treatment at the time of testing, many of them were still using the drug at the time. We required 
that they remain abstinent for seven days prior to testing; however, this was not always the case. 
Therefore we required that they abstain from using the drug on the day of testing. All participants 
were recruited according to strict inclusion and exclusion criteria. 
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Group 1: Methamphetamine dependence with a history of psychosis (MA+) 
 
Inclusion criteria 
 Chronic diagnosis of MA dependence on the SCID-IV  
 History of experiencing psychotic symptoms lasting at least one week in total and 
associated with methamphetamine use. Psychotic symptoms defined as a minimum 
score of 3 or more on any one of items P1, P2, P3, and G9 of the PANSS rating scale 
 Current drug abstinence (on the day of testing) 
 Age range between 18 and 45 years 
 
Exclusion criteria 
 Substance dependence other than MA (except nicotine and marijuana) 
 Lifetime and current diagnosis of psychiatric disorders (with the exception of a 
substance induced psychotic disorder) 
 History of psychosis prior to MA use 
 Medical or neurological illness or trauma that would affect the central nervous 
system,  
 Reported history of a seropositive test for HIV  
 Severe renal, hepatic, pulmonary, endocrine disease  
 Severe head injury 
 Lack of fluency in English, as this may impair understanding of testing procedures 
 Patients judged to be experiencing substance intoxication or withdrawal delirium 
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Group 2: Methamphetamine Dependence without a history of psychosis (MA-) 
 
Inclusion Criteria 
 Chronic diagnosis of MA dependence on the SCID-IV  
 Current drug abstinence (on the day of testing) 
 Age range between 18 and 45 years 
 
Exclusion Criteria 
 Substance dependence other than MA (except nicotine and marijuana) 
 Lifetime and current diagnosis of psychiatric disorders  
 Medical or neurological illness or trauma that would affect the central nervous 
system,  
 Reported history of a seropositive test for HIV  
 Severe renal, hepatic, pulmonary, endocrine disease  
 Severe head injury 
 Lack of fluency in English, as this may impair understanding of testing procedures 
 Patients judged to be experiencing substance intoxication or withdrawal delirium 
 
Group 3: Healthy Controls (NC) 
 
Inclusion Criteria 
 No evidence of any drug dependency on the SCID-IV  
 Demographic details resembling those of the methamphetamine dependent samples 
 
Exclusion Criteria 
 Substance dependence other than nicotine 
 Lifetime and current diagnosis of psychiatric disorders  
46 
 
 
 Medical or neurological illness or trauma that would affect the central nervous 
system  
 Reported history of a seropositive test for HIV  
 Severe renal, hepatic, pulmonary, endocrine disease  
 Severe head injury 
 Lack of fluency in English, as this may impair understanding of testing procedures 
 Participants judged to be experiencing substance intoxication or withdrawal delirium 
 
The three comparison groups were matched as closely as possible in terms of age, gender, years of 
education and social demographics (see Table 1 and Figures 1-7 below). Participants received 
compensation for participating in this study in the form of food vouchers, which could not be 
exchanged for cigarettes or alcohol. Participants did not receive cash monies for participating in this 
study. Transport was provided for participants by a professional transport service provider, when 
necessary. 
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Table 1. Demographic and Clinical Characteristics for Participants Across all 3 Participant Groups 
Variable                                              MA+ 
(n = 20) 
MA- 
(n = 19) 
NC 
(n = 20) 
    
Age 
Gender (M:F) 
Handedness (R:L) 
Years of Education 
IQ (FSIQ) 
Duration of Abuse (months) 
Duration of Abuse (range) 
Length of Abstinence (days) 
Length of Abstinence (range) 
Quantity Used/Week (grams) 
Quantity Used/Week (range) 
Cigarette smokers % 
Cannabis users % 
25.45 (7.57) 
16:4 
20:0 
9.6 (1.43) 
74.4 (12.7) 
62.33 (38.9) 
12 – 144  
56.2 (53.18) 
0 – 180  
1.4 (1.27)* 
0.25 – 5* 
95% 
100% 
24.0 (3.83) 
17:2 
16:2 
10.68 (2.24) 
79.53 (17.46) 
70.7 (29.1) 
36 – 120  
52.56 (62.20) 
0 – 240  
2.97 (2.45)* 
0.5 – 10* 
84% 
74% 
24.2 (4.32) 
14:6 
19:1 
12.45 (1.61) 
89.65 (16.28) 
--- 
--- 
--- 
--- 
--- 
--- 
50% 
45% 
    
Note: For all variables except gender, handedness and ranges, data presented are means with 
standard deviations in parentheses. MA+ = Methamphetamine dependence with a history of 
psychosis. MA- = Methamphetamine dependence without a history of psychosis. NC = Normal 
Controls 
*These data were gathered by means of self-report interviews and are included only for interest. No 
guarantees can be made that these data are accurate. We were therefore reluctant to include 
‘Quantity’ in any statistical analyses, given that the source of such information is questionable. 
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Figure 2. Population groups present in the MA+ group 
 
Figure 3. Population groups present in the MA- group 
 
Figure 4. Population groups present in the control group 
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Black
White
MA- Group
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Black
White
Control Group
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Black
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Figure 5. Employment status of participants in the MA+ group 
 
Figure 6. Employment status of participants in the MA- group 
 
Figure 7. Employment status of participants in the control group 
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MATERIALS 
 
The following measures were used in the study; screening questionnaire; informed consent sheet; 
demographics, drug use and pre-morbid mental health questionnaire; structured clinical interview 
for DSM-IV (SCID-IV); The Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1997) and a 
neuropsychological test battery including subtests from the CANTAB (Cambridge Cognition) battery 
and the D-KEFS (Delis, Kaplan & Kramer, 2001), The Stroop Task (Stroop, 1935), a Delay Discounting 
Task, The Balloon Analogue Risk Taking Task (Lejuez et al., 2002), The Attention Network Task (Fan et 
al. (2002), Task Switching, and the Wisconsin Card Sorting Task (Psychological Assessment 
Resources, 2003); and an ADHD self report questionnaire (Burke & Austin, 2010). 
 
Demographic and Clinical Questionnaires 
 
Screening Questionnaire (see Appendix A) 
A screening Questionnaire was used to screen potential participants, either in person or 
telephonically in order to decide whether they were eligible to participate in the study. Previous 
head injuries, epilepsy or any other neurological condition would have excluded participants from 
the study. Information such as handedness, metal implants or pregnancy was necessary information 
required before conducting the MRI scans.  
 
Informed consent sheet (see Appendix B) 
A document detailing the purpose of the study as well as the participant’s role in the study was 
presented to each participant, before the commencement of their participation. Their rights and 
responsibilities were explained to them. Participants were made aware that they would not be 
harmed in any way during the study and that they may withdraw without any undue discriminations 
against them as a result of their withdrawal. Their participation was voluntary and they were 
informed that all their information would be kept confidential and their identity would be kept 
anonymous. Participants were required to agree to these terms by signing the informed consent 
sheet before participation. 
 
51 
 
 
Demographics, drug use and pre-morbid mental health questionnaire (see Appendix C) 
Measures of demographics included current age, sex, employment status and number of years of 
education completed, marital status, number of dependents and dwelling types. Drug use measures 
included:  life-time use of all major drug types and days of drug use in the past month by drug type. 
Measures of MA use included the participant’s main route of methamphetamine administration in 
the past year, age of ﬁrst MA use, frequency of MA use in the past year and MA dependence in the 
past year.  A history of mental illnesses was also recorded. 
 
Structured Clinical Interview for DSM-IV (SCID-IV) 
The SCID-IV is a clinician administered semi-structured interview used to diagnose psychiatric 
disorders based on the criteria of the Diagnostic and Statistical Manual (Rodriguez 2004). 
Administration of the SCID will be restricted to the Axis-I psychiatric disorders and Axis-V. 
 
Positive and Negative Syndrome Scale (PANSS) 
The PANSS is a clinician administered scale that determines positive, negative as well as general 
psychopathological symptoms (Kay et al., 1987). This scale measures psychotic and general 
psychopathology on a Likert type continuous scale. As the scale includes general psychopathological 
measures such as anxiety tension and depression, this scale will also be administered to control 
groups without a history of psychosis. 
 
The Wechsler Abbreviated Scale of Intelligence (WASI) 
The WASI is a widely used clinical tool giving an estimate of IQ. It was developed out of the need for 
a short and reliable measure of intelligence in both clinical and research settings. It is designed for 
use with individuals aged from 6 – 89 years. The WASI contains four subtests. Two of these are 
verbal measures, namely vocabulary and similarities, and two of these are performance measures, 
namely block design and matrix reasoning. Raw scores are obtained from these four sections and 
then converted into T-scores from which IQ estimates are made. An individual’s verbal, non-verbal, 
and general cognitive functioning can be estimated in approximately 30 minutes through 
administration of this scale and yields the three conventional verbal, performance and full scale IQ 
scores. The WASI has been used extensively in research, particularly in clinical populations.   
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Neuropsychological Test Battery 
 
The Cambridge Neuropsychological Test Automated Battery (CANTAB)  
The computerized neuropsychological tests in the CANTAB are currently used in more than 50 
countries, with a bibliography of over 500 peer-reviewed journal articles. Johanson et al. (2006) have 
previously used the CANTAB tests in a methamphetamine abusing sample. These widely validated 
tests allow for quick and accurate assessment of many cognitive domains, with excellent sensitivity. 
Furthermore, as no reading or verbal responses are required, the CANTAB tests are well suited for 
cross-cultural administration, particularly valuable for the South African population. Most 
importantly, the battery was developed with the aid of functional neuroimaging techniques; 
therefore, the neuroanatomical regions associated with performance on each subtest within the 
battery have been well defined. All CANTAB tests are administered on a touch screen computer, and 
are presented in the form of games that the examinee must complete. 
 
The CANTAB battery used in the current study consisted of the Big/Little Circle (BLC) task to assess 
basic comprehension; decision making and response control subtests including the  Affective Go/No 
Go (AGN) task, the Cambridge Gambling task (CGT), the Information Sampling Task (IST) and the Stop 
Signal Task (SST);  and the executive functions, working memory and planning subtests including the 
Spatial Span (SSP) task, the Spatial Working Memory (SWM) task and the Reaction Time (RT) task.   
 
          The Big/Little Circle test assesses comprehension, learning and reversal. This task was used to 
assess basic understanding of verbal instruction. It was also used to train participants in the general 
idea of following and reversing a rule, before proceeding to the rest of the CANTAB battery as well as 
a training task to familiarize participants with using a touch screen. The participants were presented 
with a series of paired squares, each one containing a circle; one large and one small. Initially the 
participants were instructed to touch the square containing the smaller of the two circles presented 
on the screen (see Figure 8). Following 20 trials, the participant was then required to change the rule 
and touch the square containing the larger of the two circles presented for a further 20 trials.  
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Figure 8. The BLC task screen 
 
 
 The Affective Go/No Go (AGN) test assesses information processing biases and inhibitory 
control for positive and negative stimuli. During this test, a series of words were rapidly presented in 
the centre of the screen. These words were either positive or happy words (for example, “smile”, 
“stamina”, “terrific”, “optimistic”) or negative or sad words (for example, “dull”, “crying”, “mistake”, 
“hopeless”). The participant was given a target valence and asked to press the button on the press 
pad when they saw a word that matched this valence (see Figure 9).  
 
 
Figure 9. The AGN task screen (positive valence condition) 
 
 
Words were displayed one at a time in the centre of the screen. Each word was displayed for 300ms 
and there was an interval between the words of 900ms. The test consisted of ten 18-word blocks. 
The first two blocks in each test were practice blocks and were therefore not scored. Affective 
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cognitive functions are thought to be related to the ventral and medial-prefrontal cortex areas of the 
brain because of the limbic connections with this region. 
 
 The Cambridge Gambling Task (CGT) was developed to assess decision making and risk 
taking behavior outside of a learning context. Relevant information is presented to the participants 
'up-front' and there is no need to learn or retrieve information over consecutive trials. On each trial, 
participants were presented with a row of ten boxes across the top of the screen, some of which 
were red and some of which were blue. At the bottom of the screen were rectangles containing the 
words ‘Red’ and ‘Blue’. Participants were required to guess whether a yellow token was hidden in a 
red box or a blue box by touching the block containing the corresponding word at the bottom of the 
screen (see Figure 10). In the gambling stages, participants began with a number of points, displayed 
on the screen, and were able to select a proportion of these points (5%, 25%, 50%, 75% or 95%), 
displayed in either increasing or decreasing order, in a second box on the screen, to gamble on their 
confidence in this judgment. A stake box on the screen displayed the current amount of the bet.  
 
 
Figure 10. The CGT task screen for the decision stage 
 
The task consisted of five stages. The first stage was a decision stage only where participants were 
required to decide whether a yellow token was hidden in a red box or a blue box and make their 
choice by touching the appropriate box at the bottom of the screen. The second stage was a training 
stage for gambling with ascending stakes. The participants had to select their colour choice as well 
as indicate the amount they chose to bet by touching the stake box at the appropriate time. If the 
stake box on the screen was not touched, the final value displayed was used. The third stage was a 
test stage for gambling where the participants’ performance was assessed. The fourth stage was a 
55 
 
 
further training stage for gambling. This time the stakes moved in a descending direction. The fifth 
stage was another test stage for gambling, with the stakes moving in the same direction as the 
fourth stage. The participants’ performance was assessed here. The likely neural substrate for this 
task is the orbitofrontal prefrontal cortex.  
 
 The Information Sampling Task (IST) tests impulsivity and decision making. The IST is 
designed to measure pre-decisional processing where the participant gathers and evaluates 
information prior to making a decision. Inadequate reflection means that decisions will be made on 
the basis of less evidence, and, therefore will reduce the accuracy of the eventual decision. 
Participants were presented with a 5x5 array of grey boxes on the screen, and two larger coloured 
panels below these boxes (see Figure 11). Participants were informed that they were playing a game 
for points, which they could win by making a correct decision about which colour is in the majority 
under the grey boxes. They touched the grey boxes one at a time, which then opened up to reveal 
one of the two colours shown at the bottom of the screen. Once a box had been touched, it 
remained open. When the participant had made their decision about which colour was in the 
majority, they touched the panel of that colour at the bottom of the screen to indicate their choice. 
After the participant had indicated their choice, all the remaining grey boxes on the screen revealed 
their colours and a message was displayed to inform the participant whether or not they were 
correct. The colours changed from trial to trial. There were two conditions: the fixed win condition, 
in which the participant was awarded 100 points for a correct decision regardless of the number of 
boxes opened; and the decreasing win condition, in which the number of points that could be won 
for a correct decision started at 250 and decreased by 10 points for every box touched. In either 
condition an incorrect decision costs 100 points.  
 
 
 
Figure 11. The IST task screen showing the training stage 
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 The Stop-Signal Task (SST) is a psychological test that measures a person's response 
inhibition ability. This test consisted of two parts. The task screen showed a white ring, displayed to 
alert the participant, and then a visual stimulus displayed within the ring after a fixed 500ms delay, 
consisting of an arrow pointing to the left or to the right (see Figure 12). The participant is then 
introduced to the press pad, and instructed to press the left hand button when they see a left-
pointing arrow and the right hand button when they see a right-pointing arrow. The first block 
consisted of 16 trials for the participant to practice this. During the second part of the task, the 
participant was told to continue pressing the buttons on the press pad when they saw the arrows, as 
before, but, if they heard an auditory signal (a beep), they should then withhold their response and 
not press the button.  
 
 
Figure 12. The SS task screen 
 
 
The task consisted of 5 assessed blocks, each block containing 64 trials. Each block was divided into 
four sub-blocks of 16 trials for analysis purposes only i.e. there were no gaps between these trials 
and they were not evident to the participant. Each sub-block contained 12 “go” trials with no 
auditory stop signal delay (SSD) period and four “stop’ trials with an auditory stop signal. The 12 go 
trials and four stop trials were given in a random order within each sub-block, but all the trials from 
one sub-block take place before the next sub-block begins. Each sub-block consisted of exactly one 
stop trial derived from each of four series (staircases), which at the start of the test were as follows: 
Series 1: 100ms; Series 2: 200ms; Series 3: 400ms; Series 4: 500ms. The timing of the auditory stop 
signal changes throughout the test, depending on the participant’s previous performances, so that 
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stopping occurred approximately 50% of the time for each participant. The shorter the SSD, the 
more likely it is that the participant was be able to hold off responding to the arrow. Note that for 
some participants the SSD may have become negative: that is, the auditory signal occurred before 
the onset of the arrow stimulus. The timing of the four series is expected to converge as the test 
proceeds. At the end of each assessed block, a feedback screen was displayed showing a graphical 
representation of the participants’ performance, which was explained to the participant who was 
then encouraged to go faster on each trial. 
 
 The Spatial Span (SSP) task is a computerized version of the Corsi’s Blocks task and provides 
a measure of working memory. A set of white squares was shown to the participant on a computer 
screen. Some of the squares changed in colour, one by one, in a variable sequence (see Figure 13). 
At the end of each sequence a tone indicated that the participant should touch each of the boxes 
coloured by the computer in the same order as they were originally presented. The number of 
squares that change colour ranged from 2 to 9. There were three possible sequences at each level, 
but as soon as the participant passed a sequence at each level they will immediately progress to the 
next level, not necessarily performing all three sequences at each level. If all three attempts at a 
particular level were completed unsuccessfully, the task would terminate. Both the sequence and 
colour used changed from sequence to sequence to minimize interference.  
 
 
Figure 13. The SSP task screen 
 
 
 The Spatial Working Memory (SWM) task assesses working memory and strategy use. It 
tests the participants’ ability to retain spatial information and to manipulate remembered items in 
working memory. It is a self-ordered task which also tests heuristic strategy. 
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The test began with a number of coloured squares (or boxes) shown on the screen. The aim of the 
test was to, by process of elimination, find one blue token that the computer had hidden in one of a 
number of boxes and then fill up an empty column on the right hand side of the screen (see Figure 
14). Only one token was hidden at a time and the participant was to remember which boxes had 
tokens inside already and which one had not, as the idea was to refrain from opening a box that had 
already had a token in it. Touching any box in which a blue token had already been found was an 
error. The number of boxes was gradually increased from three to eight, thereby increasing in 
difficulty. The colour and position of the boxes used were changed from trial to trial to discourage 
the use of stereotyped search strategies. The participant decided the order in which the boxes were 
searched. The computer determined the number of boxes that should be visited (discounting 
errors). Performance at the harder levels of this task was enhanced by the use of a heuristic search 
strategy. 
 
 
Figure 14. The SWM task screen (4 boxes) 
 
 
 The Reaction Time (RTI) task provides a measure of response speed and movement in 
single and 5-choice paradigms. The task was divided into five stages, with each successive stage 
having increasingly complex response requirements. In the first stage, the participant was required 
to touch the screen when a yellow spot appeared in the centre of the screen, neither touching too 
soon nor too late (see Figure 15). Once the participant had achieved 5 out of 6 correct, or completed 
a maximum of 18 attempts, the second stage was introduced. The second stage was the choice 
reaction task and here the yellow spot may appear in any one of five locations. Again, the participant 
was trained to a criterion of 5 out of 6 correct, with a maximum of 40 attempts. If the participant 
failed to achieve the criterion on this stage, the test terminated. Successful participants were then 
introduced to the press pad. The third stage required the participant to hold down the press pad 
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button until the yellow spot appears in the centre of the screen, at which time, they would release 
the button, but they did not have to touch the screen. The fourth stage, again, required the 
participant to hold down the button of the press pad until the yellow spot appears but this time they 
had to release the button and then touch the screen. The fifth and final stage required participants 
to do the same as stage 4 only this time there were five possible locations where the yellow spot 
may have appeared. The participant had to release the button on the press pad and then touch the 
screen where the spot was presented.  
 
 
 
Figure 15. The RTI task screen for the first stage if the RTI task 
 
 
The Stroop Task 
The Stroop task is a classic psychological test of inhibitory control. This task consisted of four trials, 
each one progressively more difficult than the next. Trial 1 requires participants to read a series of 
words (“blue”, “red” or “green”), printed in black ink, in random sequence. Trial 2 required 
participants to name the ink colour of a series of square blocks on the page (again the blue, red or 
green coloured blocks are printed in random sequence on the page). Trial 3 required participants to 
name the ink colour of the words (“blue”, “red” or “green”). Here, the word that is printed does not 
correspond to the colour in which it has been printed; therefore the participant had to inhibit the 
obvious response of reading the word, as opposed to naming the ink colour in which the word is 
printed. Trial 4 contained a series of words printed on a page in one of the three colours (blue, red or 
green). This trial contained 2 rules; if the word did not have a block printed around it, the participant 
named the ink colour and if the word did have a block around it they then read the word. This trial 
required participants to not only inhibit typical responses, but they also had to hold the two rules in 
mind, demonstrating cognitive flexibility. Each trial was timed from start to finish and errors were 
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recorded (both non-corrected errors and self-corrected errors). Therefore three measures are 
obtained from this task. This task is a widely validated measure of response inhibition and cognitive 
control in clinical populations and is also widely used in methamphetamine-dependent populations 
(Salo, 2009).  
 
Wisconsin Card Sorting Test (WCST; computerized version) 
The WCST is a neuropsychological test of set-shifting, i.e. the ability to display flexibility in the face of 
changing schedules of reinforcement. During this task, a number of stimulus cards appeared on the 
computer screen in front of the participant. The shapes on the cards were different in color, 
quantity, and design. The computer decided whether the cards were to be matched by color, design 
or quantity. The participant was then given a card at the bottom of the screen and asked to match it 
to one of the stimulus cards, thereby forming separate virtual “piles” of cards for each (see Figure 
16). Once the card had been matched the words “right” or “wrong” appeared on the screen, 
depending on whether the participant made a correct choice or an incorrect choice. Once that card 
had been matched and feedback had been given, another card appeared on the screen and again, 
the participant was required to match it to one of the four at the top of the screen. The participant 
was not told how to match the cards; however, he or she was told whether a particular match was 
right or wrong. During the course of the task the matching rules were changed and the time taken 
for the participant to learn the new rules, and the mistakes made during this learning process were 
analyzed to arrive at a score. 
 
 
Figure 16. The WCST task screen 
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Delis-Kaplan Executive Functions System (D-KEFS): FAS and Category Fluency Subtests 
The D-KEFS is a standardized battery of tests, designed to evaluate higher level cognitive functions in 
both children and adults for both neuropsychological research and clinical utility. Studies of internal 
consistency revealed the reliability of different sub-tests was largely in the moderate to high range 
(Delis, Kaplan & Kramer, 2001). The validity of the D-KEFS instruments has been demonstrated in 
numerous neuropsychological studies completed over the last 50 years (Delis, Kaplan & Kramer, 
2001). The D-KEFS assesses vital executive functions such as flexibility of thinking, inhibition, 
problem solving, planning, impulse control, concept formation, abstract thinking, and creativity in 
both verbal and spatial modalities. The D-KEFS (FAS and Category Fluency Subtests) is a test of 
generativity or verbal fluency of both the semantic and phonemic types. Verbal fluency refers to the 
rate at which an individual can produce words.  
 
The D-KEFS Verbal Fluency subtests are comprised of three conditions: letter fluency (FAS), category 
fluency, and category switching. The first condition, “Letter Fluency” assesses the fluency with which 
the participant can generate lexical items while simultaneously observing a number of rules. 
Participants were required to generate words verbally beginning with a specified letter of the 
alphabet (F, A, and S), as quickly as possible. Participants had 60 seconds in which to give as many 
words as they were able to, whilst conforming to three simple rules; (1) they may not say names of 
people (for example “Frank”); (2) they may not say names of places (for example “France”); and (3) 
they may not say two or more of the same words with different endings (for example “fun” and 
“funny”). The higher level functions assessed by this task include initiation, simultaneous processing, 
systematic retrieval of phonetically similar lexical items and speed of processing. Performance on 
this task is dependent upon a number of fundamental cognitive components, including vocabulary, 
spelling ability, and attention. The outcome measure for this task is the total number of correct 
responses across all three letters (F, A, S). 
 
The second condition, “Category Fluency” required the participant to retrieve and generate words 
belonging to a designated high-frequency semantic category, i.e. “Boy’s Names” and “Animals”. 
Again, participants had 60 seconds to give as many words from these semantic categories as 
possible. This task is more familiar to participants than generating words that start with a particular 
letter of the alphabet and therefore higher scores are often observed. The outcome measure for this 
task is the total number of correct responses across both categories. 
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The third condition, “Category Switching” assesses the rate at which semantic knowledge can be 
retrieved as well as cognitive flexibility in shifting between two semantic categories. The 
combination of fluency and switching in the same task increases the sensitivity of the instrument to 
frontal dysfunction. This task required the participant to alternate between two different semantic 
categories, namely “Fruit” and “Furniture”.  Participant alternated between these two categories as 
many times as possible in 60 seconds. The outcome measures for this task was the total number of 
correct responses.  
 
Attention Network Task (ANT) 
Attention is a complex cognitive function, dependent on interacting neural systems of the brain.  
According to the Attention Network Theory, the systems can be subdivided into an alerting or 
vigilance network, a network of orientation or selection, and an executive or conflict network. Fan, 
McCandliss, Sommer, Raz & Posner (2002) developed an experimental task called the Attention 
Network Task (ANT), combining a cue-target and a flanker test to obtain measures of the efficiency 
and accuracy of the three networks.   
 
During the ANT task participants were shown a series of arrows on a computer screen. A cross was 
presented in the middle of the screen and the arrows were presented either above or below the 
cross. Participants were instructed to keep their eyes on the cross throughout the experiment. Five 
arrows appeared on the screen at the same time and the participant had to respond to the central 
arrow. The central arrow was surrounded by distracter arrows, displayed in one of three possible 
conditions; the distracter arrows were pointing in the same direction as the central arrow; the 
distracter arrows were pointing in the opposite direction to the central arrow; or the distracter 
arrows did not have arrow heads at all and appeared as solid lines on either side of the central arrow 
(see Figure 17). 
 
 
 
 
 
  
 
X
Figure 17. The three different task screens for the ANT
 
Balloon Analogue Risk Taking Task (BART)
The BART is a computerised task that serves as a 
Lejuez et al. (2002) reported 
indicating convergence with other indices of risk
impulsivity and anxiety-relevant variables such as anxiety sensitivity.  In the BART, a balloon is 
displayed on a computer screen and participa
in order to pump up the balloon (in order to earn points), using the left arrow key and stop pumping 
X
 
 
 
 
 
 
 
 
 
behavioural index of basic risk decision
favourable convergent and discriminant proper
-taking (e.g., gambling), and divergence from 
nts are instructed to use the left and right arrow keys 
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using the right arrow key.  Participants earn rewards by blowing up 15 virtual balloons including both 
red (see Figure 18) and blue balloons (see Figure 19). Each pump earns the participant 5 points.  
Each balloon has an explosion threshold that varies from balloon to balloon and which, if reached, 
results in the loss of all points for that balloon.  Therefore, in deciding whether to make each pump, 
participants weigh the potential gain against the potential risk of losing all the points for that 
balloon. BART performance provides a more valid and generalizable assessment of risk decision-
making than many other standard risk-taking tasks (Lejuez et al., 2002).  
 
Left key to pump
Right key to stop
 
Figure 18. The BART task screen representing a non-inflated red balloon 
 
Left key to pump
Right key to stop
 
Figure 19. The BART task screen representing a partially-inflated blue balloon 
 
Task Switching 
Task Switching is a measure of an individual’s ability to shift frequently between cognitive tasks. 
Alternating between two separate tasks places high demands on working memory processes. Task 
Switching probes the control processes that reconfigure mental resources for a change of task by 
requiring participants to switch frequently among a small set of simple tasks.  
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The participant is required to respond to objects on a computer screen depending on cues at the top 
of the screen (see Figure 20). Each cue indicates whether the participant should respond to the 
colour of the object or the shape of the object (both being displayed in a single image). The colours 
are red or green (for example, press the left button if the colour is red and the right button if the 
colour is green), and the shapes are triangles or circles (for example, press the left button if the 
shape is a triangle and the right button if the shape if a circle). There are a number of practice trials 
for this task and participants have to score a minimum of 60% in order to proceed to the 
experimental trials. Feedback is given on practice trials indicating whether the participant was 
correct or incorrect. This task measures reaction time as the task changes from trial to trial as well as 
total number of errors. 
 
SHAPE
        
COLOUR
 
COLOUR
        
SHAPE
 
Figure 20. The 4 conditions for Task Switching 
 
Delay Discounting Task (DDT) 
The Delay Discounting Task is a measure of an individual’s tendency to discount rewards that are 
delayed in time, rather than immediate (thus “Delay Discounting”). This task has been widely studied 
in methamphetamine-dependent samples (for example see Hoffman et al., 2008; Monterosso et al., 
2007; Paulus et al., 2002). It measures the preference for receiving smaller rewards immediately, 
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versus larger rewards later.  Participants are presented with a series of choices regarding money 
options. For each item, the participant must choose if they would prefer to receive a certain amount 
of money today, or a larger amount of money later (see Figure 21). Although the participant will not 
be receiving any actual money during this task, it is important that they respond to the questions as 
if they would actually receive the money options they chose. There are 27 total items on the task. 
Various scores can be obtained which measure the degree to which the participant “discounts” the 
delayed rewards.  
 
Would you prefer to receive
R35 in 20 days R20 today 
 
Figure 21. The DD task screen 
 
 
ADHD self report questionnaire (see Appendix D) 
Burke and Austin (2010) identified the need for a valid self-report measure of adult ADHD for the 
South African context. The authors therefore designed a scale containing a number of items based 
on 7 factors yielded through a preliminary pilot study of 402 undergraduate students. This 
questionnaire is similar to previous questionnaires of adult ADHD, in that it covers items that 
retrospectively assess symptoms of childhood ADHD, and also covers items on current symptoms of 
ADHD. However, it is more comprehensive than previous measures in that it covers a wider variety 
of symptoms, as well as behavioural, cognitive and emotional aspects of ADHD (Burke & Austin, 
2010).  
 
This ADHD self report questionnaire contains three sections. The first section contains information 
relating to the demographic details of the participant, such as age and level of education. The 
second section contains information pertaining to the participants’ childhood. Childhood here refers 
to between 3 and 17 years of age. This section consists of 39 questions that are based on the DSM-IV 
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criteria of ADHD. Additional questions are also included, relating to aspects such as the impact of the 
symptoms, learning disorders and emotional consequences. The third section contains information 
pertaining to the participants’ adulthood. Adulthood here refers to any age over 17 years. This 
section contains a total of 51 questions; grouped according to cognition (relating to response 
inhibition, working memory and planning), social interactions, behaviour (specifically impulsivity), 
and emotion (relating to frustration tolerance). All items on the questionnaire are rated according to 
the presence and the frequency of a particular symptom. Participants answered the items by circling 
either a “yes” or “no” response, indicating the presence or lack thereof, of a particular symptom. 
This gives an indication of the number of symptoms present. If the participant responded “yes” to a 
particular item, then they had to indicate the frequency of the symptom. This was done on a 5-point 
Likert-scale, i.e. “Almost Never”, “Now and again”, “At least once a week”, “At least once a day”, or 
“More than once per day”. Each item was given a score ranging from 0 – 5; where 0 equals “no” and 
5 equals “more than once per day”.  Rating the items in this way gives an indication of the severity, 
impact and/or frequency of a symptom (Burke & Austin, 2010).  
 
 
PROCEDURE 
 
This study consisted of four phases. A telephonic screening interview (Phase 1) was conducted with 
those participants who responded to the flyers, and those who were recruited through clinics and 
hospitals, to ensure that they satisfied the initial inclusion/exclusion criteria. Participants who 
qualified were tested on three separate days. Screening took place on the first day, during which the 
SCID-I for Axis I diagnoses was administered by a qualified clinician (Phase 2). The Edinburgh 
Handedness Questionnaire was also administered during this session. The screening session took 
place either at Valkenberg hospital or in the Psychiatric Department at Groote Schuur Hospital. If 
participants were found to be ineligible for the study after the SCID-I, they were compensated for 
their time by means of food vouchers, but were not invited back for the third and fourth phases of 
the study. If participants were found to be eligible for the study according to the SCID-I, they were 
invited back for the MRI scanning session (Phase 3). MRI scans were conducted at the Cape 
Universities Brain Imaging Centre, CUBIC, using a Siemens Magnetom Allegra 3T system with a high-
resolution, T1-weighted, 3D-multiecho MPRAGE sequence with the following scan parameters: 
TR=2530ms; graded TE=1.53, 3.21, 4.89, 6.57ms; flip angle=7°; FOV=256mm; slice thickness=1mm; 
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160 slices; and acquisition duration of 10.49 min. Thereafter, participants were invited to the final 
testing session (Phase 4) where a neuropsychological test battery was administered.  
 
The SCID-IV session took approximately 1-3 hours to complete, depending on which group the 
participant belonged; the MRI session took approximately 3-4 hours to complete, and the 
neuropsychological testing session took approximately 4-5 hours to complete. A sample timeline of 
study events during the neuropsychological testing session is presented in Table 2 below. All 
neuropsychological tests were administered in a random sequence to minimize sequence effects. 
Urine screens were performed on both days of testing to verify drug abstinence.  
 
Table 2. Sample Timeline of Study Events for the Neuropsychological Testing Session 
Time (in minutes) from Study Start Event 
00.00 ADHD Questionnaire 
30.00 CANTAB Battery 
100.00 WASI 
140.00 WCST 
160.00 D-KEFS Verbal Fluency 
175.00 Stroop Task 
185.00 Attention Network Task 
200.00 Balloon Analogue Risk Taking Task 
210.00 Delay Discounting Task 
220.00 Task Switching 
240.00 Debriefing 
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DATA ANALYSIS 
 
Test Scoring 
 
ADHD Self Report Questionnaire 
This questionnaire yields two main scores; a childhood score and an adulthood score. The childhood 
section contains 39 questions, scored between 0 (no, the thought/feeling/behaviour did not apply to 
me) and 5 (the thought/feeling/behaviour applied to me more than once per day). This gave a score 
range of 0 – 195. A higher score indicates more symptoms of childhood ADHD. The adulthood 
section contains 51 questions pertaining to aspects of the participants’ life, namely, “thoughts”, 
“interactions with others”, “behaviour”, and “feelings”, scored in the same manner as the childhood 
items. This gave a score range of 0 – 255. A higher score indicates more symptoms of adulthood 
ADHD. 
 
Weschler Abbreviated Scale of Intelligence (WASI) 
Rules and criteria for scoring the WASI are provided for each subtest in the scoring manual. The 
scoring for Block Design and Matrix Reasoning is fairly objective; however, the scoring for 
Vocabulary and Similarities requires more judgement. Therefore the scoring manual contains sample 
responses in addition to the general scoring criteria. Responses are scored as 0, 1, or 2, depending 
on the level of understanding the participant displays. The maximum score obtainable on Vocabulary 
is 80, from 42 items. The maximum score obtainable on Similarities is 48, from 26 items. 
 
Block Design contains 13 items where the participant is timed on a task requiring them to build a 
particular pattern out of blocks. Items 1 – 9 allows 60 seconds for completion; items 10 – 13 allows 
120 seconds for completion. Items 1 -4 are scored 0, 1, or 2 depending on whether they were 
completed in the required time on trial 1 (score 2) or trial 2 (score 1) or not correct on trial 1 or 2 
(score 0). The maximum score obtainable on Block Design is 71. 
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Matrix Reasoning contains 35 items plus two practice items. The participant is scored 0 (for an 
incorrect response) or 1 (for a correct response). The maximum score obtainable on Matrix 
Reasoning is 35. 
 
All subtests were scored strictly according to the scoring manual guidelines. Raw scores were then 
converted to T scores, using the tables in Appendix A of the scoring manual that corresponded to the 
age group of the participant. T scores were then used to look up the corresponding IQ in the IQ table 
in Appendix A of the scoring manual.  
 
Cambridge Neuropsychological Test Automated Battery (CANTAB) 
CANTABeclipse stores all test results directly into a data file which is stored electronically under the 
ID code created for each participant. For each test the values for a number of outcome measures are 
automatically calculated and stored in a “Summary Test Results” file for each participant. The 
outcome measures for the tasks are as follows: 
 
          The BLC results in five outcome measures, namely; Mean Correct Latency; Percent Correct; 
Total Correct; Total Errors and Total Attempts. For the purpose of this study, only Percent Correct 
was recorded. Participants needed to score a total of 100% in order to continue with the 
neuropsychological tests. If it was found that the participant was not able to follow the instructions, 
and did not score 100%, the assessment would be discontinued.  
 
          The AGN yielded four main outcome measures; mean correct latency (positive), mean correct 
latency (negative), total omissions (positive) and total omissions (negative). These outcome 
measures are explained in Table 3 below. 
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Table 3. Outcome Measures for the AGN 
Outcome Measure Explanation 
Mean Correct Latency 
(positive) 
 
Mean Correct Latency 
(negative) 
 
Total Omissions 
(positive) 
Total Omissions 
(negative) 
 
This is the mean time taken to respond correctly to each target word 
stimulus in the blocks with targets matching this target type (i.e. 
positive). 
This is the mean time taken to respond correctly to each target word 
stimulus in the blocks with targets matching this target type (i.e. 
negative). 
This is the total number of missed responses to targets in the blocks 
with targets matching this target type (i.e. positive). 
This is the total number of missed responses to targets in the blocks 
with targets matching this target type (i.e. negative). 
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The CGT has six outcome measures; quality of decision making; deliberation time; risk 
taking; risk adjustment; delay aversion; overall proportion bet. These outcome measures are 
explained in Table 4 below. 
 
Table 4. Outcome Measures for the CGT 
Outcome Measure Explanation 
Quality of decision making This measure is the proportion of trials on which participants 
chose to gamble on the more likely outcome.  
Deliberation time This is the mean latency from presentation of the coloured boxes 
to the participant’s choice of which colour to bet on. 
Risk taking This measure refers to the mean proportion of the current points 
total that the participant chose to risk on gambling trials for 
which they had chosen the more likely outcome. 
Risk adjustment Participants are more likely to gamble larger amounts when the 
odds are strongly in their favor. This measure refers to the 
tendency to bet a higher proportion of points on trials where the 
large majority of the boxes are the colour chosen than when a 
small number of boxes are of the colour chosen. 
Delay aversion Participants who are unable or unwilling to wait will bet larger 
amounts on the descending trials than on the ascending trials. 
This measure reflects this tendency. It is calculated by subtracting 
the Risk Taking measure calculated for ascending trials from the 
Risk Taking measure on descending trials. 
Overall proportion bet This measure refers to the average proportion of the current 
points total that the participant chose to risk on each gambling 
test trial, including trials on which they bet on the less likely 
outcome as well as trials where both outcomes were equally 
likely. 
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  The IST yields six outcome measures; mean number of boxes opened per trail; mean P correct; total 
correct; sampling errors; discrimination errors; and mean box opening latency. These outcome 
measures are explained by Table 5 below: 
 
Table 5. Outcome Measures for the IST 
Outcome Measure Explanation 
Mean number of boxes opened 
per trial 
This measure gives the mean number of boxes opened per trial 
for the specified win condition. 
Mean P (Correct) This is the mean of a per-trial probability value over all trials with 
the specified win condition. The value is the probability that the 
colour chosen by the participant at the point of decision would 
be correct, based only on the evidence available to the 
participant at that time, and assuming each box has a 0.5 
probability of assuming a particular colour.   
Total Correct This is the number of trials for which the participant correctly 
chose the colour that was in the overall majority for the specified 
win condition. 
Sampling Errors This is the number of trials where the participant chose a colour 
that was not in the overall majority but was in the majority at the 
point of decision, for the specified win condition. 
Discrimination Errors This is the number of trials where the participant chose a colour 
that was not in the majority at the point of decision, for the 
specified win condition. Even of the colour chosen was revealed 
to be the correct colour; this is considered to be an error, as the 
participant made a decision which was not logically based on the 
evidence available to the participant at the time. 
Mean Box Opening Latency Box opening latency is the time elapsed between the participant 
opening a box and then opening a subsequent box, or, for the 
first box opened, the time elapsed from the start of the trial to 
the first box opening. This measure calculates the mean of these 
latencies for the specified win condition. 
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          The SST yields five outcome measures; direction errors; proportion of successful stops; reaction 
time on go trials; stop signal delay (50%); stop signal reaction time. These outcome measures are 
explained by Table 6 below.  
 
Table 6. Outcome Measures for the SST 
Outcome measure Explanation 
Direction Errors This occurs when the participant presses the wrong button on 
the press pad i.e. the left button is pressed when the right 
button should have been pressed or vice versa. 
Proportion of Successful Stops This refers to the number of times the participant stopped 
successfully, divided by the total number of stop signals. 
Reaction Time on GO Trials This is the reaction time on Go Trials 
Stop Signal Delay (50%) This is the SSD at which the participant was able to stop 50% of 
the time. It is calculated as the arithmetic mean of the 
measured SSD, or failed-stop reaction time if applicable, from 
completed assessment stop trials. 
Stop Signal Reaction Time (SSRT) This is an estimate of the length of time between the go 
stimulus and the stop stimulus at which the participant is able 
to successfully inhibit their response on 50% of trials. 
 
          The SSP Task produced one outcome measure. Span Length is the longest sequence 
successfully recalled by the participant. The maximum score is 9.  
 
          The SWM Task produces two outcome measures. “Between Errors” are defined as the number 
of times a participant revisits a box in which a token has previously been found. This is calculated for 
trials of four or more tokens only. The second outcome measure is termed “Strategy”. It has been 
suggested that an efficient strategy for completing this task is to follow a predetermined sequence 
by beginning with a specific box and then, once a blue token has been found, to return to that box to 
start the new search sequence. An estimate of the use of this strategy is obtained by counting the 
number of times the participant begins a new search with a different box for 6- and 8-box problems 
only. A high score represents poor use of this strategy and a low score equates to effective use. 
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          The RTI Task yields two outcome measures. The “Five-Choice Reaction Time” is a measure of 
the speed with which the participants release the press pad button in response to a stimulus in any 
one of five locations. Choice reaction time latency is measured in milliseconds and tends towards a 
positive skew. The “Five-Choice Movement Time” is a measure of the time taken to touch the 
stimulus after the press pad button has been released in trials where the stimuli has been presented 
in one of five possible locations. Movement time latency is measured in milliseconds and is usually 
normally distributed for correct responses. 
 
The Stroop Task 
The Stroop Task yields three scores per participant per trial over a total of 4 trials. Errors refer to the 
total number of errors (that were not corrected by the participant) for a particular trial. Self 
corrected errors refer to the total number of errors corrected by the participant for a particular trial. 
Total time refers to the total time a participant took to complete a particular trial, in seconds. 
Therefore a total of 12 (3 outcome measures x 4 trials) outcome measures were recorded per 
participant.  
 
Wisconsin Card Sorting Task 
The WCST yields a total of 5 outcome measures; number of trials administered; total correct; total 
errors; perseverative responses; and perseverative errors. These outcome measures are explained in 
Table 7 below: 
Table 7. WCST Outcome Measures 
Outcome measure Explanation 
Number of Trials Administered 
 
Total Correct 
Total Errors 
Perseverative Responses 
The total number of trials administered to the participant. 
Fewer errors in card matching resulted in fewer trials being 
administered. 
The number of correctly matched cards. 
The number of incorrectly matched cards. 
The number of similar responses made despite knowledge that 
the previous response was incorrect. 
Perseverative Errors The number of similar, but incorrect, responses made despite 
knowledge that the previous response was incorrect. 
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D-KEFS: Verbal Fluency  
Verbal Fluency yielded a total of four outcome measures. Phonemic Fluency includes the total 
number of words generated by participants over three letters namely F, A, and S. Semantic Fluency 
includes the total number of words generated over two categories namely Boy’s Names and 
Animals. Category Switching produced one outcome measure; Total Correct Responses which is the 
total number of correct words generated. 
 
Attention Network Task (ANT) 
The ANT yielded six outcome measures (see Table 8 below). These include three Reaction Time 
measures and three Accuracy measures across three different conditions, namely, Congruent Trials 
(when all arrows are pointing in the same directions), Non-congruent Trials (when distracter arrows 
are pointing in the opposite direction to the response arrow) and Neutral Trials (when distracters do 
not have arrow heads and are simply lines). 
 
Table 8. Outcome Measures for the ANT 
 
Reaction Time 
Trials 
Non-congruent Trials 
Neutral Trials 
 
Accuracy 
Congruent Trials 
Non-congruent Trials 
Neutral Trials 
Congruent Trials 
 
BART 
The adjusted number of pumps across balloons (i.e. the BART score) serves as the primary 
dependent variable. This adjusted value is defined as the average number of pumps on balloons that 
did not explode. This score is preferable to the unadjusted average because the number of pumps is 
essentially constrained on balloons that exploded, thereby limiting between-participant variability in 
the unadjusted averages below (Bornovalova et al., 2009).  
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Task Switching 
Task Switching produces two outcome measures. These are Total Errors and Reaction Time. Total 
Errors are the total number of errors made over the test trial. Reaction Time is the average RT over 
all items on the test trial.  
 
Delay Discounting Task 
The Delay Discounting task provides one outcome measure; the total number of discounts by the 
participant, i.e. the total number of times the participant chose the smaller immediate (monetary) 
option over the larger delayed (monetary) option. 
 
Cortical Thickness 
 
The FreeSurfer 5.1.0 software package (http://surfer.nmr.mgh.harvard.edu/) was used to create a 
three-dimensional model of the cortex surface of each participant and to estimate cortical thickness 
from the T1-weighted images. Following the automated image processing, a visual inspection of the 
whole cortex of each individual lead to manual corrections where necessary. Brain surfaces were 
reconstructed and inflated and cortical thickness values were computed as the shortest distance 
(mm) between the pial surface and the grey/white matter surface (Dale et al., 1999; Fischl et al., 
1999). Mean cortical thickness values for regions of interest in the frontal and cingulate cortex of 
both hemispheres were calculated (Desikan et al., 2006; Fischl et al., 2004) and exported to SPSS 
20.0 for statistical analysis. Table 9 below indicates the regions of interest examined. 
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Table 9. Frontal regions of interest 
Left hemisphere Right hemisphere 
Caudal anterior cingulate Caudal anterior cingulate 
Caudal middle frontal Caudal middle frontal 
Lateral orbitofrontal Lateral orbitofrontal 
Medial orbitofrontal Medial orbitofrontal 
Paracentral Paracentral 
Pars orbitalis Pars orbitalis 
Pars triangularis Pars triangularis 
Pars opercularis Pars opercularis 
Precentral Precentral 
Rostral Anterior cingulate Rostral Anterior cingulate 
Rostral middle frontal Rostral middle frontal 
Superior frontal Superior frontal 
frontal pole frontal pole 
Insula Insula 
 
 
Descriptive Statistics 
 
All data were checked and cleaned before analyses. Mean scores with standard deviations in 
parentheses, as well as ranges, are presented under the results sections below, for each dependent 
variable. Graphical illustrations of means are also presented in the Results chapters that follow. 
 
Inferential Statistics 
 
One-way ANOVAs were conducted in order to examine between-group differences. Raw scores were 
used in these analyses for each outcome variable for each executive domain. ANOVA assumptions 
include equal sample sizes, independence of observations, normal distribution of data, and 
homogeneity of variance. Our sample sizes were generally equal (see Table 1) and the observations 
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were independent. The assumption of normality was largely upheld (see Appendix E) and where the 
assumption of homogeneity of variance is violated, an adjusted F is reported. The homogeneity of 
variance and normality assumptions can be violated without serious consequences (Howell, 2002), 
as ANOVA is a relatively robust statistical test. However, in order to compensate for these violations, 
Kruskal-Wallis non-parametric ANOVA tests were conducted on the data. Results did not differ from 
those of the parametric one-way ANOVA results; therefore we have chosen to report the parametric 
one-way ANOVA results in the following results chapters. Due to the exploratory nature of this 
thesis, we do not want to apply methods that are too stringent and have therefore chosen not to 
correct for multiple comparisons. 
 
It was our aim to conduct a MANCOVA analysis in order to control for covariates such as age, highest 
level of education (HLOE) and full scale IQ (FSIQ) estimates. However, our data violated too many 
assumptions and therefore it was not appropriate to run such analyses. We observed significant 
differences between our groups in terms of HLOE and FSIQ and our data were not normally 
distributed.  
 
Composite neuropsychological scores were then computed to reduce the number of variables 
initially examined. Z-scores for each outcome measure were computed in order to do this. Z-scores 
are expressed as the distance from the sample mean divided by the standard deviation. These Z-
scores were calculated using the mean of the control group. Outcome measures were grouped 
according to executive domain, as presented in Results Chapters 4, 5, 6 and 7, namely, decision 
making and impulsivity, inhibition and set-shifting, attention and working memory, and verbal 
fluency. Cronbach’s alphas were calculated in order to establish reliability of the individual outcome 
measures. Four composite scores were created for each of the four executive domains. One-way 
ANOVAs were conducted in order to examine between-group differences on the four composite 
scores. Tests of normality indicated largely normally distributed data, with few violations (see 
Appendix E) and where Levene’s test of homogeneity of variance was violated, an adjusted Welch’s F 
is reported. Tables of Levene’s statistics can be found in Appendix F. Specific results are presented 
under the Results sections.  
 
It was also our aim to run multiple regression analyses in order to establish relationships between 
neuropsychological data and structural MRI data, however, again too many assumptions were 
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violated and therefore it was not appropriate to run these analyses. We had far too many variables 
and too many covariates to run a multiple regression. We investigated potential avenues of reducing 
our variables, but none of these were successful. Our data were log-transformed in order to improve 
normality; however, this did not result in normally distributed data. We therefore decided to run 
Spearman’s Rho non-parametric correlational analyses in order to examine the relationship between 
executive functioning and prefrontal cortical thickness. Specific results are presented under the 
Results sections.  
 
All statistical analyses were carried out using the SPSS v20 software package (SPSS Inc., Chicago, IL). 
The statistical significance threshold was set at α = 0.05. Details of each individual analysis are 
presented under the Results chapters below. 
 
 
ETHICAL CONSIDERATIONS 
 
The study was conducted in accordance with the guidelines of The Declaration of Helsinki (Edinburgh 
2000) and The Medical Research Council of South Africa’s guidelines (2002) on the ethical conduct of 
research studies in humans. The principal investigator ensured that these guidelines were adhered 
to for the duration of the study. 
 
Informed consent (see Appendix B) was obtained in writing from all participants. The participants 
were informed that all data collected would be kept strictly confidential and that the results of the 
study would be made public and published without compromising confidentiality. Participants were 
also ensured of their anonymity throughout the duration of the study. Participation is this study was 
voluntary and it was made clear to all participants that they were free to refuse to participate, or to 
withdraw from the study at any point, without prejudice. 
 
In the interest of ethics, no participants were issued with any cash monies; however, time taken to 
participate was compensated for by means of food vouchers from a local grocery store where no 
cigarettes or alcohol were to be purchased.  
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The chapters that follow include the Results and Discussions relating to the research questions 
identified at the start of this thesis. Chapter Four introduces the four broad domains of executive 
functions and presents findings relating to these domains. Chapters Five, Six and Seven and Eight 
expand the results from each domain and investigate each task and its associated outcome 
measures. Each of these chapters includes a discussion of the results. Chapter Nine presents the 
results of the correlational analyses between cortical thickness and executive functions. Chapter Ten 
presents the results of our ADHD questionnaire. Chapter Eleven presents a summary of the results 
as well as directions for future research and concluding remarks.  
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CHAPTER FOUR: EXECUTIVE IMPAIRMENT IN METHAMPHETAMINE 
 
Executive functioning was examined using a number of neuropsychological tasks. These tasks were 
divided into four domains of executive functioning namely, Decision Making and Impulsivity, 
Attention and Working Memory, Response Inhibition and Set-Shifting, and Verbal Fluency. Each 
domain was tested using a number of tasks. Each task contained a number of outcome measures, 
details of which can be found in the methods section. 
 
In order to reduce the number of variables or outcome measures examined, composite 
neuropsychological scores were computed. A method described by Ferret, Carey, Thomas, Tapert 
and Fein (2011) was employed. Outcome measures were grouped into domains based on what each 
measure was designed to measure. Z-scores were computed for each outcome measure after which 
average z-scores for each domain were computed. Cronbach’s alphas were calculated in order to 
establish the reliability of each domain. Results indicated Cronbach’s alphas of between 0.519 and 
0.939, indicating moderate to strong reliability. The Attention and Working Memory domain showed 
the lowest internal consistency (α = 0.519), indicating the possibility that the tests in this domain are 
not all testing the same function. This may be due to the fact that the tests include “accuracy” 
measures as well as “reaction time” measures.  
 
Four composite domain scores were derived from the individual neuropsychological tasks as follows: 
1. Decision Making and Impulsivity: Delay Discounting Task, Balloon Analogue Risk 
Taking Task, Information Sampling Task, Cambridge Gambling Task. 
2. Attention and Working Memory: Task Switching, Attention Network Task, Reaction 
Time, Spatial Working Memory, and Spatial Span. 
3. Response Inhibition and Set-Shifting: Affective Go/No Go Task, Stop Signal Task, 
Stroop Task, and the Wisconsin Card Sorting Task. 
4. Verbal Fluency: Letter Fluency and Category Fluency. 
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Descriptive statistics for all outcome measures are presented in the tables below. Means with 
standard deviations in parentheses are presented, as well as ranges. Mean z-scores and standard 
deviations are also presented for each domain as well as z-score ranges. Cronbach’s alphas are 
presented for each executive domain.
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Table 10. Executive Functioning Performance within the Decision-Making Composite Domain 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
Range M (SD) Range M (SD) Range M (SD) 
Decision Making and Impulsivity 
α = 0.653 
-1.08 – 0.56 -0.29 (0.51) -1.12 – 0.62 -0.19 (0.40) -0.63 – 0.73 0.001 (0.41) 
Delay Discounting Task 
 Number of discounts 
 Percentage (%) 
 
13 – 22 
40.74 – 81.48 
 
16.30 (2.27) 
60.00 (9.35) 
 
13 – 21 
48.15 – 77.78 
 
16.37 (2.09) 
60.82(7.44) 
 
10 – 14 
37.04 – 66.67 
 
12.15 (1.31) 
54.26 (11.61) 
Balloon Analogue Risk Taking Task 
 Number of pumps 
 Average number of pumps 
 Maximum number of pumps 
 Total points earned 
 
137 – 1108 
3.43 – 27.70 
7 – 113 
470 - 3515 
 
495.39 (252.39) 
12.39 (6.31) 
33.85 (27.13) 
1700.75 (700.3) 
 
272 – 932 
6.80 – 23.30 
12 – 66 
915 - 3515 
 
445.05 (168.38) 
11.13 (4.21) 
25.58 (11.57) 
1648.95 (561.22) 
 
52 – 863 
1.30 – 21.58 
3 – 92 
60 – 3470 
 
401.6 (205.39) 
10.04 (5.13) 
25.45 (20.94) 
1494.25 (787.84) 
Information Sampling Task 
Win condition fixed 
 Mean no. of boxes opened/trial 
 Mean P (correct) 
 Total correct 
 Sampling errors 
 Discrimination errors 
 Mean box opening latency 
Win condition decreasing 
 Mean no. of boxes opened/trial 
 Mean P (correct) 
 Total correct 
 Sampling errors 
 Discrimination errors 
 Mean box opening latency 
 
 
3.8 – 25 
0.52 – 1 
1 – 10 
0 – 4 
0 – 5 
394.3 – 3793.67 
 
1.5 – 25 
0.55 – 1 
4 – 10 
0 – 5 
0 – 6 
335.92 – 5753.47 
 
 
14.83 (8.00) 
0.78 (0.15) 
7.9 (2.10) 
1.05 (1.23) 
1.55 (1.7) 
1132.50 (849.74) 
 
8.93 (6.28) 
0.69 (0.13) 
6.75 (1.89) 
2.25 (1.59) 
1.95 (1.64) 
1831.41 (1567.67) 
 
 
6 – 25 
0.65 – 1 
7 – 10 
0 – 3 
0 – 3 
421.98 –1116.03 
 
5.3 – 25 
0.62 – 1 
6 – 10 
0 – 4 
0 – 3 
445 – 1766.88 
 
 
14.42 (6.2) 
0.79 (0.11) 
8.41 (1.06) 
1.12 (0.86) 
0.82 (0.95) 
1116.03 (671.26) 
 
10.13 (4.72) 
0.72 (0.09) 
7.59 (1.12) 
1.76 (1.14) 
1.06 (0.97) 
1108.78 (397.91) 
 
 
3.9 – 25 
0.58 – 1 
5 – 10 
0 – 5 
0 – 4 
368.55 – 8156.25 
 
4 – 22.9 
0.61 – 0.94 
5 – 10 
0 – 5 
0 – 3 
537.98 – 7330.19 
 
 
12.48 (6.51) 
0.76 (0.13) 
7.95 (1.64) 
1.5 (1.5) 
1.15 (1.18) 
1501.61 (1661.95) 
 
9.26 (4.64) 
0.71 (0.08) 
7.7 (1.34) 
2 (1.2) 
0.9 (0.97) 
1606.36 (1484.13) 
Cambridge Gambling Task 
 Delay aversion 
 Deliberation time 
 Overall proportion bet 
 Quality of decision making 
 Risk adjustment 
 Risk taking 
 
-0.07 – 0.9 
1385.61 – 6363.12 
0.31 – 0.94 
0.39 – 0.98 
-2.27 – 2.38 
0.28 – 0.94 
 
0.5 (0.33) 
3367.15 (1332.87) 
0.57 (0.17) 
0.72 (0.23) 
0.18 (1.00) 
0.59 (0.18) 
 
0 - 0.9 
1373.73 – 8371.32 
0.27 – 0.89 
0.3 – 1.00 
-0.46 – 1.48 
0.26 – 0.94 
 
0.44 (0.28) 
3217.37 (1571.16) 
0.58 (0.18) 
0.74 (0.19) 
0.24 (0.49) 
0.61 (0.18) 
 
0.03 – 0.77 
1257.7 –11185.69 
0.39 – 0.74 
0.14 – 1.00 
-0.63 – 2.27 
0.38 – 0.87 
 
0.41 (0.21) 
3041.36 (2156.82) 
0.57 (0.11) 
0.83 (0.18) 
0.86 (0.86) 
0.62 (0.13) 
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Table 11. Executive Functioning Performance within the Attention and Working Memory Domain 
 
 
 
Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Attention and Working Memory 
α = 0.519 
-1.12 - -0.10 -0.58 (0.29) -1.98 – 1.05 -0.62 (0.66) -1.03 – 0.44 -0.01 (0.33) 
Task switching 
 Errors 
 Average reaction time 
 
9 – 111 
655.88 – 1976.61 
 
61.90 (32.87) 
1220.5 (409.65) 
 
1 – 264 
571 - 1761 
 
52.84 (63.74) 
1104.02 (258.79) 
 
1 – 93 
601.41 – 2255.03 
 
20.85 (25.36) 
1121.32 (467.39) 
Reaction Time 
Five choice movement time 
Five choice reaction time 
 
493.25 – 1267.71 
299.12 - 680 
 
687.44 (190.37) 
375.90 (100.52) 
 
399.29 – 1538.5 
264.5 – 549.25 
 
623.29 (285.11) 
342.62 (82.49) 
 
309.62 – 688.25 
257.88 – 387.75 
 
530.09 (113.46) 
317.73 (38.09) 
Attention network task 
Accuracy:  
 Neutral trials 
 Congruent trials 
 Incongruent trials 
Reaction time: 
 Neutral trials 
 Congruent trials 
 Incongruent trials 
 
 
33.33 – 100 
33.33 – 100 
10.42 – 100 
 
432 – 1019 
416 – 1037 
485 – 1030 
 
 
87.28 (17.55) 
87.61 (17.48) 
71.42 (29.97) 
 
649.65 (138.20) 
633.35 (135.61) 
703.25 (138.28) 
 
 
85.42 – 100 
89.58 – 100 
68.75 – 100 
 
462 – 803 
420 – 805 
528 - 1046 
 
 
97.02 (4.19) 
97.59 (3.63) 
91.56 (7.43) 
 
567.74 (93.02) 
573.21 (105.63) 
671.21 (137.71) 
 
 
95.83 – 100 
93.75 – 100 
87.5 – 100 
 
425 – 752 
414 – 760 
492 - 795 
 
 
99.06 (1.26) 
99.17 (1.57) 
94.89 (3.35) 
 
547.65 (92.37) 
543 (88.96) 
620.2 (80.22) 
Spatial working memory 
 Between errors 
 Strategy 
 
8 – 75 
30 - 44 
 
43.70 (20.32) 
37.75 (3.71) 
 
1 – 73 
24 - 41 
 
35.87 (21.78) 
34.01 (5.68) 
 
0 – 52 
22 - 43 
 
20.85 (15.27) 
32.1 (6.01) 
Spatial Span 
 Span length 
 
2 - 8 
 
5.00 (1.49) 
 
3 - 8 
 
5.53 (1.36) 
 
3 - 9 
 
6.05 (1.54) 
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Table 12.Executive Functioning Performance within the Response Inhibition and Set-Shifting Domain 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Response Inhibition and Set Shifting 
α = 0.830 
-9.25 - -0.19 -2.79 (2.58) -3.31 – 0.48 -0.67 (1.07) -0.74 – 0.72 0.00 (0.43) 
Affective Go/No Go task 
 Mean correct latency (positive) 
 Mean correct latency (negative) 
 Total omissions (positive) 
 Total omissions (negative) 
 
380.79 – 946.89 
310 – 872.31 
2 – 34 
4 – 35 
 
690.45 (162.60) 
649.75 (151.09) 
15.89 (10.76) 
15.89 (9.7) 
 
411.67 – 759 
502.20 – 838.50 
1 – 23 
1 – 15 
 
636.60 (89.93) 
653.95 (101.98) 
10.17 (7.00) 
8.56 (4.31) 
 
262.55 – 686.25 
386.90 – 688.33 
0 – 22 
0 – 16 
 
512.47 (98.45) 
528.63 (79.37) 
5.22 (5.77) 
3.50 (3.85) 
Stop signal task 
 Directions errors on stop/go trials 
 Proportion of successful stops 
 Median correct RT on go trials 
 SSD (last half) 
 SSRT (last half) 
 
0 – 32 
0.15 – 0.8 
319 – 825 
-186.22–548.25 
113.48 – 588.98 
 
7.79 (9.25) 
0.46 (0.14) 
564.63 (147.48) 
283.81 (231.19) 
280.82 (134.31) 
 
0 – 11 
0.35 – 0.9 
365.5 – 953 
72.1 – 708.2 
102.62 – 403.72 
 
3.31 (3.2) 
0.53 (0.14) 
589.47 (167.7) 
366.97 (174.84) 
222.47 (75.41) 
 
0 – 7 
0.28 – 0.82 
394.5 – 897 
150.62 – 738.82 
139.92 – 291.92 
 
1.72 (2.02) 
0.5 (0.16) 
552.89 (142.32) 
341.87 (147.28) 
211.02 (44.43) 
Stroop task 
Trial 1:  Total time 
 Errors 
 Self corrected errors 
Trial 2:  Total time 
 Errors 
 Self corrected errors 
Trial 3:  Total time 
 Errors 
 Self corrected errors 
Trial 4:  Total time 
 Errors 
 Self corrected errors 
 
21 – 43 
0 – 4 
0 – 4 
31 – 79 
0 – 6 
0 – 5 
49 – 122 
0 – 16 
1 – 13 
40 – 230 
0 – 21 
0 – 18 
 
33.00 (9.17) 
0.74 (1.15) 
1.47 (1.39) 
53.00 (13.96) 
1.53 (1.9) 
2.16 (1.30) 
81.89 (21.12) 
3.11( 4.16) 
4.42 (3.02) 
103.68 (57.65) 
3.58 (6.14) 
4.42 (4.54) 
 
18 – 42 
0 – 3 
0 – 3 
21 – 58 
0 – 3 
0 – 5 
44 – 105 
0 – 5 
0 – 6 
47 – 150 
0 – 5 
0 – 7 
 
26.26 (6.61) 
0.26 (0.81) 
0.79 (1.08) 
37.16 (11.07) 
0.37 (0.83) 
1.58 (1.43) 
68.84 (16.98) 
0.84 (1.3) 
3.16 (1.86) 
79.21 (25.41) 
1.00 (1.33) 
2.42 (1.77) 
 
15 – 31 
0 – 1 
0 – 1 
21 – 53 
0 – 3 
0 – 3 
37 – 69 
0 – 5 
0 – 7 
43 – 104 
0 – 6 
0 – 5 
 
22.60 (3.91) 
0.1 (0.31) 
0.1 (0.31) 
31.10 (6.8) 
0.15 (0.67) 
0.7 (0.92) 
52.5 (9.53) 
0.3 (1.13) 
1.45 (1.82) 
59.85 (14.73) 
0.8 (1.77) 
0.9 (1.33) 
Wisconsin card sorting task 
 Total correct 
 Total errors 
 Perseverative responses 
 Perseverative errors 
 
44 – 95 
12 – 84 
5 – 77 
5 – 66 
 
67.53 (15.09) 
47.88 (25.68) 
33.00 (22.32) 
28.29 (18.52) 
 
58 – 86 
11 – 70 
5 – 33 
5 – 29 
 
74.5 (10.47) 
30.58 (18.43) 
15 (8.91) 
13.67 (7.67) 
 
42 – 83 
8 – 86 
4 – 66 
4 - 53 
 
64.23 (11.6) 
32.46 (28.91) 
19.54 (20.19) 
16.77 (16.22) 
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Table 13. Executive Functioning Performance within the Verbal Fluency Domain 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Verbal Fluency 
α = 0.939 
-2.32 – 0.68 -1.2 (0.70) -1.79 – 0.64 -0.73 (0.77) -1.76 – 1.96 0.00 (0.79) 
Phonemic (letter) fluency 
 F 
 A 
 S 
 Total 
 
5 – 22 
4 – 14 
4 – 17 
14 – 52 
 
9.58 (4.54) 
6.42 (2.85) 
8.79 (3.57) 
24.79 (9.46) 
 
4 – 20 
1 – 15 
4 – 18 
13 – 47 
 
10.21 (4.72) 
7.74 (4.0) 
10.95 (4.39) 
28.74 (11.7) 
 
6 – 24 
1 – 26 
3 – 25 
10 - 75 
 
14.05 (4.65) 
11.4 (5.48) 
15.35 (5.07) 
40.80 (13.9) 
Semantic (category) fluency 
 Animals 
 Boy’s Names 
 Total 
 
6 – 21 
6 – 24 
12 – 44 
 
13.00 (3.93) 
13.53 (4.22) 
26.68 (7.77) 
 
10 – 25 
8 – 27 
24 – 48 
 
16.84 (4.19) 
16.58 (4.78) 
34.63 (7.3) 
 
12 – 29 
12 – 29 
27 – 58 
 
19.45 (4.51) 
19.7 (4.87) 
39.15 (8.1) 
Category switching 
 Total correct responses 
 
6 - 18 
 
11.11 (2.83) 
 
8 – 19 
 
11.95 (2.84) 
 
10 – 18 
 
13.7 (2.11) 
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The first set of analyses combined all z-scores from the four composite domains and derived an 
average in order to create one Executive Functioning score. Descriptive statistics are presented in 
Table 14 below and Figure 22 below. 
 
Table 14. Descriptive Statistics for the Executive Functioning Composite Scores 
Executive Functioning Mean (SD) Range 
 
Group 1: MA+ (n = 20) 
 
-1.18 (0.85) 
 
-3.14 - -0.9 
Group 2: MA-  (n = 19) -0.55 (0.51) -1.69 – 0.22 
Group 3: NC    (n = 20) -0.00 (0.29) -3.14 -0.59 
 
 
 
Figure 22. Executive Functioning Composite Scores for the 3 Participant Groups 
 
The prediction for this outcome variable was that MA participants would perform worse than 
control participants. One-way ANOVAs were conducted on these overall “EF” scores in order to 
establish between-group differences. For the most part, data were normally distributed. Where 
Levene’s test of homogeneity of variance, was violated, Welch’s F is reported. The groups were more 
or less equal in size.  
-1.40
-1.20
-1.00
-0.80
-0.60
-0.40
-0.20
0.00
MA+ MA- NC
C
o
m
p
o
si
te
 z
-s
co
re
Group
89 
 
 
 
The analysis compared EF across all 3 participant groups. Levene’s test was significant F(2, 56) = 
13.532, p <.001; therefore the assumption of homogeneity of variance was violated and an adjusted 
F is reported here. Statistically significant between-group differences were observed, Welch’s F(2, 
56) = 22.11 , p < .001. The Games-Howell post-hoc calculation of multiple comparisons was 
used to shed further light on the data. Statistically significant differences were found 
between all three participant groups; MA+ and MA- groups (p = .023); MA- and NC groups (p = 
.001); and MA+ and NC groups (p < .001), respectively, with the most impairment observed in the 
MA+ group and the least impairment observed in the NC group. The MA- group performed 
somewhere in between the MA+ and NC groups. Our prediction was therefore confirmed that 
Executive Functioning is impaired in methamphetamine. Subsequent analyses begin to expand 
further on this result. 
 
The second set of analyses examined the average z-scores for each of the 4 composite domains; 
Decision Making and Impulsivity (DM), Response Inhibition and Set-Shifting (RI), Attention and 
Working Memory (WM) and Verbal Fluency (VF). Descriptive statistics are presented in Table 15 
below and graphically illustrated in Figure 23 below. 
 
Table 15. Descriptive Statistics for the Four Executive Domains 
 Group 1: MA+ 
(n = 20) 
Group 2: MA- 
(n = 19) 
Group 3: NC 
(n = 20) 
 M (SD) Range M (SD) Range M (SD) Range 
DM 
WM** 
-0.29 (0.51) 
-2.79 (2.58) 
-1.08 – 0.56 
-9.25 - -0.19 
-0.19 (0.40) 
-0.67 (1.07) 
-1.12 – 0.62 
-3.31 – 0.48 
0.001 (0.41) 
0.00 (0.43) 
-0.63 – 0.73 
-0.74 – 0.72 
RI** -0.58 (0.29) -1.12 - -0.10 -0.62 (0.66) -1.98 – 1.05 -0.01 (0.33) -1.03 – 0.44 
VF** -1.2 (0.70) -2.32 – 0.68 -0.73 (0.77) -1.79 – 0.64 0.00 (0.79) -1.76 – 1.96 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 23. Mean Composite z-scores for the 4 Executive Functioning Domains 
 
 
One-way ANOVAs were conducted on each of the 4 domains in order to establish between-group 
differences. For the most part, data were normally distributed. Where Levene’s test of homogeneity 
of variance was violated, Welch’s F is reported. The groups were more or less equal in size.  
 
The analysis compared 4 composite domains across the 3 participant groups. All domains yielded 
significant between-group differences, except for Decision Making and Impulsivity. These results can 
be seen in Table 16 below. 
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Table 16. ANOVA Results Summary Table 
 Sum of Squares df Mean Square F Sig. 
 
Decision Making and 
Impulsivity 
 Between Groups 
 Within Groups 
 Total 
 
 
.915 
10.788 
11.703 
 
 
2 
55 
57 
 
 
.457 
.196 
 
 
2.332 
 
 
.107 
Response Inhibition and 
Set-shifting 
 Between Groups 
 Within Groups 
 Total 
 
 
4.607 
11.581 
16.189 
 
 
2 
55 
57 
 
 
2.304 
.211 
 
 
17.948 
 
 
< .001 
Attention and Working 
Memory 
 Between Groups 
 Within Groups 
 Total 
 
 
81.739 
144.284 
226.024 
 
 
2 
55 
57 
 
 
40.870 
2.623 
 
 
13.037 
 
 
< .001 
Verbal Fluency 
 Between Groups 
 Within Groups 
 Total 
 
14.804 
31.348 
46.151 
 
2 
55 
57 
 
7.402 
 
12.987 
 
< .001 
 
Post-hoc analyses were conducted in order to shed further light on where the specific between-
group differences were found. Either Tukey’s HSD or Games-Howell calculations were used 
depending on whether an adjusted F was reported. 
 
Response inhibition and set-shifting yielded significant between-group differences, Welch’s F(2, 55) 
= 17.948, p < .001. The Games-Howell calculation of multiple comparisons indicated significant 
differences between the MA+ and NC groups, p < .001 and between the MA- and NC groups, p = 
.004. No significant difference was observed between the MA+ and MA- groups (p = .975), indicating 
that these two groups performed similarly. For this domain, however, the MA- group performed 
slightly worse than the MA+ group. Tukey’s HSD homogenous subsets revealed two homogenous 
groups. Group 1 included the MA+ and MA- groups and Group 2 included the NC group. 
 
Attention and Working Memory yielded significant between-group differences, Welch’s F(2, 55) = 
13.037, p < 001. The Games-Howell calculation of multiple comparisons indicated significant 
differences between the MA+ and NC groups, p = .001; the MA- and NC groups, p = .047; and 
between the MA+ and MA- groups, p = .008. Results show that the MA+ group performed worse 
than both the MA- and NC groups, with the NC group performing the best. Tukey’s HSD homogenous 
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subsets revealed two homogenous groups. Group 1 included the MA+ group and Group 2 included 
the MA- and NC groups. 
 
Verbal Fluency yielded significant between-group differences, F(2, 56) = 12.987, p < .001. Tukey’s 
HSD calculation of multiple comparisons indicated significant differences between the MA+ and NC 
groups, p < .001, and between the MA- and NC groups, p = .011. No significant difference was 
observed between the MA+ and MA- groups (p = .119), indicating that these two groups performed 
similarly. Both MA groups performed significantly worse than the NC group. Tukey’s HSD 
homogenous subsets revealed two homogenous groups. Group 1 included the MA+ and MA- groups 
and Group 2 included the NC group.  
 
We then combined the two MA groups in order to improve statistical power on the Decision Making 
and Impulsivity domain. An independent-samples t-test was run in order to establish a between-
groups difference. A significant difference was observed between the MA group and the NC group (p 
= .035), where previously we did not observe a significant difference. The MA group showed greater 
impairment than the NC group. 
 
In summary, statistically significant between groups differences were observed between the three 
participant groups on Response Inhibition and Set-shifting, Attention and Working Memory, and 
Verbal Fluency, but not on Decision Making and Impulsivity. However, when the two MA groups 
were combined, this improved the statistical power of our analyses and a significant difference was 
observed on tasks of Decision Making and Impulsivity. Our predictions were therefore largely 
confirmed by our results. These results will now be expanded upon. Subsequent chapters will 
expand on each of the four executive functions domains, analysing between-group differences for 
each task. The results will be discussed individually for each domain in Chapters 5, 6, 7, and 8. 
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CHAPTER FIVE: DECISION MAKING IMPAIRMENT IN METHAMPHETAMINE 
 
Decision making was assessed using the following four tasks: a Delay Discounting Task, the 
Balloon Analogue Risk Taking Task, the Information Sampling Task and the Cambridge 
Gambling Task. The outcome measures for each of these tasks, as explained in the methods 
section, will be analysed below. Descriptive statistics for each outcome measure for each 
task are presented in tables and figures below. One-way ANOVAs were conducted in order 
to establish between-group differences.  
 
Delay Discounting Task (DDT) 
 
The Delay Discounting Task yielded one dependent variable or outcome measure of interest, 
namely, total number of discounts. This is the number of times a participant chose the 
immediate option over the delayed option when given an option of a smaller immediate 
monetary reward, or a larger delayed monetary reward.  Results indicate that, in general, 
the MA groups discounted more often than the NC group. Descriptive statistics are 
presented in Table 17 below and graphically represented in Figure 24 below. 
 
Table 17. Descriptive Statistics for the Delay Discounting Task 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
 
Number of 
discounts** 
 
13 – 22 
 
 
16.30 (2.27) 
 
 
13 – 21 
 
 
16.37 (2.09) 
 
 
10 – 14 
 
 
12.15 (1.31) 
 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 24. Mean Number of Discounts per Group 
 
The prediction for this outcome measure was that MA participants would discount more 
often and therefore show greater impairment than NC participants. Furthermore, it was 
predicted that the normal control group would discount less frequently, and therefore show 
less impairment, than both the MA groups.  
 
One-way ANOVAs were conducted on the data. Levene’s test was significant F(2, 56) = 
2.640, p = .08; therefore the assumption of homogeneity of variance was upheld. A 
statistically significant between-group difference was observed, F(2, 56) = 30.976, p < .001 
(see Table 17). Tukey’s HSD post-hoc calculation of multiple comparisons revealed a 
statistically significant difference between the MA+ and NC groups (p < .001) and between 
the MA- and NC groups (p < .001). No significant between group differences (p = .993) were 
observed between the MA+ and MA- groups, indicating similar performances between 
these two groups on the Delay Discounting Task. Both MA groups discounted more often 
than the NC group. This was further illustrated by a Tukey’s HSD analysis that identified the 
MA+ and MA- groups as a homogenous subset.  
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Table 18. ANOVA Results Summary Table for Number of Discounts 
 Sum of 
Squares 
 
df 
Mean Square  
F 
 
Sig. 
Between Groups 
Within Groups 
Total 
231.405 
209.171 
440.576 
 
2 
56 
58 
115.703 
3.735 
30.976 < .001 
 
 
Balloon Analogue Risk Taking Task (BART) 
 
The BART yielded four dependent variables or outcome measures of interest, namely, total 
number of pumps, adjusted average number of pumps, maximum number of pumps, and 
total points earned. Results indicate that, in general, the MA+ group show a greater number 
of pumps, a greater adjusted average number of pumps and a greater maximum number of 
pumps than the other two groups. The MA+ group also earned more points than the other 
two groups. NC participants scored the lowest on all four measures. This trend is what we 
would expect to find, given that MA users take more risks than non-MA users. Descriptive 
statistics are presented in Table 19 below and graphically represented in Figures 25 - 58 
below.
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Table 19. Descriptive Statistics for the Balloon Analogue Risk Taking Task 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Number of pumps 
Average number of pumps 
Maximum number of pumps 
Total points earned 
137 – 1108 
3.43 – 27.70 
7 – 113 
470 – 3515 
495.39 (252.39) 
12.39 (6.31) 
33.85 (27.13) 
1700.75 (700.3) 
272 – 932 
6.80 – 23.30 
12 – 66 
915 – 3515 
445.05 (168.38) 
11.13 (4.21) 
25.58 (11.57) 
1648.95 (561.22) 
52 – 863 
1.30 – 21.58 
3 – 92 
60 – 3470 
401.6 (205.39) 
10.04 (5.13) 
25.45 (20.94) 
1494.25 (787.84) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 25. Adjusted average Number of Pumps per Balloon 
 
 
Figure 26. Maximum Number of Pumps on a Balloon 
 
 
Figure 27.Total Number of Pumps 
 
 
 
 
Figure 28. Total Points Earned 
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The prediction for these outcome measures were that MA participants would take more 
risks than NC participants and therefore show higher numbers of pumps and ultimately earn 
a larger number of points. Furthermore, it was predicted that the control group would take 
fewer risks than the MA groups. 
 
While the bar charts above indicate that the MA participants took more risks that the NC 
participants, none of these group differences were found to be statistically significant. 
Levene’s test for all four outcome variables was not significant. Therefore, the assumption 
of homogeneity of variance was upheld. No statistically significant between-group 
differences were observed on any of the outcome measures for the BART (see Table 20). 
 
Table 20. ANOVA Results Summary Table for the BART 
 Sum of Squares df Mean Square F Sig. 
 
Total pumps 
 Between Groups 
 Within Groups 
 Total 
 
88714.798 
2522203.947 
2610918.746 
 
2 
56 
58 
 
44357.399 
45039.356 
 
.985 
 
.380 
Adjusted average 
 Between Groups 
 Within Groups 
 Total 
 
55.447 
1576.377 
1631.824 
 
2 
56 
58 
 
27.723 
28.150 
 
.985 
 
.380 
Maximum pumps 
 Between Groups 
 Within Groups 
 Total 
 
919.089 
24720.132 
25639.220 
 
2 
56 
58 
 
459.544 
441.431 
 
1.041 
 
.360 
Total Points 
 Between Groups 
 Within Groups 
 Total 
 
460517.281 
26780856.447 
27241373.729 
 
2 
56 
58 
 
230258.641 
478229.579 
 
.481 
 
.620 
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Information Sampling Task (IST) 
 
The IST yielded a total of 12 outcome measures, 6 per condition across 2 conditions. The 
first condition was a “Fixed Win Condition” and the second condition was a “Decreasing Win 
Condition”. For each condition there were 6 outcome measures; Mean Number of Boxes 
Opened Per Trial; Mean P Correct; Total Correct; Sampling Errors; Discrimination Errors; and 
Mean Box Opening Latency. Explanations of these outcome measures can be found under 
the Methods section. Results indicated few differences between the groups on this task. 
Descriptive statistics for the two conditions are presented in Table 21 below. Four outcome 
measures, yielding the most interesting results, are graphically illustrated in Figures 29 - 32 
below. 
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Table 21. Descriptive Statistics for the Information Sampling Task 
 
 
 
 
 
 
 
 
 
 
Note: * indicates significance at p < .05; ** indicates significance at p < .001
 Group 1: MA+ (n = 20) Group 2: MA- (n = 17) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Win condition fixed 
Boxes opened/trial 
Mean P (correct) 
Total correct 
Sampling errors 
Discrimination errors 
Mean box opening latency 
Win condition decreasing 
Boxes opened/trial 
Mean P (correct) 
Total correct 
Sampling errors 
Discrimination errors* 
Mean box opening latency 
 
3.8 – 25 
0.52 – 1 
1 – 10 
0 – 4 
0 – 5 
394.3 – 3793.67 
 
1.5 – 25 
0.55 – 1 
4 – 10 
0 – 5 
0 – 6 
335.92 – 5753.47 
 
14.83 (8.00) 
0.78 (0.15) 
7.9 (2.10) 
1.05 (1.23) 
1.55 (1.7) 
1132.50 (849.74) 
 
8.93 (6.28) 
0.69 (0.13) 
6.75 (1.89) 
2.25 (1.59) 
1.95 (1.64) 
1831.41(1567.67) 
 
6 – 25 
0.65 – 1 
7 – 10 
0 – 3 
0 – 3 
421.98 –1116.03 
 
5.3 – 25 
0.62 – 1 
6 – 10 
0 – 4 
0 – 3 
445 – 1766.88 
 
14.42 (6.2) 
0.79 (0.11) 
8.41 (1.06) 
1.12 (0.86) 
0.82 (0.95) 
1116.03 (671.26) 
 
10.13 (4.72) 
0.72 (0.09) 
7.59 (1.12) 
1.76 (1.14) 
1.06 (0.97) 
1108.78 (397.91) 
 
3.9 – 25 
0.58 – 1 
5 – 10 
0 – 5 
0 – 4 
368.55 – 8156.25 
 
4 – 22.9 
0.61 – 0.94 
5 – 10 
0 – 5 
0 – 3 
537.98 – 7330.19 
 
12.48 (6.51) 
0.76 (0.13) 
7.95 (1.64) 
1.5 (1.5) 
1.15 (1.18) 
1501.61(1661.95) 
 
9.26 (4.64) 
0.71 (0.08) 
7.7 (1.34) 
2 (1.2) 
0.9 (0.97) 
1606.36(1484.13) 
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Figure 29. Fixed Win Condition: Mean Number of Boxes 
Opened per Trial 
 
Figure 30. Decreasing Win Condition: Mean Number of 
Boxes Opened per Trial 
 
 
Figure 31. Fixed Win Condition: Discrimination Errors 
 
Figure 32. Decreasing Win Condition: Discrimination Errors 
 
The prediction for this outcome measure was that MA participants would make decisions 
based on less evidence i.e. open fewer boxes and as a result make more errors than NC 
participants. It was also predicted that the NC participants would use more evidence to 
make their decisions i.e. open more boxes, and this would lead to fewer errors. This was not 
necessarily the case. Interestingly, on the Fixed Win Condition, the MA participants actually 
opened more boxes than the NC participants. However, on the Decreasing Win Condition, 
where participants lost points for every box they opened, the MA+ group drastically 
decreased the number of boxes opened per trail. The other two groups (MA- and NCs) 
performed similarly to the Fixed Win Condition. 
 
One-way ANOVAs were conducted in order to establish between-group differences. Where 
the assumption of homogeneity of variance assumption was violated, an adjusted F is 
11
12
13
14
15
16
MA+ MA- NC
N
u
m
b
e
r 
o
f 
B
o
xe
s
Group
8
9
9
10
10
11
MA+ MA- NC
N
u
m
b
e
r 
o
f 
B
o
xe
s
Group
0
1
1
2
2
MA+ MA- NC
D
is
cr
im
in
at
io
n
 E
rr
o
rs
Group
0
1
1
2
2
3
MA+ MA- NC
D
is
cr
im
in
at
io
n
 E
rr
o
rs
Group
102 
 
 
reported. Results did not reveal any statistically significant between-group differences on 
the Fixed Win Condition. ANOVA results are presented in Table 22 below. 
 
Table 22. ANOVA Results Summary Table for the IST Fixed Win Condition 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Mean number of boxes opened 
per trial 
 Between groups 
 Within groups 
 Total 
 
 
62.338 
2634.917 
2697.255 
 
 
2 
54 
56 
 
 
31.169 
48.795 
 
 
.639 
 
 
.532 
Mean P correct 
 Between groups 
 Within groups 
 Total 
 
.010 
.911 
.920 
 
2 
54 
56 
 
.005 
.017 
 
.291 
 
.748 
Total correct 
 Between groups 
 Within groups 
 Total 
 
2.852 
152.868 
155.719 
 
2 
54 
56 
 
1.426 
2.831 
 
.504 
 
.607 
Sampling errors 
 Between groups 
 Within groups 
 Total 
 
2.320 
83.715 
86.035 
 
2 
54 
56 
 
1.160 
1.550 
 
.748 
 
.478 
Discrimination errors 
 Between groups 
 Within groups 
 Total 
 
4.907 
95.971 
100.877 
 
2 
54 
56 
 
2.453 
1.777 
 
1.380 
 
.260 
Mean box opening latency 
 Between groups 
 Within groups 
 Total 
 
1844550.592 
73408142.585 
75252693.177 
 
2 
54 
56 
 
922275.296 
1359410.048 
 
.678 
 
.512 
 
 
Results revealed only one statistically significant between-group difference on the 
Decreasing Win Condition; all other outcome measures showed no statistically significant 
between-group differences. ANOVA results are presented in Table 23 below. 
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Table 23. ANOVA Results Summary Table for the IST Decreasing Win Condition 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Mean number of boxes opened 
per trial 
 Between groups 
 Within groups 
 Total 
 
 
13.854 
1516.725 
1530.579 
 
 
2 
54 
56 
 
 
6.927 
28.088 
 
 
.247 
 
 
.782 
Mean P correct 
 Between groups 
 Within groups 
 Total 
 
.012 
.563 
.574 
 
2 
54 
56 
 
.006 
.010 
 
.556 
 
.577 
Total correct 
 Between groups 
 Within groups 
 Total 
 
10.599 
122.068 
132.667 
 
2 
54 
56 
 
5.300 
2.261 
 
2.344 
 
.106 
Sampling errors 
 Between groups 
 Within groups 
 Total 
 
2.174 
96.809 
98.982 
 
2 
54 
56 
 
1.087 
1.793 
 
 
.606 
 
.549 
Discrimination errors 
 Between groups 
 Within groups 
 Total 
 
12.625 
83.691 
96.316 
 
2 
54 
56 
 
6.312 
1.550 
 
4.073 
 
.023 
Mean box opening latency 
 Between groups 
 Within groups 
 Total 
 
4947030.729 
91077984.503 
96025015.233 
 
2 
54 
56 
 
2473515.365 
1686629.343 
 
1.467 
 
.240 
 
Therefore the only statistically significant between-group differences were observed on 
Discrimination Errors on the Decreasing Win Condition, F(2,54) = 4.073, p = .023. The 
Tukey’s HSD post-hoc calculation of multiple comparisons was used to shed further light on 
the data. Statistically significant differences were found between the MA+ and NC groups, p 
= .027. No statistically significant differences were observed between the MA- and NC 
groups (p = .921), or the MA+ and MA- groups (p = .086). Tukey’s HSD homogenous subsets 
analysis separated the MA+ and MA- groups on the one hand, and the MA- and NC groups 
on the other.  
 
These results have not confirmed the prediction that MA participants make choices based 
on less information than NCs. However, these results do confirm the prediction that MA+ 
participants make more errors than NC participants.  
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Cambridge Gambling Task (CGT) 
 
The CGT yielded a total of six outcome measures; Delay Aversion, Deliberation Time, Overall 
Proportion Bet, Quality of Decision Making, Risk Adjustment, and Risk Taking. Descriptive 
statistics are presented in Table 24 below and graphically illustrated in Figures 33 - 38 
below.  
 
The prediction for these outcome measures were that the MA participants would be more 
averse to waiting to bet larger amounts (i.e. behave more impatiently), take longer to make 
choices, show a poorer quality of decision making and more risk taking than NC participants. 
Furthermore, it was predicted that NC participants would be less averse to waiting to bet 
larger amounts (i.e. behave more patiently), take less time to make choices, show a better 
quality of decision making and take less risks that MA participants.  
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Table 24. Descriptive Statistics for the Cambridge Gambling Task 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
 
 
 
 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 18) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Delay aversion 
Deliberation time 
Overall proportion bet 
Quality of decision making 
Risk adjustment* 
Risk taking 
-0.07 – 0.9 
1385.61 – 6363.12 
0.31 – 0.94 
0.39 – 0.98 
-2.27 – 2.38 
0.28 – 0.94 
0.5 (0.33) 
3367.15 (1332.87) 
0.57 (0.17) 
0.72 (0.23) 
0.18 (1.00) 
0.59 (0.18) 
0 - 0.9 
1373.73 – 8371.32 
0.27 – 0.89 
0.3 – 1.00 
-0.46 – 1.48 
0.26 – 0.94 
0.44 (0.28) 
3217.37 (1571.16) 
0.58 (0.18) 
0.74 (0.19) 
0.24 (0.49) 
0.61 (0.18) 
0.03 – 0.77 
1257.7 –11185.69 
0.39 – 0.74 
0.14 – 1.00 
-0.63 – 2.27 
0.38 – 0.87 
0.41 (0.21) 
3041.36 (2156.82) 
0.57 (0.11) 
0.83 (0.18) 
0.86 (0.86) 
0.62 (0.13) 
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Figure 33. Mean Delay Aversion Scores 
 
 
 
Figure 34. Mean Deliberation Time  
 
 
 
Figure 35. Mean Overall Proportion Bet 
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Figure 36. Mean Quality of Decision Making Score 
 
 
 
Figure 37. Mean Risk Adjustment Score 
 
 
 
Figure 38. Mean Risk Taking Score 
 
 
The bar charts above illustrate, generally, what we would expect to find. However, only one 
statistically significant result was observed. The other five outcome measures yielded 
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statistically non-significant results. Levene’s test of homogeneity of variance was generally 
found to be non-significant; therefore the assumption of homogeneity of variance was 
upheld. 
 
Table 25. ANOVA Results Summary for the CGT 
 Sum of Squares df Mean Square F Sig. 
 
Delay aversion 
 Between groups 
 Within groups 
 Total 
 
.088 
4.248 
4.336 
 
2 
55 
57 
 
.044 
.077 
 
 
.573 
 
 
.567 
 
Deliberation time 
 Between groups 
 Within groups 
 Total 
 
1063512.228 
164105173.007 
165168685.235 
 
2 
55 
57 
 
531756.114 
2983730.418 
 
 
.178 
 
 
.837 
 
Overall proportion bet 
 Between groups 
 Within groups 
 Total 
 
.001 
1.342 
1.343 
 
2 
55 
57 
 
.001 
.024 
 
.022 
 
 
.978 
Quality of decision making 
 Between groups 
 Within groups 
 Total 
 
.121 
2.220 
2.341 
 
2 
55 
57 
 
.060 
.040 
 
 
1.497 
 
 
.233 
 
Risk adjustment 
 Between groups 
 Within groups 
 Total 
 
5.534 
36.849 
42.383 
 
2 
55 
57 
 
2.767 
.670 
 
 
4.130 
 
 
.021 
 
Risk taking 
 Between groups 
 Within groups 
 Total 
 
.009 
1.496 
1.505 
 
2 
55 
57 
 
.005 
.027 
 
 
.166 
 
 
.847 
 
 
 
The only outcome measure from the CGT to reveal a statistically significant between-group 
difference was Risk Adjustment, F(2, 54) = 4.130, p = .021. Tukey’s HSD post-hoc tests 
revealed significant differences between the MA+ and NC groups, p = .031. No statistically 
significant differences were observed between the MA- and NC groups (p = .061), or the 
MA+ and MA- groups (p = .973).Tukey’s HSD homogenous subsets revealed two 
homogenous groups. Group 1 included the MA+ and MA- groups and group 2 included the 
MA- and NC groups.  
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Combining the two MA groups, in order to improve statistical power had no effect on the 
Decision Making and Impulsivity tasks. The outcome measures that were not found to be 
statistically significant in the above analyses remained unchanged by the independent-
samples t-test.  
 
In summary, the results from these analyses show significant between-group differences on 
few outcome measures regarding Decision-Making. Both MA groups discounted more 
frequently than controls on the DDT. The BART showed no significant between-group 
differences. The MA+ group committed significantly more errors than the controls on the 
IST. The MA+ group displayed a higher level of risk than controls on the CGT. Combining the 
two MA groups did not reveal any further significant results. These results will now be 
discussed below. 
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DISCUSSION 
 
Our hypothesis predicted that Decision-Making would be impaired in methamphetamine 
dependence. Particularly, it was predicted that the MA groups would perform worse on decision-
making tasks than the control participants; indicated by the following: MA+ > MA- > NC. This 
prediction was partially confirmed by our results.  
 
Our results indicate that certain aspects of decision-making are impaired in MA. In particular, MA 
participants discounted the value of a higher delayed reward more frequently than control 
participants, indicating that MA participants may act more impulsively and impatiently than control 
participants. This finding is consistent with previous research findings that indicate impaired 
decision-making in general (Bechara et al., 2001; Paulus, Hozack, Frank, Brown & Schuckit, 2003) and 
an association between MA and delay discounting (Hoffman et al., 2006; Monterosso et al., 2007; 
Paulus et al., 2002) in particular.  
 
The Balloon Analogue Risk Taking Task did not yield any statistically significant results, contradicting 
both our hypothesis that this task would identify MA participants as higher risk takers than control 
participants and previous literature indicating that substance abuse is associated with risky decision 
making (Bornovalova et al., 2005; Duarte et al., 2011; Lane & Cherek, 2000).  
 
There are a number of factors that could explain this result. Firstly, Bornovalova et al. (2009) suggest 
that individuals exhibit less risky behaviour when the reward/loss magnitude is large. In other words, 
the higher the potential reward, the higher the potential loss, and therefore the less risky one is 
inclined to be. This sheds some light on our findings. Given that our participants earned only 5 points 
per pump, this reward/loss magnitude could have been too small to illicit the risky behaviour that is 
associated with substance dependence. It is suggested that future studies consider a larger 
reward/loss magnitude in order to illicit risky behaviour. Secondly, it is important to note that there 
are differences between the three participant groups as shown by the bar charts in the results 
sections above; even though these differences were not statistically significant. Thus, the lack of 
statistical significance may be due to inadequate sample size.  
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The Information Sampling Task only yielded one statistically significant result. Results indicated that 
MA+ participants made more Discrimination Errors during the Decreasing Win Condition than 
control participants. Discrimination errors are the number of times a participant chose a colour that 
was not in the majority at the time of making the decision. Therefore MA+ participants made more 
decisions that were not logically based on the evidence available to them at the time. This is 
consistent with what we expected in terms of the MA+ participants, and is in agreement with 
previous literature suggesting that MA impairs decision-making (Clark et al., 2006; Hoffman et al., 
2006, 2008; Monterosso et al., 2007; Paulus et al., 2002, 2003).  
 
Furthermore, we would have expected the MA- group to also perform poorly on this task. Although 
the MA- group performed worse than the control group, these differences were not statistically 
significant. Clark et al. (2006) found that substance users, both current and abstinent, responded at 
a lower probability of making correct responses on the IST. Our results only partially reflect this 
finding, again perhaps reflecting the relatively small sample size. However, these data are consistent 
with previous work conducted by Passetti et al. (2008) that compared abstinent opiate addicts to 
non-abstinent opiate addicts on the IST and found no significant differences between their groups 
on any of the outcome measures. In addition, only one participant from their entire sample was 
found to be impaired. This may suggest that this task is not sensitive to the decision-making 
impairments found in opiate addicts (Passetti et al., 2008). Similarly this task may not be a sensitive 
measure of decision-making in this sample of methamphetamine-dependent individuals. 
 
The Cambridge Gambling Task only yielded one statistically significant result. It was found that MA+ 
participants scored significantly lower than control participants on Risk Adjustment. There were no 
statistically significant differences between the MA- participants and the control participants. This 
indicates that control participants are more likely to bet larger amounts when the odds are strongly 
in their favour. In other words, they tend to bet a higher proportion of points on trials where the 
large majority of the boxes are the colour chosen than when a small number of boxes are of the 
colour chosen. This result is consistent with our prediction for this outcome measure. Passetti et al. 
(2008) also found similar results when comparing abstinent opiate addicts to non-abstinent opiate 
addicts on the Cambridge Gambling Task. The authors found that the abstinent addicts scored higher 
on Risk Adjustment than the non-abstinent addicts. Further to this finding, we would also expect 
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significant differences on all other outcome measures for this task. However, this was not the case. 
Our results do however show that the MA+ group was more likely to place bets on trials where the 
smaller majority of the boxes were of the chosen colour. We conclude that the MA+ group’s 
decisions were therefore more risky than the NC and MA- groups.  
 
In summary, it would appear that certain aspects of decision-making are impaired in our sample of 
MA dependent participants. We have shown that MA participants are more impulsive than controls 
as they discount the value of future (delayed) rewards and instead opt for smaller, immediate 
rewards. MA+ participants in particular have been shown to make poor decisions based on minimal 
information and also make risky decisions. Scott et al. (2007, p. 287) suggest that this may 
predispose individuals with methamphetamine-psychosis to “real world” risky behaviours such as 
needle sharing and unprotected sex. Therefore clinical management of these individuals should 
address such impairment. 
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CHAPTER SIX: RESPONSE INHIBITION IMPAIRMENT IN METHAMPHETAMINE 
 
 
Response Inhibition was assessed using the following four tasks; the Affective Go/No Go Task; the 
Stop Signal Task; the Stroop Task, and the Wisconsin Card Sorting Task. The outcome measures for 
each of these tasks, as explained in the methods section, will be analysed below. Descriptive 
statistics for each outcome measure for each task are presented in tables and figures below. 
One-way ANOVAs were conducted in order to establish between-group differences. 
Repeated-measures ANOVAs were also conducted on some of these data. 
 
Affective Go/No Go Task (AGN) 
 
The AGN Task yielded four dependent variables or outcome measures, namely, Mean Correct 
Latency (positive), Mean Correct Latency (negative), Total Omissions (positive) and Total Omissions 
(negative). Results indicate that, in general, MA participants performed worse than control 
participants on this task. Descriptive statistics are presented in Table 26 and graphically represented 
in Figures 39 - 40 below. Each outcome measure will be dealt with separately, however, the ANOVA 
results summary can be found in Table 27 below. 
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Table 26. Descriptive Statistics for the AGN Task 
 Group 1: MA+ (n = 19) Group 2: MA- (n = 18) Group 3: NC (n = 18) 
 Range M (SD) Range M (SD) Range M (SD) 
Mean correct latency 
(positive)** 
Mean correct latency (negative) 
Total omissions (positive) 
Total omissions (negative)** 
380.79 – 946.89 
 
310 – 872.31 
2 – 34 
4 – 35 
690.45 (162.60) 
 
649.75 (151.09) 
15.89 (10.76) 
15.89 (9.7) 
411.67 – 759 
 
502.20 – 838.50 
1 – 23 
1 – 15 
636.60 (89.93) 
 
653.95 (101.98) 
10.17 (7.00) 
8.56 (4.31) 
262.55 – 686.25 
 
386.90 – 688.33 
0 – 22 
0 – 16 
512.47 (98.45) 
 
528.63 (79.37) 
5.22 (5.77) 
3.50 (3.85) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Table 27. ANOVA Results Summary for the AGN 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Mean correct latency (positive) 
 Between groups 
 Within groups 
 Total 
Mean correct latency (negative) 
 Between groups 
 Within groups 
 Total 
Total omissions (positive) 
 Between groups 
 Within groups 
 Total 
Total omissions (negative) 
 Between groups 
 Within groups 
 Total 
 
305766.495 
778130.797 
1083897.293 
 
183847.110 
694782.128 
878629.238 
 
1056.309 
3483.401 
4539.709 
 
1440.793 
2262.734 
3703.527 
 
 
2 
52 
54 
 
2 
52 
54 
 
2 
52 
54 
 
2 
52 
54 
 
152883.248 
14964.054 
 
 
91923.555 
13361.195 
 
 
528.154 
66.988 
 
 
720.397 
43.514 
 
 
10.217 
 
 
 
6.880 
 
 
 
7.884 
 
 
 
16.555 
 
 
< .001 
 
 
 
.002 
 
 
 
.001 
 
 
 
< .001 
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The prediction for the outcome measure Mean Correct Latency (mean time taken to respond) was 
that MA participants would perform at a slower rate than NC participants on both the positive and 
negative items. This prediction was largely confirmed as illustrated by Figure 39 below. As shown, 
the MA groups performed more slowly on both positive and negative items, compared to the NC 
group. 
 
 
 
 
A one-way ANOVA was conducted to compare the three group means. Levene’s test for Mean 
Correct Latency (positive) was significant F(2, 52) = 6.263, p = .004; therefore the assumption of 
homogeneity was violated, and an adjusted F is reported here. A statistically significant between-
group difference was found, Welch’s F(2, 52) = 11.294, p < .001. The Games-Howell calculation of 
multiple comparisons was used to shed further light on the data. Statistically significant differences 
were found between the MA+ and NC groups (p = .001); and between the MA- and NC groups (p = 
.001). No statistically significant between group differences were observed between the MA+ and 
MA- groups (p = .381). Tukey’s HSD homogenous subsets revealed two homogenous groups. Group 1 
included the MA+ group and group 2 included the MA- and NC groups.  
 
Levene’s test for Mean Correct Latency (negative) was significant F(2, 52) = 2.804, p = .070; therefore 
the assumption of homogeneity of variance was violated, and an adjusted F is reported here. A 
statistically significant between-group difference was found, Welch’s F(2, 52) = 6.88, p = .002. The 
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Games-Howell calculation of multiple comparisons was used to shed further light on the data. 
Statistically significant differences were observed between the MA+ and NC groups (p = .013); and 
between the MA- and NC groups (p = .001). No statistically significant differences were observed 
between the MA+ and MA- groups (p = 993). Tukey’s HSD homogenous subsets revealed two 
homogenous groups. Group 1 included the MA+ group and group 2 included the MA- and NC groups.  
 
The prediction for the outcome measure Total Omissions (incorrect responses) was that the MA 
participants would show more omissions than NC participants, for both positive and negative items. 
This prediction was confirmed as illustrated by Figure 40 below. As shown, the MA+ group scored a 
higher number of omissions than the MA- and NC groups, with the NC group scoring the least 
number of omissions, for both positive and negative items. 
 
Figure 40. Total Omissions of Positive and Negative Items 
 
A one-way ANOVA was conducted in order to compare the three group means. Levene’s test for 
Total Omissions (positive) was significant F(2, 52) = 7.221, p = .002; therefore the assumption of 
homogeneity of variance was violated, and an adjusted F is reported here. A statistically significant 
between-group difference was found, Welch’s F(2, 52) = 7.747, p = .002. The Games-Howell 
calculation of multiple comparisons was used to shed further light on the data. A statistically 
significant difference was observed between the MA+ and NC groups (p = .002). The differences 
between the MA- and NC groups (p = .068) and between the MA+ and MA- groups (p = .148) were 
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not statistically significant. Tukey’s HSD homogenous subsets revealed two homogenous groups. 
Group 1 included the MA+ and MA- groups and group 2 included the MA- and NC groups.  
Levene’s test for Total Omissions (negative) was significant F(2, 52) = 12.336, p < .001; therefore the 
assumption of homogeneity of variance was violated, and an adjusted F is reported here. A 
statistically significant between-group difference was found, Welch’s F(2, 52) = 16.067, p < .001. The 
Games-Howell calculation of multiple comparisons was used to shed further light on the data. 
Statistically significant differences were observed between the MA+ and MA- groups (p = .016); 
between the MA+ and NC groups (p < .001); and between the MA- and NC groups (p = .002). Tukey’s 
HSD homogenous subsets revealed two homogenous groups. Group 1 included the MA+ and MA- 
groups and group 2 included the MA- and NC groups.  
 
The Stop Signal Task (SST) 
 
The SST yielded five outcome measures, namely, Direction Errors on Stop and Go Trials, Proportion 
of Successful Stops (last half),  Median Correct RT on Go Trials, Stop Signal Delay (last half), Stop 
Signal Reaction Time (last half). Most of the outcome measures have yielded the expected 
differences between the groups; however they are not all necessarily statistically significant. 
Descriptive statistics are presented in Table 28 below and means are graphically illustrated in Figures 
41 - 43 below.  
Predictions for these outcome measures were as follows: 
1. Directions Errors on Stop and Go Trials: MA participants would make more errors on (where 
the wrong button was pressed, i.e. the incorrect direction was chosen) than NC participants. 
2. Proportion of Successful Stops: MA participants would not be able to successfully stop as 
often as NC participants and therefore have fewer successful stops. 
3. Median Correct Reaction Time on Go Trials: MA participants would show slower reaction 
times compared to NC participants. 
4. Stop Signal Delay: MA participants would have a shorter stop signal delay. This is due to the 
fact that this group often responds before the stop signal is deployed, thereby resulting in 
more errors. Their stop signal is therefore shortened in order to minimize errors. 
Furthermore, NC participants were predicted to have a longer stop signal delay. 
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5. Stop Signal Reaction Time: MA participants would show slower SSRTs than NC control 
participants. 
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Table 28. Descriptive Statistics for the Stop Signal Task 
 Group 1: MA+ (n = 19) Group 2: MA- (n = 16) Group 3: NC (n = 18) 
 Range M (SD) Range M (SD) Range M (SD) 
Directions errors on stop/go 
trials* 
Proportion of successful stops 
Median correct RT on go trials 
SSD (last half) 
SSRT (last half) 
0 – 32 
 
0.15 – 0.8 
319 – 825 
-186.22–548.25 
113.48 – 588.98 
7.79 (9.25) 
 
0.46 (0.14) 
564.63 (147.48) 
283.81 (231.19) 
280.82 (134.31) 
0 – 11 
 
0.35 – 0.9 
365.5 – 953 
72.1 – 708.2 
102.62 – 403.72 
3.31 (3.2) 
 
0.53 (0.14) 
589.47 (167.7) 
366.97 (174.84) 
222.47 (75.41) 
0 – 7 
 
0.28 – 0.82 
394.5 – 897 
150.62 – 738.82 
139.92 – 291.92 
1.72 (2.02) 
 
0.5 (0.16) 
552.89 (142.32) 
341.87 (147.28) 
211.02 (44.43) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 41. Mean Direction Errors on Stop and Go Trials 
 
 
 
Figure 42. Proportion of Successful Stops (last half) 
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Figure 43. Bar chart illustrating outcome measures of the SST relating to time 
 
One-way ANOVAs were conducted on the data in order to establish between-group differences. The 
ANOVA results summary is presented in Table 29 below. 
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Table 29. ANOVA Results Summary for the SST 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Directions errors on stop/go 
trials 
 Between groups 
 Within groups 
 Total 
Proportion of successful stops 
 Between groups 
 Within groups 
 Total 
Median correct RT on go trials 
 Between groups 
 Within groups 
 Total  
SSD (last half) 
 Between groups 
 Within groups 
 Total 
SSRT (last half) 
 Between groups 
 Within groups 
 Total 
 
 
366.246 
1764.207 
2130.453 
 
.051 
1.085 
1.136 
 
11699.255 
1157725.933 
1169425.189 
 
64835.257 
1789363.438 
1854198.695 
 
51678.856 
458221.075 
509899.931 
 
 
 
2 
50 
52 
 
2 
50 
52 
 
2 
50 
52 
 
2 
50 
52 
 
2 
50 
52 
 
 
183.123 
35.284 
 
 
.025 
.022 
 
 
5849.628 
23154.519 
 
 
32417.629 
35787.269 
 
 
25839.428 
9164.422 
 
 
 
4.762 
 
 
 
1.171 
 
 
 
.253 
 
 
 
.906 
 
 
 
2.820 
 
 
 
.016 
 
 
 
.318 
 
 
 
.778 
 
 
 
.411 
 
 
 
.069 
 
 
 
Directions Errors on Stop/Go Trials was the only outcome measure to yield a statistically significant 
result, Welch’s F(2, 50) = 4.762, p = .016. The Games-Howell calculation of multiple comparisons was 
used to shed further light on the data. Statistically significant differences were found between the 
MA+ and NC groups (p = .029). No statistically significant differences were found between the MA+ 
and MA- groups (p = .077), nor the MA- and NC groups (p = .717). Tukey’s HSD homogenous subsets 
analysis separated the MA+ and MA- groups on the one hand, and the MA- and NC groups on the 
other.  
 
No other outcome measures of this task yielded statistically significant results, however, between-
group differences on SSRT were marginally significant, p = .069. This indicates a non-significant trend 
in the predicted direction indicating that MA+ participants performed slower than MA- and NC 
groups, MA- participants performed quicker than MA+ participants, but slower than NC participants, 
and NC participants performed more quickly than the other two groups. This indicates that the MA+ 
group was the most impaired on this outcome measure. 
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The Stroop Task 
 
The Stroop Task yielded a number of outcome measures per participant. There were a total of 4 
trials and for each trial there were three outcome measures; Total Time, Non Corrected Errors, and 
Self Corrected Errors. Results largely confirmed predictions for this task. Descriptive statistics are 
presented in Table 30 below and are graphically illustrated in Figure 44 below.  
 
The prediction for the Total Time over the 4 trials across the 3 comparison groups was that there 
would be significant differences between groups across all four trials as they increase in difficulty. 
Our predictions were largely confirmed by our results. 
 
Table 30. Descriptive Statistics for the Stroop Task 
 Group 1: MA+ (n = 19) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Trial 1:   
Total time 
Errors 
Self corrected  
Trial 2:   
Total time 
Errors 
Self corrected  
Trial 3:   
Total time 
Errors 
Self corrected  
Trial 4:  
Total time 
Errors 
Self corrected  
 
21 – 43 
0 – 4 
0 – 4 
 
31 – 79 
0 – 6 
0 – 5 
 
49 – 122 
0 – 16 
1 – 13 
 
40 – 230 
0 – 21 
0 – 18 
 
33.00 (9.17) 
0.74 (1.15) 
1.47 (1.39) 
 
53.00 (13.96) 
1.53 (1.9) 
2.16 (1.30) 
 
81.89 (21.12) 
3.11( 4.16) 
4.42 (3.02) 
 
103.68 (57.65) 
3.58 (6.14) 
4.42 (4.54) 
 
18 – 42 
0 – 3 
0 – 3 
 
21 – 58 
0 – 3 
0 – 5 
 
44 – 105 
0 – 5 
0 – 6 
 
47 – 150 
0 – 5 
0 – 7 
 
26.26 (6.61) 
0.26 (0.81) 
0.79 (1.08) 
 
37.16 (11.07) 
0.37 (0.83) 
1.58 (1.43) 
 
68.84 (16.98) 
0.84 (1.3) 
3.16 (1.86) 
 
79.21 (25.41) 
1.00 (1.33) 
2.42 (1.77) 
 
15 – 31 
0 – 1 
0 – 1 
 
21 – 53 
0 – 3 
0 – 3 
 
37 – 69 
0 – 5 
0 – 7 
 
43 – 104 
0 – 6 
0 – 5 
 
22.60 (3.91) 
0.1 (0.31) 
0.1 (0.31) 
 
31.10 (6.8) 
0.15 (0.67) 
0.7 (0.92) 
 
52.5 (9.53) 
0.3 (1.13) 
1.45 (1.82) 
 
59.85 (14.73) 
0.8 (1.77) 
0.9 (1.33) 
 
 
125 
 
 
 
Figure 44. Mean Times Taken per Trial for the Stroop Task 
 
A repeated-measures ANOVA was conducted on the data. Mauchly’s test was significant,  χ2 (5) = 
0.107, p < .001; therefore the assumption of sphericity was violated. Therefore, degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (Є = .453). There was a statistically 
significant main effect of Trials on Total Time to complete the trial when testing within-subjects 
effects, F(1.358, 74.708) = 112.13, p < .001. The Trials x Group interaction was also statistically 
significant, F(2.717, 74.708) = 3.218, p = .032; and  there was a statistically significant main effect of 
Group, F(2, 55) = 15.546, p = < .001. Pairwise comparisons indicated statistically significant 
differences across all four trials. The Games-Howell calculation of multiple comparisons revealed 
statistically significant differences between the MA+ and MA- groups, p = .034; between the MA- 
and NC groups, p = .004; and between the MA+ and NC groups, p < .001.  
 
The predictions for the Errors (Non Corrected) over the 4 trials across the 3 comparison groups were 
that there would be significant differences between groups across all four trials as they increase in 
difficulty. Our predictions were largely confirmed by our results, as illustrated by Figure 45 below. 
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Figure 45. Mean Number of Non Corrected Errors on the Stroop Task 
 
A repeated-measures ANOVA was conducted on the data. Mauchly’s test was significant,   χ2 (5) = 
0.274, p < .001; therefore the assumption of sphericity was violated. Therefore, degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (Є = .605). There was a statistically 
significant main effect of Trials on Non Corrected Errors when testing within-subjects effects, 
F(1.814, 99.783) = 6.479, p = .003. The Trials x Group interaction was not statistically significant, 
F(3.628, 74.708) = 1.783, p = .144. There was however a statistically significant main effect of Group, 
F(2, 55) = 7.114, p = .002. Pairwise comparisons revealed few significant differences across trials. 
Statistically significant between-trials differences were observed between trials 1 and 3 (p = .034), 
trials 1 and 4 (p = .037) and trials 2 and 4 (p = .049). The Games-Howell calculation of multiple 
comparisons revealed statistically significant differences between the MA+ and NC groups, p = .022. 
None of the other between-group comparisons were statistically significant.  
 
The predictions for the Self Corrected Errors over the over the 4 trials across the 3 comparison 
groups was that there would be significant differences between groups across all four trials as they 
increase in difficulty. Our predictions were largely confirmed by our results, as illustrated by Figure 
46 below. 
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Figure 46. Mean Number of Self Corrected Errors on the Stroop Task 
 
A repeated-measures ANOVA was conducted on the data. Mauchly’s test was significant,   χ2 (5) = 
0.446, p < .001; therefore the assumption of sphericity was violated. Therefore, degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (Є = .710). There was a statistically 
significant main effect of Trials on Self Corrected Errors when testing within-subjects effects, 
F(2.130, 117.148) = 20.491, p < .001. The Trials x Group interaction was not statistically significant, 
F(4.260, 117.148) = 2.038, p = .089. There was however a statistically significant main effect of 
Group, F(2, 55) = 14.180, p < .001. Pairwise comparisons indicated significant differences across all 
trials, excluding trials 3 and 4. Results indicate similar number of Self Corrected Errors for these 
trials. The Games-Howell post-hoc calculation of multiple comparisons revealed statistically 
significant differences between the MA+ and NC  groups, p < .001; between the MA- and NC groups, 
p = .002; but no statistically significant difference was observed between the MA+ and MA- groups.  
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The Wisconsin Card Sorting Task (WCST) 
 
The WCST yielded a total of 5 outcome measures, namely, Trials administered, Total Correct, Total 
Errors, Perseverative Responses, and Perseverative Errors. Less data were collected for this task due 
to a technical error that occurred during data collection and required fixing. The task could therefore 
not be administered to a number of participants during the data collection process. While a large 
number of participants returned in order for testing to take place, a number of others chose not to 
return. Predictions were that the MA participants would perform worse than the NC participants on 
this task. Descriptive statistics are presented in Table 31 below and are graphically illustrated in 
Figures 47 - 48 below.  
 
The prediction for the outcome measure “Trials Administered” was that more trials would be 
administered to MA participants than NC participants, due to the fact that they would make more 
Perseverative Responses and therefore more Perseverative Errors than NC participants. It was also 
predicted that NC participants would score a higher number of Total Correct choices, and therefore 
make fewer Total Errors than MA participants. Predictions were largely confirmed as illustrated 
graphically in Figure 47 below. 
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Table 31. Descriptive Statistics for the Wisconsin Card Sorting Task 
 Group 1: MA+ (n = 17) Group 2: MA- (n = 12) Group 3: NC (n = 13) 
 Range M (SD) Range M (SD) Range M (SD) 
Trials Administered 
Total correct 
Total errors 
Perseverative responses* 
Perseverative errors* 
76 - 128 
44 – 95 
12 – 84 
5 – 77 
5 – 66 
115.41(19.31) 
67.53 (15.09) 
47.88 (25.68) 
33.00 (22.32) 
28.29 (18.52) 
75 - 128 
58 – 86 
11 – 70 
5 – 33 
5 – 29 
105.08 (21.86) 
74.50 (10.47) 
30.58 (18.43) 
15.00 (8.91) 
13.67 (7.67) 
70 - 128 
42 – 83 
8 – 86 
4 – 66 
4 - 53 
96.69 (21.52) 
64.23 (11.6) 
32.46 (28.91) 
19.54 (20.19) 
16.77 (16.22) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 47. Mean Number of Trials administered per Group; Mean Number of Total Correct Choices 
per Group; and Mean Total Errors per Group 
 
 
 
Figure 48. Mean Number of Perseverative Responses per Group; and Mean Number of Perseverative 
Errors per Group 
 
0
20
40
60
80
100
120
140
MA+ MA- NC
N
u
m
b
e
r 
o
f 
Tr
ia
ls
 /
 E
rr
o
rs
Group
Trials Administered
Total Correct
Total Errors
0
5
10
15
20
25
30
35
MA+ MA- NC
N
u
m
b
e
r 
o
f 
R
e
sp
o
n
se
s 
/ 
Er
ro
rs
Group
Perseverative Responses
Perseverative Errors
131 
 
 
 
One-way ANOVAs were conducted on the data in order to compare means across the three 
participant groups. Levene’s statistics are presented in Table 32below. Where Levene’s test was 
found to be significant, an adjusted (Welch’s) F is reported.  
 
Table 32. ANOVA Results Summary for the WCST 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Trials Administered 
 Between groups 
 Within groups 
 Total 
Total correct 
 Between groups 
 Within groups 
 Total 
Total errors 
 Between groups 
 Within groups 
 Total 
Perseverative responses 
 Between groups 
 Within groups 
 Total 
Perseverative errors 
 Between groups 
 Within groups 
 Total 
 
2623.530 
16779.804 
19403.333 
 
648.957 
6461.543 
7146.500 
 
2717.921 
24315.912 
27033.833 
 
2603.745 
13737.231 
16340.976 
 
1773.901 
9290.504 
11064.405 
 
2 
39 
41 
 
2 
39 
41 
 
2 
39 
41 
 
2 
39 
41 
 
2 
39 
41 
 
1311.765 
430.251 
 
 
342.479 
165.681 
 
 
1358.961 
623.485 
 
 
1301.873 
352.237 
 
 
886.950 
238.218 
 
 
3.049 
 
 
 
2.067 
 
 
 
2.180 
 
 
 
4.404 
 
 
 
4.153 
 
 
 
.059 
 
 
 
.140 
 
 
 
.127 
 
 
 
.024 
 
 
 
.028 
 
 
Results from the number of Trials Administered were marginally significant, p = 0.59. This indicates a 
non-significant trend in the direction predicted. Therefore MA participants were administered more 
trials than NC participants.  
 
Statistically significant between-group differences were observed on Perseverative Responses, 
Welch’s F(2, 39) = 4.404, p = .024. The Games-Howell calculation of multiple comparisons was used 
to shed further light on the data. Statistically significant differences were observed between the 
MA+ and MA- groups (p = .017). No other statistically significant between-group differences were 
observed. Tukey’s HSD homogenous subsets revealed two homogenous groups. Group 1 included 
the MA+ and NC groups and Group 2 included the MA+ and MA- groups.  
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Statistically significant between-group differences were also observed on Perseverative Errors, 
Welch’s F(2, 39) = 4.153, p = .028. The Games-Howell calculation of multiple comparisons was used 
to shed further light on the data. Statistically significant differences were observed between the 
MA+ and MA- groups (p = .020). No statistically significant between-group differences were 
observed between the MA+ and NC groups (p = .184), or between the MA- and NC groups (p = .812). 
Tukey’s HSD homogenous subsets revealed two homogenous groups. Group 1 included the MA+ and 
NC groups and Group 2 included the MA+ and MA- groups.  
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DISCUSSION 
 
Our hypothesis predicted that Response Inhibition would be impaired in methamphetamine 
dependence. Particularly, it was predicted that the MA+ group would perform worse than the 
control group; indicated by the following: MA+ > MA- > NC. This prediction was largely confirmed.  
 
Our results indicate that, in general, Response Inhibition is impaired in methamphetamine 
dependence. Specifically, the AGN task indicated that MA participants performed more slowly and 
made more errors than control participants. The MA+ group performed the slowest out of the three 
groups. Statistically significant results were observed between the MA+ and control groups and 
between the MA- and control groups. However, no differences were observed between the MA+ 
and MA- groups, indicating that these groups performed similarly. The MA+ group scored the 
highest number of both positive and negative omissions. Statistically significant differences were 
observed between the MA+ and control groups regarding positive omissions. While there were 
differences observed between all three participant groups, in the direction predicted, none of the 
other between-group differences were statistically significant. Consistent with our predictions, 
statistically significant differences were observed between all three participant groups regarding 
negative omissions. These findings are consistent with previous research (Kim et al., 2006; Lelands et 
al., 2008; Monterosso, Aron, Cordova, Xu & London, 2005; Scott et al., 2007; Salo et al., 2002). 
Although Leland et al. (2008) observed improved response inhibition in MA Dependence when the 
Go/No Go task was cued, the authors still observed impairment on that task, when compared to 
controls. 
 
The SS Task only produced one significant result. The MA+ group scored more Direction Errors than 
the control group. No other statistically significant between-group differences were observed. 
Monterosso et al. (2005) found somewhat different results when investigating performance on the 
SST in MA abusers. Their results indicated that MA abusers performed worse than controls on the 
SSRT outcome measure. No other statistically significant differences were observed on the other 
outcome measures of the SST. Our results are similar in the sense that we observed a trend towards 
significance on the SSRT outcome measure. This indicates that, in our sample, the latency to inhibit 
an initiated motor response was slightly longer for the MA+ group; however this difference did not 
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reach statistical significance. Our results are also similar to those of Monterosso et al. (2005) in the 
sense that few outcome measures of this task yielded significant results.  
 
The Stroop Task indicated that MA participants performed more slowly across all four trials and 
made more Non Corrected Errors and more Self Corrected Errors than controls. Statistically 
significant differences were observed between all three groups regarding Time. The MA+ group 
made significantly more Non –Corrected Errors than the control group. The MA+ and MA- groups 
made significantly more Self-Corrected Errors than the control group. No statistically significant 
difference was observed between the MA+ and MA- groups, indicating that they performed 
similarly. These results are contrary to previous findings indicating that MA participants perform 
similarly to controls (Chang et al., 2002; Kim et al., 2006). However, our results are consistent with 
relatively recent research indicating a significant difference between MA participants and controls 
on Stroop RT (Salo et al., 2009). Our results are also consistent with results from Scott et al.’s (2007) 
meta-analysis indicating that response inhibition on the Stroop is particularly impaired in MA. 
 
The WCST was used to measure cognitive control in our sample. We observed statistically significant 
results on Perseverative Responses and Perseverative Errors. Results indicated that the MA+ group 
made significantly more Perseverative Responses and Perseverative Errors than the MA- group. 
Neither of these groups differed significantly from the control group.  This was contrary to our 
prediction and to previous findings that suggest a significant difference between MA- participants 
and control participants on the WCST Errors (Kim, S. J. et al., 2006; Kim, Y. T. et al., 2009). Kim, S. J. et 
al. (2006) found a significant difference between all error measures on the WCST, including Errors, 
Perseverative Errors, and Non-Perseverative Errors. Moreover, Kim, Y. T. et al. (2009) observed that 
the MA dependent participants in their study completed fewer categories and made more 
Perseverative Errors and Total Errors than control participants on the WCST.  
 
Although there was not a statistically significant difference between our groups on number of trials 
administered, there was a trend towards significance in the predicted direction. This indicates that 
the most number of trials were administered to the MA+ group and the least number of trials were 
administered to the control group, indicating that the control group was able to task-switch with 
relative ease and therefore able to move onto the next set of trials, resulting in fewer total number 
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of trials administered. We therefore suggest that a larger sample size would magnify our group 
differences and produce significant results. 
In summary, we found that the MA+ group had the most severe impairments on tests of response 
inhibition and set-shifting compared to the MA- and NC groups, with MA- participants considerably 
slower to respond on the majority of tasks compared to controls. There is a strong attentional 
component in most of these tasks, and the results from our Attention and Working Memory tasks 
will now be presented and discussed.  
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CHAPTER SEVEN: ATTENTION AND WORKING MEMORY 
 
 
Attention and Working Memory were assessed using the following five tasks: Task Switching, 
Reaction Time, the Attention Network Task, Spatial Working Memory and Spatial Span. The 
outcome measures for each of these tasks, as explained in the methods section, will be 
analysed below. Descriptive statistics for each outcome measure for each task are 
presented in tables and figures below. One-way ANOVAs were conducted in order to 
establish between-group differences. The data were generally normally distributed (see 
Appendix D) and Levene’s test of homogeneity of variance was generally upheld. Where this 
assumption was violated, an adjusted (Welch’s) F is reported. Our groups were largely equal 
in size. 
 
Task Switching 
 
Task Switching yielded two dependent variables or outcome measures, namely, Errors, and Reaction 
Time. Results indicate that in general, MA participants made more errors and performed more 
slowly than NC participants. Descriptive statistics are presented in Table 33 below and are 
graphically illustrated in Figures 49 - 50 below.   
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Table 33. Descriptive Statistics for the Task Switching Task 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Errors** 
 
Reaction Time 
9 – 111 
 
655.88 - 1976.61 
61.90 (32.87) 
 
1220.5 (409.65) 
1 – 264 
 
571 - 1761 
52.84 (63.74) 
 
1104.02 (258.79) 
1 – 93 
 
601.41 – 2255.03 
20.85 (25.36) 
 
1121.32 (467.39) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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The prediction for the outcome measure Errors was that MA participants would make more Errors 
than NC participants. It was further predicted that MA participants would exhibit slower Reaction 
Times than NC participants. Predictions were largely confirmed as illustrated graphically in Figures 
49 - 50 below.  
 
 
Figure 49. Mean Number of Errors per Group for the Task Switching Task 
 
 
Figure 50. Mean Reaction Times per Group for the Task Switching Task 
 
A one-way ANOVA was conducted on the group means in order to establish significant differences 
between the three participant groups on Errors. Levene’s test was significant F(2, 56) = 5.307, p = 
.008; therefore the assumption of homogeneity of variance was violated, and an adjusted F is 
reported here.  A statistically significant between-group difference was observed, Welch’s F(2, 56) =  
10.172, p < .001. The Games-Howell post-hoc calculation of multiple comparisons was used to shed 
0
10
20
30
40
50
60
70
MA+ MA- NC
N
u
m
b
e
r 
o
f 
Er
ro
rs
Group
1000
1050
1100
1150
1200
1250
MA+ MA- NC
Ti
m
e
 in
 M
ili
se
co
n
d
s
Group
139 
 
 
further light on the data. Statistically significant differences were found between the MA+ and NC 
groups, p < .001. No statistically significant between-group differences were observed between the 
MA- and NC groups (p = .064), or between the MA+ and MA- groups (p = .846). Tukey’s HSD 
homogenous subsets revealed two homogenous groups. Group 1 included the MA+ and MA- groups 
and group 2 included the MA- and NC groups.  
 
Levene’s test for Average Reaction Time was significant F(2, 56) = 3.453, p = .039; therefore the 
assumption of homogeneity of variance was violated, and an adjusted F is reported here. No 
statistically significant between-group differences were observed, Welch’s F(2, 56) = 0.617, p = .545.  
 
Reaction Time Task 
 
The Reaction Time Task has two outcome measures, namely, Five Choice Movement Time, and Five 
Choice Reaction Time. Results indicate that in general, MA participants performed more slowly than 
NC participants on both outcome measures, however, only negligibly. Descriptive statistics are 
presented in Table 34 below and are graphically illustrated in Figure 51 below.  
 
The predictions for both outcome measures were that the MA participants would perform more 
slowly than NC participants. This prediction was largely confirmed, however, the results were not 
statistically significant.  
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Figure 51. Mean Reaction Times for Two Conditions of the Reaction Time Task 
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Table 34. Descriptive Statistics for the Reaction Time Task 
 Group 1: MA+ (n = 19) Group 2: MA- (n = 14) Group 3: NC (n = 18) 
 Range M (SD) Range M (SD) Range M (SD) 
 
Five Choice Movement Time 
 
Five Choice Reaction Time 
 
493.25 – 1267.71 
 
299.12 - 680 
 
687.44 (190.37) 
 
375.90 (100.52) 
 
399.29 – 1538.5 
 
264.5 – 549.25 
 
 
623.29 (285.11) 
 
342.62 (82.49) 
 
309.62 – 688.25 
 
257.88 – 387.75 
 
530.09 (113.46) 
 
317.73 (38.09) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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A one-way ANOVA was conducted on the group means in order to establish significant differences 
between the three participant groups on Five Choice Movement Time and Five Choice Reaction 
Time. Levene’s test was not significant for the Five Choice Movement Time outcome measure, F(2, 
48) = 1.480, p = .238; therefore the assumption of homogeneity of variance was upheld. Results 
from this outcome measure indicated marginally significant between-group differences, F(2, 48) = 
2.869, p = .067. This indicates a non-significant trend in the predicted direction. MA+ participants 
therefore performed more slowly than the MA+ and NC groups. The NC group performed faster than 
the two MA groups. 
 
Levene’s test was significant for the Five Choice Reaction Time outcome measure, F(2, 48) = 4.367, p 
= .018; therefore the assumption of homogeneity of variance was violated, and an adjusted F is 
reported here. Results from this outcome measure indicated marginally significant between-group 
differences, Welch’s F(2, 48) = 2.951, p = .071. This indicates a non-significant trend in the predicted 
direction. MA+ participants performed more slowly than the MA- and NC groups. The NC group 
performed faster than the two MA groups. 
 
The Attention Network Task (ANT) 
 
The ANT yielded 6 outcome measures; three measures across two conditions. Accuracy is measured 
across Congruent Trials, Incongruent Trials and Neutral Trials; and Reaction Time is measured across 
Congruent Trials, Incongruent Trials and Neutral Trials. Results indicate in that in general, NC 
participants performed better on this task than MA participants. Descriptive statistics are presented 
in Table 35 below and are graphically illustrated in Figures 52 - 53 below. 
 
The prediction for these outcome measures was that MA groups would score lower on Accuracy 
than the NC group and would also perform slower than the NC group. These predictions were largely 
confirmed as illustrated by Figure 52 below. 
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Table 35. Descriptive Statistics for the Attention Network Task 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Accuracy:  
 Neutral Trials* 
 Congruent Trials* 
 Incongruent Trials* 
 
Reaction Time: 
 Neutral Trials* 
 Congruent Trials* 
 Incongruent Trials 
 
33.33 – 100 
33.33 – 100 
10.42 – 100 
 
 
432 – 1019 
416 – 1037 
485 – 1030 
 
87.28 (17.55) 
87.61 (17.48) 
71.42 (29.97) 
 
 
649.65 (138.20) 
633.35 (135.61) 
703.25 (138.28) 
 
85.42 – 100 
89.58 – 100 
68.75 – 100 
 
 
462 – 803 
420 – 805 
528 - 1046 
 
97.02 (4.19) 
97.59 (3.63) 
91.56 (7.43) 
 
 
567.74 (93.02) 
573.21 (105.63) 
671.21 (137.71) 
 
95.83 – 100 
93.75 – 100 
87.5 – 100 
 
 
425 – 752 
414 – 760 
492 - 795 
 
99.06 (1.26) 
99.17 (1.57) 
94.89 (3.35) 
 
 
547.65 (92.37) 
543 (88.96) 
620.2 (80.22) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 52. Accuracy on the Attention Network Task 
 
 
Figure 53. Reaction Time on the Attention Network Task 
   
One-way ANOVAs were conducted on the group means in order to establish significant differences 
between the three participant groups on Accuracy and Reaction Time (see Table 36). Statistically 
significant between-group differences were observed on all outcome measures except Reaction 
Time for Incongruent Trials. Post hoc calculations of multiple comparisons were conducted in order 
to shed further light on the data. 
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Table 36. ANOVA Results Summary for the ANT 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Accuracy:  
Neutral Trials 
 Between groups 
 Within groups 
 Total 
Congruent Trials 
 Between groups 
 Within groups 
 Total 
Incongruent Trials 
 Between groups 
 Within groups 
 Total 
Reaction Time: 
Neutral Trials 
 Between groups 
 Within groups 
 Total 
Congruent Trials 
 Between groups 
 Within groups 
 Total 
Incongruent Trials 
 Between groups 
 Within groups 
 Total 
 
 
1579.474 
6199.319 
7778.793 
 
1564.376 
6086.566 
7650.942 
 
6421.478 
18274.499 
24695.976 
 
 
116349.724 
680742.782 
797092.508 
 
84515.818 
700627.708 
785143.525 
 
70132.028 
826940.108 
897072.136 
 
 
2 
56 
58 
 
2 
56 
58 
 
2 
56 
58 
 
 
2 
56 
58 
 
2 
56 
58 
 
2 
56 
58 
 
 
789.737 
110.702 
 
 
782.188 
108.689 
 
 
3210.739 
326.330 
 
 
 
58174.862 
12156.121 
 
 
42257.909 
12511.209 
 
 
35066.014 
14766.788 
 
 
6.294 
 
 
 
5.569 
 
 
 
7.237 
 
 
 
 
9.839 
 
 
 
4.786 
 
 
 
3.378 
 
 
.006 
 
 
 
.009 
 
 
 
.003 
 
 
 
 
.012 
 
 
 
.041 
 
 
 
.102 
 
 
 
 
 
The Games-Howell post-hoc calculation of multiple comparisons was used to shed further light on 
the Neutral Trials data. Statistically significant differences were found between the MA+ and NC 
groups, p = .019. No statistically significant between-group differences were observed between the 
MA+ and MA- groups (p = .062), or between the MA- and NC groups (p = .127). Tukey’s HSD 
homogenous subsets revealed two homogenous groups. Group 1 included the MA+ group and 
Group 2 included the MA- and NC groups.  
 
The Games-Howell post-hoc calculation of multiple comparisons was used to shed further light on 
the Congruent Trials. Statistically significant differences were found between the MA+ and NC 
groups, p = .021. No statistically significant between-group differences were observed between the 
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MA+ and MA- groups (p = .053), or between the MA- and NC groups (p = .208). Tukey’s HSD 
homogenous subsets revealed two homogenous groups. Group 1 included the MA+ group and group 
2 included the MA- and NC groups. 
 
The Games-Howell calculation of multiple comparisons was used to shed further light on the 
Incongruent Trials. Statistically significant differences were found between the MA+ and NC groups, 
p = .007; and between the MA+ and MA- groups, p = .021. No statistically significant between-group 
difference was observed between the MA- and NC groups (p = .193). Tukey’s HSD homogenous 
subsets revealed two homogenous groups. Group 1 included the MA+ group and group 2 included 
the MA- and NC groups.  
 
The following post hoc comparisons were conducted on Reaction Time. Tukey’s HSD multiple 
comparisons were conducted on Neutral Trials and revealed a statistically significant difference 
between the MA+ and NC groups, p = .014. No statistically significant between-group differences 
were observed between the MA+ and MA- groups (p = .061), or between the MA- and NC groups (p 
= .837). Tukey’s HSD homogenous subsets revealed two homogenous groups. Group 1 included the 
MA+ and MA- groups and group 2 included the MA- and NC groups. 
 
Tukey’s HSD multiple comparisons were conducted on Congruent Trials and revealed a statistically 
significant difference between the MA+ and NC groups, p = .035. No statistically significant between-
group differences were observed between the MA+ and MA- groups (p = .222), or between the MA- 
and NC groups (p = .678). Tukey’s HSD homogenous subsets revealed two homogenous groups. 
Group 1 included the MA+ and MA- groups and group 2 included the MA- and NC groups. 
 
 
Spatial Working Memory 
 
Spatial Working Memory yielded two dependent variables or outcome measures, namely, Between 
Errors and Strategy. Results indicate that in general, MA participants scored more errors and showed 
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poorer strategy when compared to NC participants. Descriptive statistics are presented in Table 37 
below and are graphically illustrated in Figure 54 below. 
 
Table 37. Descriptive Statistics for Spatial Working Memory 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 15) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
 
Between 
Errors* 
Strategy* 
 
8 – 75 
 
30 - 44 
 
43.70 (20.32) 
 
37.75 (3.71) 
 
1 – 73 
 
24 - 41 
 
35.87 (21.78) 
 
34.01 (5.68) 
 
0 – 52 
 
22 - 43 
 
20.85 (15.27) 
 
32.1 (6.01) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
 
The predictions for these outcome variables were that MA participants would make more errors and 
show a poorer strategy than NC participants. This would be indicated by high scores on both of these 
outcome measures for MA participants and low scores on both of these measures for NC 
participants. These predictions were confirmed as illustrated in Figure 54 below. One-way ANOVAs 
were conducted on the data in order to establish between-group differences. 
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Figure 54. Mean Error and Strategy Scores for the Spatial Working Memory Task 
 
The outcome measure Between Errors revealed a non-significant Levene’s test, F(2, 52) = 1.641, p = 
.204; therefore the assumption of homogeneity of variance was upheld. Statistically significant 
between-group differences were observed, F(2, 52)  = 7.370, p = .002. Tukey’s HSD multiple 
comparisons revealed a statistically significant difference between the MA+ and NC groups, p = .001. 
No statistically significant between-group differences were observed between the MA+ and MA- 
groups (p = .457), or between the MA- and NC groups (p = .064). Tukey’s HSD homogenous subsets 
revealed two homogenous groups. Group 1 included the MA+ and MA- groups and group 2 included 
the MA- and NC groups. 
 
The outcome measure Strategy revealed a non-significant Levene’s test, F(2, 52) = 1.800, p = .175; 
therefore the assumption of homogeneity of variance was upheld. Statistically significant between-
group differences were observed, F(2, 52) = 6.084, p = .004. Tukey’s HSD multiple comparisons 
revealed a statistically significant difference between the MA+ and NC groups, p = .003. No 
statistically significant between-group differences were observed between the MA+ and MA- groups 
(p = .104), or between the MA- and NC groups (p = .512). Tukey’s HSD homogenous subsets revealed 
two homogenous groups. Group 1 included the MA+ and MA- groups and group 2 included the MA- 
and NC groups. 
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Spatial Span 
 
Spatial Span yielded only one dependent variable or outcome measure, namely, Span Length. 
Results indicate that in general MA participants had a shorter Span Length than NC participants. 
Descriptive statistics are presented in Table 38 below and are graphically illustrated in Figure 55 
below. 
 
Table 38. Descriptive Statistics for Spatial Span 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 15) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
 
Span length* 
 
2 - 8 
 
5.00 (1.49) 
 
3 - 8 
 
5.53 (1.36) 
 
3 - 9 
 
6.05 (1.54) 
 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
 
The prediction for this outcome measure, Span Length, was that MA participants would have a 
shorter Spatial Span than NC participants. It was further predicted that NC participants would have a 
longer Spatial Span than MA participants, as indicated by the following: MA+ < MA- < NC. This 
prediction was largely confirmed as illustrated by Figure 55 below. However, results were not 
statistically significant.   
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Figure 55. Mean Span Length per Group 
 
 
A One-way ANOVA was conducted on the group means in order to establish significant differences 
between the three participant groups on Strategy. Levene’s test was not significant, F(2, 52) = 0.217, 
p = .805; therefore the assumption of homogeneity of variance was upheld. Results from this 
outcome measure indicated marginally significant between-group differences w, F(2, 52) = 2.544, p = 
.088. This indicates a non-significant trend in the predicted direction indicating that the MA groups 
had shorter Spatial Spans than the NC group. 
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DISCUSSION 
 
Our hypothesis predicted that Attention and Working Memory would be impaired in 
methamphetamine dependence. Particularly, it was predicted that MA+ participants would perform 
worse than the control group; indicated by the following: MA+ > MA- > NC. This prediction was 
largely confirmed.  
 
Our results indicate that, in general, attention and working memory are impaired in MA. The Task 
Switching Task measures the individual’s ability to switch between cognitive tasks and places high 
demands on their working memory processes. Results from this task indicated that MA participants 
scored a larger number of errors than control participants. Particularly, a statistically significant 
difference was observed between the MA+ and the control groups. No statistically significant 
differences were observed between the MA- group and the other two groups. Statistically significant 
differences were also not observed on the Reaction Time outcome measure for this task. This task 
places high demands on working memory processes, as the participant needs to keep a number of 
rules in mind during the task. A larger number of errors on this task therefore indicate that MA+ 
participants were not able to hold these rules in mind as well as control participants, indicating 
impairment in working memory.  
 
Our results are consistent with research indicating such an association (Scott et al., 2007). For 
example, Chang et al. (2002) observed in their study that MA participants performed similarly to 
controls on simple tasks. However, on more complex tasks, where high demand was placed on 
working memory processes, MA participants performed worse than controls. This result is also 
confirmed by Gonzalez et al (2007) who also observed working memory deficits in their sample of 
MA abusers.  
 
No statistically significant results were observed on the Reaction Time task. This result is consistent 
with previous research that indicated no significant differences between MA participants and 
controls regarding psychomotor speed (Chang et al., 2002).  
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The ANT indicated that the MA+ group generally performed worse than the control group on both 
conditions of this task: Accuracy and Reaction Time. The MA+ group performed significantly worse 
than the control group on the Accuracy trials. This task requires a high level of attention in order to 
complete the trials accurately, therefore our MA+ group showed a high degree of inattention on this 
task. Our results are consistent with previous research indicating attentional difficulties in MA 
(Gonzalez, Bechara and Martin, 2007; Chang et al., 2002). 
 
Reaction Times across the three conditions produced similar results. Statistically significant 
differences were observed between the MA+ and control groups on the Neutral and Congruent 
Trials; however the incongruent trials yielded no significant results. This last result is consistent with 
results from the Chang et al. (2002) study mentioned above, that indicated no significant differences 
between MA participants and controls regarding psychomotor speed. 
 
The SWM task yielded similar results to those from the Task Switching Task. Statistically significant 
differences were observed between the MA+ and control groups on both outcome measures 
(Between Errors and Strategy). No significant results were observed regarding the MA- group. This 
task assesses the participants’ ability to retain spatial information and to manipulate remembered 
items in working memory. It is a self-ordered task which also tests heuristic strategy. MA+ 
participants scored more Between Errors than controls, indicating that they revisited boxes in which 
a token had already been found. They therefore seemed to struggle with keeping this information in 
mind during the task. In addition, they also scored higher on Strategy then controls. A high score 
indicates poor strategy on this task, indicating that MA+ participants did not apply a predetermined 
sequence, but rather approached the task in a haphazard manner. This outcome measure may apply 
more to planning behaviour and indicates that MA+ participants showed poor planning skills on this 
task. These results are consistent with previous research using a similar task. Van Der Plaas et al. 
(2009) used a Tic Tac Toe working memory task where participants were presented with a spatial 
array of X’s and O’s and these had to be kept in mind by the participant in order to identify the 
pattern seconds later. Results from their study indicated that MA participants performed more 
poorly than control participants. MA participants performed more slowly and made more errors 
than controls, indicating impairment in working memory. 
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The SSP task yielded slight differences between the groups; however, these were not statistically 
significant. Span Length was found to be similar between the groups. This result is similar to those of 
Simon et al. (2000) who used a backward digit span task to assess working memory in MA 
participants compared to controls. The authors did not find a significant difference between their 
groups.  
 
In summary, our results indicate that MA+ participants show impairment on tasks of Attention and 
Working Memory, indicating that they have trouble holding items in memory for short periods of 
time. This is consistent with previous research indicating an association between attention and 
working memory deficits and MA (Chang et al., 2002; Gonzalez et al., 2007; van der Plaas et al., 
2009). 
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CHAPTER EIGHT: VERBAL FLUENCY IMPAIRMENT IN METHAMPHETAMINE 
 
 
Verbal Fluency was assessed using the D-KEFS Verbal Fluency subtests. Phonemic Fluency was 
assessed using FAS and Semantic Fluency was assessed using Category Fluency and Category 
Switching. Results indicate that in general, MA participants performed worse than NC participants on 
all tasks of Verbal Fluency. Descriptive statistics are presented in Table 39 below and are graphically 
represented in Figures 56 - 58 below. 
 
The predictions for the all outcome measures were that MA participants would generate fewer 
items when compared to control participants. It was further predicted that control participants 
would generate more items when compared to the MA participants, as follows: MA+ > MA- > NC. 
This prediction was confirmed as illustrated by Figures 56 - 58 below. 
 
All results were analysed using one-way ANOVAs in order to establish between-group differences. 
ANOVAs results are presented in Table 40 below.  
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Table 39. Descriptive Statistics for Tasks of Verbal Fluency 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
Verbal Fluency 
α = 0.92 
      
Phonemic (letter) fluency 
 F* 
 A* 
 S** 
 Total** 
 
5 – 22 
4 – 14 
4 – 17 
14 – 52 
 
9.58 (4.54) 
6.42 (2.85) 
8.79 (3.57) 
24.79 (9.46) 
 
4 – 20 
1 – 15 
4 – 18 
13 – 47 
 
10.21 (4.72) 
7.74 (4.0) 
10.95 (4.39) 
28.74 (11.7) 
 
6 – 24 
1 – 26 
3 – 25 
10 - 75 
 
14.05 (4.65) 
11.4 (5.48) 
15.35 (5.07) 
40.80 (13.9) 
Semantic (category) fluency 
 Animals** 
 Boy’s Names** 
 Total** 
 
6 – 21 
6 – 24 
12 – 44 
 
13.00 (3.93) 
13.53 (4.22) 
26.68 (7.77) 
 
10 – 25 
8 – 27 
24 – 48 
 
16.84 (4.19) 
16.58 (4.78) 
34.63 (7.3) 
 
12 – 29 
12 – 29 
27 – 58 
 
19.45 (4.51) 
19.7 (4.87) 
39.15 (8.1) 
Category switching 
 Total correct responses* 
 
6 - 18 
 
11.11 (2.83) 
 
8 – 19 
 
11.95 (2.84) 
 
10 – 18 
 
13.7 (2.11) 
Note: * indicates significance at p < .05; ** indicates significance at p < .001 
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Figure 56. Mean Number of Words Generated per Group for F, A, and S 
 
 
 
Figure 57. Mean Number of Words Generated per Group on Categories 
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Figure 58. Mean Number of Words Generated per Group for Category Switching 
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Table 40. ANOVA Results Summary for Verbal Fluency 
 Sum of 
Squares 
df Mean Square F Sig. 
 
F 
 Between groups 
 Within groups 
 Total 
A 
 Between groups 
 Within groups 
 Total 
S 
 Between groups 
 Within groups 
 Total  
Total 
 Between groups 
 Within groups 
 Total 
Animals 
 Between groups 
 Within groups 
 Total 
Boy’s Names 
 Between groups 
 Within groups 
 Total 
Total 
 Between groups 
 Within groups 
 Total 
Category Switching 
 Between groups 
 Within groups 
 Total 
 
230.036 
1182.739 
1412.77 
 
261.108 
1005.116 
1266.224 
 
437.965 
1064.655 
1502.621 
 
2729.837 
7748.042 
10477.879 
 
409.006 
981.476 
1390.483 
 
371.535 
1181.568 
1553.103 
 
1544.993 
3293.076 
4838.069 
 
68.649 
372.937 
441.586 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
2 
55 
57 
 
115.018 
21.504 
 
 
130.554 
18.275 
 
 
218.983 
19.357 
 
 
1364.919 
140.873 
 
 
204.503 
17.845 
 
 
185.768 
21.483 
 
 
772.496 
59.874 
 
 
34.325 
6.781 
 
5.349 
 
 
 
7.144 
 
 
 
11.313 
 
 
 
9.689 
 
 
 
11.460 
 
 
 
8.647 
 
 
 
12.902 
 
 
 
5.062 
 
  .008 
 
 
 
  .002 
 
 
 
< .000 
 
 
 
< .000 
 
 
 
< .000 
 
 
 
  .001 
 
 
 
< .000 
 
 
 
  .010 
 
 
Statistically significant between-group differences were observed on all outcome measures of Verbal 
Fluency. Post hoc multiple comparisons were conducted in order to shed further light on the data. 
 
Comparisons for F, A, and S yielded the same results as the combined total of FAS together. 
Therefore only FAS total (Phonemic Fluency) is reported here. Tukey’s HSD multiple comparisons 
revealed a statistically significant difference between the MA+ and NC groups, p < .001, and between 
the MA- and NC groups, p = .007. No statistically significant differences were observed between the 
159 
 
 
MA+ and MA- groups (p = .564). Tukey’s HSD homogenous subsets revealed two homogenous 
groups. Group 1 included the MA+ and MA- groups and group 2 included the NC group. 
 
When Animals and Boy’s Names were combined (Semantic Fluency), Tukey’s HSD multiple 
comparisons revealed a statistically significant difference between the MA+ and NC groups, p < .001; 
and between the MA+ and MA- groups, p = .007. No significant differences were observed between 
the MA- and NC groups (p = .172). Tukey’s HSD homogenous subsets revealed two homogenous 
groups. Group 1 included the MA+ group and Group 2 included the MA- and NC groups. 
 
Tukey’s HSD multiple comparisons for Category Switching revealed a statistically significant 
difference between the MA+ and NC groups, p = .008. No statistically significant between-group 
differences were observed between the MA- and NC groups (p = .099) or the MA+ and MA- groups 
(p = .582). Tukey’s HSD homogenous subsets revealed two homogenous groups. Group 1 included 
the MA+ and MA- groups and Group 2 included the MA- and NC groups. 
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DISCUSSION 
 
Our hypothesis predicted that Verbal Fluency would be impaired in methamphetamine dependence. 
Particularly, it was predicted that MA+ participants would perform worse than controls; indicated by 
the following: MA+ > MA- > NC. This prediction was confirmed by our results. 
 
The FAS condition, both individual letters and the total combined score, assessing phonemic fluency, 
yielded statistically significant results. Significant differences were observed between the MA+ and 
control groups as well as between the MA- and control groups. No statistically significant differences 
were observed between the two MA groups, indicating that they performed similarly. 
 
Similar results were observed for semantic fluency. The Category Fluency condition yielded 
statistically significant results for the category “Animals” and “Boy’s Names”. Statistically significant 
differences were observed between the MA+ and control groups as well as between the MA+ and 
MA- groups for the “Animals” category. For the category “Boy’s Names” statistically significant 
differences were observed between the MA+ and control groups only. Combining these two 
categories also produced significant results. Statistically significant differences were observed 
between the MA+ and control groups and between the MA+ and MA- groups. Statistically significant 
differences were also observed between the MA+ and control groups on Category Switching. Thus, 
our methamphetamine dependent participants showed significant impairment on Verbal Fluency, 
both phonemic and semantic. 
 
These findings are consistent with previous literature indicating moderate impairments in verbal 
fluency (Scott et al., 2007). Further studies, for example, Kalechstein et al. (2003) and Simon et al. 
(2007) also found significant verbal fluency deficits associated with MA. 
 
In summary, our methamphetamine dependent groups were impaired on verbal fluency. Both 
groups performed similarly on phonemic fluency, however there were some differences on semantic 
fluency. The MA+ group were the most impaired on all three conditions of verbal fluency. 
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CHAPTER NINE: THE CORRELATION BETWEEN EXECUTIVE FUNCTIONING AND CORTICAL THICKNESS 
IN METHAMPHETAMINE 
 
The correlation between performance on tasks of executive functioning and cortical thickness of 
frontal brain regions was investigated by correlating neuropsychological data with structural MRI 
data. Specifically, we investigated which of the executive functioning domains that showed 
statistically significant differences between our groups correlated with left and/or right frontal 
hemisphere brain regions in terms of cortical thickness. The MRI data for our sample revealed 
cortical thickening in the MA-group and cortical thinning in the MA+ group. The prediction was 
therefore that impaired performance on tasks of executive functioning would be associated with 
decreased cortical thickness in the MA+ group and increased cortical thickness in the MA- group in 
the associated frontal brain regions. Specific hypotheses for each domain are presented under the 
corresponding sections below. Results indicate a number of significant correlations. Our predictions 
were therefore largely confirmed. 
 
Structural MRI data were collected on 45 of the 58 participants used in this study. Demographic 
details for these 45 participants are presented in Table 41 below. 
 
Table 41. Demographic Characteristics for Participants in the Correlation Groups 
 MA+ 
(n = 15) 
MA- 
(n = 15) 
NC 
(n = 15) 
Age 24.13 (6.15) 23.87 (3.82) 24.6 (4.76) 
Gender  
(Male : Female) 
12 : 3 13 : 2 11 : 4 
Years of Education 9.73 (1.03) 10.73 (2.28) 12.2 (1.66) 
IQ (FSIQ) 73.8 (14.1) 78.8 (18.6) 89.9 (17) 
    
 
Our data were not normally distributed, as discussed under the methods section and therefore we 
report Spearman’s Rho instead of Pearson’s r. A series of Spearman’s rank-order correlational 
analyses were conducted in order to determine if there were any relationships between 
performance on tasks of executive functioning, where significant between-group differences were 
observed, and frontal cortical thickness. Two-tailed tests of significance revealed a number of 
significant relationships. These are presented for each executive domain below. 
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Decision Making and Impulsivity 
 
The Decision-Making and Impulsivity domain yielded two statistically significant between-group 
differences in our ANOVA results, presented in Chapter 4 above. The Number of Discounts outcome 
measures from the Delay Discounting task and the Discrimination Errors on condition two of the 
Information Sampling Task yielded statistically significant between-group differences. We predicted 
that impairment on Decision Making and Impulsivity would be associated with thinner orbitofrontal 
cortex in the MA+ group and thicker orbitofrontal cortex in the MA-group.  
 
Delay Discounting, i.e. Number of Discounts, was associated with decreased cortical thickness in a 
number of frontal regions. In the MA+ group the impairment on the DDT was associated with 
decreased cortical thickness of the left pars triangularis, r(15) = -.583, p = .022; the left precentral, 
r(15) = -.801, p < .001; the left frontal pole, r(15) = -.634, p = .011; and the left insula, r(15) = -.690, p 
= .004. This indicates that greater discounting, or impulsivity, is associated with cortical thinning of 
left frontal hemisphere regions. 
 
There were also a number of significant correlations between Number of Discounts and areas in the 
right hemisphere in the MA+ group. Impairment on the DDT was associated with decreased cortical 
thickness of the right lateral orbitofrontal, r(15) = -.721, p = .002; the right paracentral, r(15) = -.654, 
p = .008; the right pars triangularis, r(15) = -.600, p = .018; the right precentral, r(15) = -.541, p = 
.037; and the right insula, r(15) = -.649, p = .009. This indicates that greater discounting, or 
impulsivity, is also associated with cortical thinning of the right frontal hemisphere regions in the 
MA+ group 
 
The Information Sampling Task, particularly Discrimination Errors, was not found to be significantly 
correlated with cortical thickness in any frontal regions.  
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In summary, it was found that impulsivity was associated with cortical thinning of both left and right 
hemisphere frontal regions in MA+ participants. 
 
Response Inhibition and Set-Shifting 
 
The Response Inhibition and Set-Shifting domain yielded a number of significant outcome measures. 
We predicted that impairment on these outcome measures would be associated with thinner 
anterior cingulate cortex (ACC) in the MA+ group and thicker ACC in the MA- group. 
 
All four outcome measures of the Affective Go/No Go task yielded statistically significant between-
group differences. Significant correlations were observed between these outcome measures and 
frontal cortical thickness. 
 
In the MA- group, Mean Correct Latency for positive items ie slower reaction times were significantly 
associated with increased cortical thickness of the left caudal middle frontal, r(15) = .677, p = .006; 
the left paracentral, r(15) = .571, p = .026; the left pars opercularis, r(15) = .775, p = .001; the left 
pars triangularis, r(15) = .725, p = .002; the left precentral, r(15) = .611, p = .016; and the left superior 
frontal r(15) = .593, p = .020. Mean Correct Latency for negative items showed similar significant 
associations with increased cortical thickness of the left caudal middle frontal, r(15) = .735, p = .002; 
the left lateral orbitofrontal, r(15) = .586, p = .022; the left paracentral r(15) = .568, p = .027; the left 
pars opercularis, r(15) = .557, p = .031; the left precentral, r(15) = .536, p = .040; and the right rostral 
middle frontal, r(15) = .543, p = .037. This indicates a relationship between slower reaction times of 
the MA- participants and cortical thickening of left and right frontal hemisphere regions. 
 
Total Omissions (positive) in the MA- group was significantly negatively correlated with cortical 
thickness of the right pars orbitalis, r(15) = -.540, p = .038. This indicates a moderate relationship 
between impaired response inhibition and cortical thinning of this right frontal hemisphere region. 
Total Omissions (negative) was not correlated with any frontal cortical areas. 
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However, in the MA+ group, Mean Correct Latency for negative items was significantly negatively 
correlated with cortical thickness of the left rostral middle frontal, r(15) = -.518, p = .048, and the 
right caudal middle frontal, r(15) = -.525, p = .044. This indicates a moderate relationship between 
slower reaction times and cortical thinning of left and right hemisphere frontal regions. Total 
Omissions, both positive and negative did not reveal any significant correlations in this group. 
 
In the control group, decreased Mean Correct Latency, i.e. quicker response times, for negative 
items was associated with cortical thickness of the left rostral anterior cingulate, r(13) = -.610, p = 
.027; the left rostral middle frontal, r(13) = -.588, p = .035. Increased Total Omissions (positive) was 
associated with cortical thickness of the left rostral anterior cingulate, r(13) = .601, p = .030; the left 
frontal pole, r(13) = .573, p = .041; and the right caudal anterior cingulate, r(13) = .698, p = .008. 
Increased Total Omissions (negative) was associated with cortical thickness of the left lateral 
orbitofrontal, r(13) = .630, p = .021, and the medial orbitofrontal, r(13) = .610, p = .027. This indicates 
that increased errors are associated with cortical thickening of left hemisphere regions. However, 
faster reaction times were also associated with cortical thickening of left, and some right, 
hemisphere regions.  
 
In summary, impairment on the AGN task in the MA+ group is associated with cortical thinning of 
frontal sub-region. However, impairment in the MA- group is associated with cortical thickening. This 
relationship was not observed for the SS task. 
 
The Stop Signal task yielded one significant result, Direction Errors on Stop/Go Trials. In the MA- 
group, increased number of Directions Errors on Stop/Go Trials was associated with increased 
cortical thickness of the right caudal anterior cingulate, r(13) = .624, p = .023; and the right pars 
orbitalis, r(13) = .661, p = .014. This indicates a strong relationship between errors and cortical 
thickening of right hemisphere frontal regions. 
 
In the MA+, increased Direction Errors on Stop/Go Trials was associated with increased cortical 
thickness of the left pars orbitalis, r(15) = .531, p = .042; the right pars orbitalis, r(15) = .564, p = .029; 
and the right pars triangularis, r(15) = .655, p = .008. This indicates moderate to strong relationships 
between errors and cortical thickening of left and right hemisphere frontal regions. 
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In the control group, Direction Errors on Stop/Go Trials was significantly positively correlated with 
the right paracentral, r(13) = .757, p = .003. This indicates a very strong relationship between errors 
and cortical thickening of this right hemisphere frontal region. 
 
Evidently, increased number of errors is associated with cortical thickening in all three participant 
groups on the SS task. In addition, all three groups predominantly show cortical thickening in the 
right hemisphere.  
 
The Stroop task yielded statistically significant between-group differences on all outcome measures; 
however, our correlational analyses will be focused on Time for Trials 3 and 4, as these are the 
inhibition trials. In the MA- group, increased Time taken for Trial 3 was associated with cortical 
thickening of the right lateral orbitofrontal, r(15) = .564, p = .029. This indicates a moderate 
relationship between increased time taken and cortical thickening of this right hemisphere frontal 
region in the MA- group. In the MA+ group Time taken for Trials 3 and 4 did yield any significant 
correlations. 
 
However, in the control group, increased Time taken for Trial 3 was associated with cortical thinning 
of the left caudal middle frontal, r(15) = -.578, p = .024; the left rostral middle frontal, r(15) = -.517, p 
= .048; and the right caudal middle frontal, r(15) = -.524, p = .045. Increased Time taken on Trial 4 
was associated with cortical thinning of the right caudal middle frontal, r(15) = -.633, p = .011. This 
result indicates a moderate relationship between increased time taken and cortical thinning of left 
and right hemisphere frontal regions. 
 
In summary, the Stroop task showed a relationship between increased time taken and cortical 
thickening in the MA- group, but cortical thinning in the control group.  
 
The WCST yielded two significant results; Perseverative Responses and Perseverative Errors. In the 
MA- group, increased Perseverative Responses was associated with cortical thinning of the left 
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frontal pole, r(10) = -.770, p = .009, and the right caudal middle frontal, r(10) = -.648, p = .043. 
Increased Perseverative Errors was also associated with cortical thinning of the left frontal pole, 
r(10) = -.760, p = .011, and the right caudal middle frontal, r(10) = -.663, p = .037. These results 
indicate a strong relationship between impairment on this task and cortical thinning in left and right 
hemisphere frontal regions in the MA- group. No significant correlations were observed in the MA+ 
group, or in the control group.  
 
In summary, results from the response inhibition tasks provide inconsistent results. Some tasks 
indicate a relationship between impairment and cortical thinning in the MA+ group and thickening in 
the MA- group, however, other tasks indicate the opposite. 
 
Attention and Working Memory 
 
The Attention and Working Memory domain yielded a number of significant between-group 
differences, except the Spatial Span and Reaction Time tasks. We predicted that working memory 
impairment would be associated with thinner dorsolateral prefrontal cortex in the MA+ group and 
thicker dorsolateral prefrontal cortex in the MA- group. 
 
The Task Switching task yielded one significant result for the Errors outcome measure. In the MA- 
group, increased Errors was associated with cortical thinning of the left pars triangularis, r(15) = -
.582, p = .023. This indicates that impairment on this task is associated with cortical thinning of this 
left hemisphere frontal region. In the MA+ and control groups, Errors did not yield any significant 
correlations.  
 
The Attention Network Task produced six outcome measures and all of these except one yielded 
statistically significant between-group differences. Reaction Time on Incongruent trials was the only 
outcome measure that did not yield significant results.  
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In the MA- group, decreased Accuracy on congruent trials was associated with cortical thinning of 
the left rostral anterior cingulate, r(15) = .583, p = .023. Increased Reaction Time for all three 
conditions (Neutral, Congruent and Incongruent) was associated with cortical thinning of the left 
precentral, r(15) = -.639, p = .010; r(15) = -.629, p = .012; and r(15) = -.736, p = .002 respectively. 
Increased Reaction Time for all three conditions was also associated with cortical thinning of the 
right caudal middle frontal, r(15) = -.821, p < .001; r(15) = -.875, p < .001; and r(15) - .857, p < .001; as 
well as the right rostral middle frontal, r(15) = -.650, p = .009; r(15) = -.686, p = .005; r(15) = -.689, p = 
.004. In addition increased Reaction Time on Congruent trials was associated with cortical thinning 
of the right insula, r(15) = -.514, p = .050. This indicates that impaired attention is associated with 
cortical thinning of these left and right hemisphere frontal regions in the MA- group. 
 
In the MA+ group, decreased Accuracy on the Neutral and Congruent trials was associated with 
cortical thinning of the left precentral, r(15) = .574, p = .025; r(15) = .563, p = .029 respectively. 
Decreased Accuracy on the Congruent trials was also associated with cortical thinning of the left 
frontal pole, r(15) = .529, p = .043. Decreased Accuracy on all three conditions was associated with 
cortical thinning of the right paracentral, r(15) = .590, p = .021; r(15) = .668, p = .007; r(15) = .560, p = 
.027. In addition, decreased Accuracy on the Neutral and Congruent trials was associated with 
cortical thinning of the right rostral middle frontal, r(15) = .598, p = .019; and r(15) = .543, p = .036 
respectively as well as the right frontal pole, r(15) = .630, p = .012; and r(15) = .552, p = .033, 
respectively. Increased Reaction Time on Congruent trials was associated with cortical thinning of 
the right caudal anterior cingulate, r(15) = -646, p = .009. Again, this indicates that impaired 
attention is associated with cortical thinning of these left and right hemisphere frontal regions in the 
MA+ group. 
 
In the control group, increased Accuracy on Incongruent trials was associated with cortical thickness 
of the left caudal anterior cingulate, r(15) = -.716, p = .003; and the left lateral orbitofrontal, r(15) = -
.533, p = .041. Increased Accuracy on Congruent trials was associated with cortical thinning of the 
right lateral orbitofrontal, r(15) = -.695, p = .004. Increased Accuracy on Neutral trials was associated 
with cortical thinning of the right paracentral, r(15) = -.647, p = .009. Increased Accuracy on 
Incongruent trials was associated with cortical thinning of the right insula, r(15) = -.748, p = .001. 
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In summary, results from the ANT indicate that impaired attention in the two MA groups is 
associated with cortical thinning of the relevant frontal regions. However, with the control group, 
intact attention was, in general, associated with cortical thickening of the relevant frontal regions. 
 
The Spatial Working Memory task yielded two statistically significant outcome measures, Between 
Errors and Strategy. In the MA- group, neither Between Errors nor Strategy was significantly 
correlated to cortical thickness of any frontal brain regions. In the MA+ group, increased Between 
Errors was associated with cortical thinning of the left lateral orbitofrontal, r(15) = -.574, p = .025. A 
high Strategy score (i.e. impaired strategy) was associated with cortical thinning of the right caudal 
anterior cingulate, r(15) = -.536, p = .039; and the right pars opercularis, r(15) = -.551, p = .033. In the 
control group, decreased Between Errors was associated with cortical thickness of the left caudal 
middle frontal, r(15) = -.546, p = .035; and the left precentral, r(15) = -.678, p = .005. A high Strategy 
score was associated with cortical thinning of the left precentral, p(15) = -.585, p = .022; and the left 
insula, p (15) = -.549, p = .034. These results indicate impaired working memory is associated with 
cortical thinning of left and right hemisphere frontal regions in the MA+ group. However, similar 
results were observed in the control group. 
 
In summary, attention and working memory are associated with cortical thinning in both MA groups 
on the ANT. However, on the SWM task, impairment was associated with cortical thinning in the 
MA+ group, with similar results observed in the control group. 
 
Verbal Fluency 
 
The Verbal Fluency domain yielded statistically significant results for all outcome measures of 
phonemic verbal fluency and semantic verbal fluency. We have therefore run correlational analyses 
on two outcome measures, one representing phonemic fluency (Total FAS score), and one 
representing semantic fluency (Total Category Fluency score). We predicted impaired verbal fluency 
would be associated with thinner anterior prefrontal and insula cortices in the MA+ group and 
thicker anterior prefrontal and insula cortices in the MA- group. In the MA- group, neither Phonemic 
Fluency nor Semantic Fluency were significantly correlated with any frontal brain regions.  
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In the MA+ group, a poor Semantic Fluency score was associated with cortical thinning of the left 
lateral orbitofrontal, p(15) = .762, p = .001; the left pars orbitalis, p(15) = .526, p = .044; the right 
lateral orbitofrontal, p(15) = .538, p = .039; and the right paracentral, p(15) = .698, p = .004. This 
indicates that impaired Semantic Fluency is associated with cortical thinning in left and right 
hemisphere frontal regions in the MA+ group. 
 
In the control group, a high Semantic Fluency score was associated with cortical thinning of the left 
caudal anterior cingulate, p(15) = -.532, p = .041; the left pars orbitalis, p(15) = -.544, p = .036; the 
left rostral anterior cingulate, r(15) = -.517, p = .048; the left frontal pole, r(15) = -.539, p = .038; and 
the right frontal pole, p(15) = -.525, p = .044. This indicates that intact verbal fluency is associated 
with cortical thinning in these left and right hemisphere regions in the control group. 
 
In summary, impaired semantic fluency is associated with cortical thinning in the MA+ group and 
intact impairment is associated with cortical thinning in the control group. 
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DISCUSSION 
 
Poor decision-making was observed in both the MA+ and MA- groups. These groups performed 
similarly on the Delay Discounting task and both of these groups performed significantly worse than 
the control group. Cortical thickening was observed in our MA- group; and cortical thinning was 
observed in our MA+ group. We therefore predicted that decision-making, in this case, number of 
discounts, would be associated with thinning of the orbitofrontal cortex in the MA+ group, and 
thickening in the MA- group. We also predicted an association with changes in thickness of the 
dorsolateral prefrontal cortex, given the association between decision-making and working memory 
(McClure et al., 2004). Specifically, we predicted thinning in the MA+ group and thickening in the 
MA- group. However, correlations between increased number of discounts and decreased cortical 
thickness were only significant in the MA+ group.  
 
These significant correlations showed strong negative relationships between number of discounts 
and cortical thinning, indicating that the larger the number of discounts, the thinner the cortical area 
in the MA+ group, but not in the MA- group. These findings are consistent with greater structural 
damage and poorer decision-making in the MA+ group than the MA- group. 
 
These results are also consistent with previous research which has associated delay discounting with 
orbitofrontal and dorsolateral prefrontal dysfunction (Paulus, et al., 2002). Our results are partially 
consistent with this finding as indicated by the strong relationship observed between delay 
discounting and thinning in the right lateral orbitofrontal cortex. We also observed significant 
correlations between delay discounting and thinning in the following cortical regions; left pars 
triagularis, precentral, and frontal pole, as well as the right paracentral, pars triangularis, and 
precentral. These brain regions are known to be involved in motor processes and are therefore 
suggested by McClure et al. (2004) to reflect non-specific aspects of task performance that may be 
engaged during the decision making process, but not necessarily directly related to immediate or 
delayed choices. 
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Impaired response inhibition was observed in both the MA+ and MA- groups. The composite z-score 
for the response inhibition domain revealed the MA- group as slightly more impaired than the MA+ 
group Significant correlations were observed within all three participant groups. First, impaired 
response inhibition was, in general, associated with cortical thickening of the DLPFC in the MA- 
group, and cortical thinning in the MA+ group. This is consistent with our prediction; however, this 
was not always the case. A few tasks showed the opposite result. On certain tasks of response 
inhibition, the MA- group showed greater impairment than the MA+ group. This may account for 
these inconsistent results. Where the MA+ group showed cortical thickening, it is suggested that this 
may be a compensatory response in order to preserve function. Similar results were observed by 
Chang et al. (2005) who found enlarged striatum, and intact neuropsychological functioning, in 
abstinent MA abusers. The association between response inhibition and cortical thickness of the 
DLPFC is consistent with previous research that found an association between response inhibition, 
the DLPFC (Gläscher et al., 2012). Second, in the control group there was a moderate to strong 
relationship between faster performance on the AGN and cortical thickening of the ACC as well as 
the OFC. Again, it can be argued that the cortical thickening preserves function and therefore this 
group was least impaired on this task.  
 
The association between response inhibition and cortical thickness of the ACC is consistent with 
those of Aron et al. (2003; as cited in Chambers et al., 2009) who found an association between 
response inhibition and the inferior frontal gyrus. However, their findings were significant for the 
right hemisphere, and ours were significant for the left. Particularly, Aron et al. (2003; as cited in 
Chambers et al., 2009) suggested damage to the pars opercularis was associated with impairments 
in response inhibition. In our MA- group, a relationship between performance on the AGN and 
cortical thickening of the left pars opercularis was observed. Our findings are therefore consistent 
with previous research. 
 
The SST confirmed this finding and revealed significant correlations between errors and cortical 
thickness in most of the regions of the inferior frontal gyrus. In the MA+ group, the expected 
associations between impaired SST and cortical thinning in the IFG were found. However, there were 
fewer such associations in MA- and control groups. This is most likely because the MA+ group is the 
most severely impaired group. In addition, it may be that a compensatory response occurred, 
resulting in cortical thickening. 
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The literature further suggests that poor performance on the Stroop task specifically has been 
associated with damage to the ACC (Gläscher et al., 2012; Bench et al. 1993, Pardo et al. 1990; as 
cited in Stuss & Levine, 2002) and the DLPFC (Gläscher et al. 2012; Stuss et al. 2001; as cited in Stuss 
& Levine, 2002). Our findings were not entirely consistent with these findings. We observed that an 
increase in time taken per trial was associated with cortical thickening in the right lateral 
orbitofrontal cortex in the MA- group. However, in the control group, reduced time taken was 
associated with cortical thickening of the middle frontal gyrus. The DLPFC lies in the middle frontal 
gyrus; therefore, this latter finding is what we would expect to find considering the suggested 
involvement of the DLPFC in the Stroop task (Gläscher et al. 2012; Stuss et al., 2001; as cited in Stuss 
& Levine, 2002). Again, the cortical thickening observed in the MA- group could be a compensatory 
mechanism in order to preserve function (Chang et al. 2005). 
 
The WCST also confirmed these results. Performance on this task was associated with the middle 
frontal gyrus, i.e. the DLPFC in the MA- group. A strong relationship was observed between 
decreased errors and cortical thickening. The MA- group performed the least number of 
Perseverative Responses and Errors compared to both the MA+ and the NC group. This provides 
strong evidence for the hypothesis that cortical thickening provides a mechanism for the 
preservation of function.  In addition, these results are consistent with previous research findings 
indicating an association between response inhibition on the WCST and the DLPFC (Kim, S. J. et al., 
2006).  
 
An association between preservation of function and cortical thickening was observed on tasks of 
attention and working memory as well. Attention and working memory were found to be impaired 
in our MA groups. Three tasks revealed statistically significant between-group differences; Task 
Switching, the Attention Network Task (ANT) and the Spatial Working Memory (SWM) task. Number 
of Errors on Task Switching was found to have no significant correlations with cortical thickness of 
any frontal regions. 
 
In the MA- group, performance on the ANT was significantly correlated with the left rostral ACC. A 
relationship was observed between increased accuracy and increased cortical thickness. A 
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relationship was also observed between decreased reaction times and increased cortical thickness in 
the left precentral, right caudal middle frontal and right rostral middle frontal as well as the right 
insula. In the MA+ group, a relationship was observed between increased accuracy and increased 
cortical thickness in the left precentral, the left frontal pole, the right paracentral, the right rostral 
middle frontal, and the right frontal pole. These regions suggest DLPFC involvement here. A 
relationship was also observed between decreased reaction time and increased cortical thickness in 
the right caudal ACC. In the control group, a relationship was observed between increased accuracy 
and increased cortical thickness of the left caudal ACC, and the left lateral OFC. However increased 
accuracy was associated with decreased cortical thickness of the right lateral OFC, the right 
paracentral, and the right insula cortex. These results are consistent with literature suggesting an 
association between working memory and the DLPFC (Bechara et al., 2000), i.e.the middle frontal 
gyrus, as well as an association with the ACC (Lenartowicz & McIntosh, 2005). 
 
The SWM task reflects a slightly different finding in that a relationship was observed between poor 
performance in the MA+ group and increased cortical thickness. The reasons for this finding are not 
entirely clear. These associations were found for the left lateral OFC, as well as the right caudal ACC 
and the right pars opercularis. The pars opercularis forms part of the inferior frontal gyrus which is 
adjacent to the middle frontal gyrus. In the control group, a relationship between poor performance 
and increased cortical thickness in the left caudal middle frontal, the left precentral, and the left 
insula was observed. Therefore more DLPFC involvement was observed in the control group than the 
MA+ group, which showed more OFC and ACC involvement. Our results are consistent with the 
results of Cazalis et al. (2011) who investigated traumatic brain injury and found that lower response 
accuracy on a spatial working memory task was associated with activity of the ACC, but only in their 
TBI participants and not controls. The authors also observed that performance on this task in the 
control participants was associated with the left sensorimotor cortex. Our results are similar to their 
findings. 
 
Verbal fluency revealed statistically significant between-group differences for both phonemic and 
semantic verbal fluency. Literature suggests an association between the anterior PFC and insula and 
verbal fluency (Gläscher et al., 2012). While it has been suggested that semantic fluency requires 
intact executive functions (Lezak et al., 2004; as cited in Neill, Garvich & Rossell, 2013), phonemic 
fluency is significantly more reliant on executive functions (Spreen & Straus, 2008; as cited in Neill, 
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Garvich & Rossell, 2013). Our results did not indicate any significant correlations between phonemic 
fluency and frontal cortical thickness; however, a number of significant correlations were observed 
between semantic fluency and cortical thickness of frontal regions.  
 
In the MA+ group, a relationship was observed between high scores on semantic fluency and cortical 
thickening of the left lateral OFC, the left pars triangularis, the right lateral OFC and the right 
paracentral. In the control group, however, a relationship was observed between high scores on 
semantic fluency and cortical thinning of the left caudal ACC, the left pars orbitalis, the left rostral 
ACC, and the left and right frontal poles. These results are consistent with those of Gläscher et al., 
(2012) who identified an association between verbal fluency and the anterior prefrontal cortex. 
However, it is not clear why cortical thinning was observed in the control group. 
 
In summary, impairment on executive functioning domains was broadly associated with increased 
cortical thickness in the MA- group and decreased cortical thickness in the MA+ group in the 
predicted frontal sub-regions. Impaired decision-making was associated with decreased cortical 
thickness of the orbitofrontal cortex in the MA+ group, but not in the MA- group. Impaired response 
inhibition was associated with decreased cortical thickness of the anterior cingulate cortex as well as 
the dorsolateral prefrontal cortex in the MA+ group, but increased cortical thickness in these regions 
in the MA- group. This trend was not as clear for working memory impairment. Accuracy on a 
working memory tasks was associated with the increased thickness of the dorsolateral prefrontal 
cortex as well as the anterior cingulate cortex in the MA- group; however, slower response times 
were associated with increased cortical thickness in this group. Impairment on working memory 
tasks was associated with increased cortical thickness in the MA+ group. Verbal fluency was 
associated with decreased thickness of the anterior prefrontal cortex in the MA+ group, but not in 
the MA- group. In general, impaired performance was associated with cortical thinning in the MA+ 
group. In the MA- group, cortical thickening was associated with impairment. However, it is 
important to also examine which of these groups shows the most impairment. A pattern emerged, 
indicating that when the MA+ group is most impaired, cortical thinning occurs. However, in 
instances where the MA- group was most impaired, cortical thinning also occurred. This indicates 
that cortical thickening may be a compensatory response in order to preserve function.  
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CHAPTER TEN: THE CO-MORBIDITY OF ADHD SYMPTOMS IN METHAMPHETAMINE 
 
Attention Deficit Hyperactivity Disorder was assessed using an ADHD self-report Questionnaire 
developed by Burke and Austin (2010). The outcome measures, as explained in the Methods section, 
will be analysed below. Descriptive statistics for each outcome measure for each task are 
presented in Table 42 and Figure 59 below One-way ANOVAs were conducted in order to 
establish between group differences. Spearman’s rank order correlational analyses were conducted 
in order to investigate the relationship between executive domains and ADHD scores.  
 
Table 42. ADHD Questionnaire Scores Across the 3 Participant Groups 
 Group 1: MA+ (n = 20) Group 2: MA- (n = 19) Group 3: NC (n = 20) 
 Range M (SD) Range M (SD) Range M (SD) 
 
Childhood Score 
Adulthood Score 
Total Score 
 
3 – 132 
0 – 252 
4 – 372 
 
47.65(46.21) 
70.8 (69.39) 
118.5 (111.26) 
 
0 – 115 
0 – 124 
0 - 239 
 
 
51.21 (35.34) 
61.53 (32.74) 
108.53 (62.33) 
 
 
4 – 48 
6 – 72 
11 - 106 
 
21.6 (13.32) 
42.35 (18.58) 
63.9 (26.13) 
 
 
 
Figure 59. ADHD self-report questionnaire scores 
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The predictions for these outcome measures were that the MA groups would score higher on both 
the Childhood and Adulthood sections, and therefore score higher on the total score. This would 
indicate that MA participants show more symptoms of ADHD than controls.  This trend can be seen 
in Figure 59 above. 
 
Results from the one-way ANOVAs are presented in Table 43 below. Levene’s test was found to be 
significant, therefore the assumption of homogeneity of variance was violated and an adjusted 
Welch’s F is reported here. 
 
Table 43. ANOVA Results Summary for ADHD Scores 
 Sum of 
Squares 
df Mean Square F Sig. 
 
Childhood Score 
 Between Groups 
 Within Groups 
 Total 
Adulthood Score 
 Between Groups 
 Within Groups 
 Total 
Total Score 
 Between Groups 
 Within Groups 
 Total 
 
10329.424 
66428.508 
76757.932 
 
8409.818 
117344.487 
125754.305 
 
33678.599 
318103.537 
351782.136 
 
2 
56 
58 
 
2 
56 
58 
 
2 
56 
58 
 
5164.712 
1186.223 
 
 
4204.909 
2095.437 
 
 
16839.299 
5680.420 
 
7.911 
 
 
 
3.550 
 
 
 
5.833 
 
.017 
 
 
 
.144 
 
 
 
.060 
 
The only score to reveal a statistically significant between-group difference was the Childhood Score 
Welch’s F (2, 56) = 7.911, p = .017. The total score revealed a trend towards significance, Welch’s F 
(2, 56) = 5.833, p = .060; however, this result did not reach statistical significance.  
 
The Games-Howell post-hoc calculation of multiple comparisons was used to shed further light on 
the data. The Childhood Score revealed statistically significant between-group differences between 
the MA- and control groups, p = .006. A trend towards a significant difference was observed 
between the MA+ and control groups, p = .060; however this difference did not reach statistical 
significance. No significant difference was observed between the MA+ and MA- groups, p = .960, 
indicating that these two groups performed similarly. 
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No significant between-group differences were observed on the Adulthood Score or the Total Score 
for the ADHD questionnaire. This indicates that the executive functioning impairment found in our 
sample cannot be attributed to pre-existing impairment similar in nature to that associated with 
ADHD. 
 
 In order to further investigate this point, Spearman’s rank order correlational analyses were 
conducted between our composite domains scores and the ADHD questionnaire scores. 
Interestingly, the only domain to show a significant correlation was Decision Making. This was the 
only domain that did not reveal the results that we expected. None of the other executive domains 
correlated with scores from the ADHD questionnaire, indicating no relationship between ADHD 
symptoms and performance on Response Inhibition, Working Memory or Verbal Fluency. The 
correlation matrix is presented in Table 44 below. 
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Table 44. Correlation Matrix for the Executive Functioning Domains and the ADHD Scores 
  Decision 
Making 
Response 
Inhibition 
Working 
Memory 
Verbal 
Fluency 
Childhood 
Score 
Adulthood 
Score 
Total 
Score 
Spearman's rho Decision Making Correlation Coefficient 1.000 -.042 -.028 .071 -.305
*
 -.084 -.197 
Sig. (2-tailed)   .754 .835 .598 .019 .529 .134 
N 59 59 59 58 59 59 59 
Response Inhibition Correlation Coefficient -.042 1.000 .721
**
 .663
**
 -.225 -.185 -.194 
Sig. (2-tailed) .754   .000 .000 .086 .160 .140 
N 59 59 59 58 59 59 59 
Working Memory Correlation Coefficient -.028 .721
**
 1.000 .662
**
 -.061 -.056 -.020 
Sig. (2-tailed) .835 .000   .000 .648 .673 .882 
N 59 59 59 58 59 59 59 
Verbal Fluency  Correlation Coefficient .071 .663
**
 .662
**
 1.000 -.186 -.144 -.155 
Sig. (2-tailed) .598 .000 .000   .162 .281 .246 
N 58 58 58 58 58 58 58 
Childhood Score Correlation Coefficient -.305
*
 -.225 -.061 -.186 1.000 .792
**
 .924
**
 
Sig. (2-tailed) .019 .086 .648 .162   .000 .000 
N 59 59 59 58 59 59 59 
Adulthood Score Correlation Coefficient -.084 -.185 -.056 -.144 .792
**
 1.000 .948
**
 
Sig. (2-tailed) .529 .160 .673 .281 .000   .000 
N 59 59 59 58 59 59 59 
Total Score Correlation Coefficient -.197 -.194 -.020 -.155 .924
**
 .948
**
 1.000 
Sig. (2-tailed) .134 .140 .882 .246 .000 .000   
N 59 59 59 58 59 59 59 
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DISCUSSION 
 
We conducted a correlational analysis in order to investigate the relationship between performance 
on our executive domains and symptoms of ADHD. Only one significant correlation was observed. 
Decision-making was significantly correlated with the Childhood ADHD Score. None of the other 
executive domains revealed significant correlations. It is therefore unlikely that the executive 
dysfunction observed was due to a pre-existing condition of ADHD, but rather more likely due to the 
toxic effects of methamphetamine. 
 
An inverse relationship was observed between decision-making and Childhood ADHD score, 
indicating that impaired decision making was associated with a higher score on Childhood ADHD. 
This result is consistent with previous research suggesting that poor decision making skills contribute 
towards the maintenance of substance use disorders (Wilson et al., 2005). 
 
High rates of co-morbidity have been observed between MA Dependence and ADHD (Duarte, 
Woods, Rooney, Atkinson & Grant, 2011; Jaffe at al., 2005; Obermeit et al., 2013). While the current 
study did not employ measures to diagnose ADHD clinically, we rather investigated the symptoms 
associated with ADHD in order to assess the co-morbidity between these symptoms and MA 
dependence. We also wanted to investigate whether more severe symptoms i.e. higher scores, 
would be associated with MA+, given the fact that ADHD has been identified as a significant 
predictor of MA-induced psychosis (Fujii, 2002; Salo et al., 2013). 
 
Our results did not indicate significant between-group differences on the Adulthood Score or the 
Total Score. Therefore, in our sample, symptoms associated with adult ADHD were not associated 
with MA. However, the Childhood Score did reveal a statistically significant between-group 
difference, indicating that childhood ADHD may be associated with later substance use, and in our 
case, this substance was MA. These results are consistent with research that indicates that childhood 
ADHD is a risk factor for substance use (Biederman et al., 1998; Matsumoto et al., 2005; Wilens et 
al., 1997). 
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CHAPTER ELEVEN: SUMMARY AND CONCLUSIONS 
 
INTRODUCTION 
 
The preceding chapters have attempted to address a number of aims and specific research questions 
that were stated at the outset of this thesis. Although in-depth discussions have been provided for 
the major findings in these chapters, I now summarise the major findings. This final chapter will 
firstly attempt to answer the original research questions formulated in the first chapter of this thesis 
and secondly provide conclusions. Lastly, limitations and suggestions for future research will be 
discussed.  
 
ANSWERING THE RESEARCH QUESTIONS 
 
Research Questions 1 and 2: Are executive functions impaired in MA? And if so which of the four 
domains shows the most severe impairment? Are these impairments more severe in MA 
Dependence with a history of psychosis compared to MA Dependence without a history of 
psychosis? 
 
Chapters 4 – 8 presented results attempting to address these questions. Previous studies were 
lacking in a comprehensive battery of tests measuring executive impairment (Scott et al. 2007). Our 
aim was to include a wide range of tests in order to assess a wide range of executive functions. This 
aim was achieved through the use of 14 tasks used across 4 different domains of executive 
functioning. When standardising these test scores and combining them to form one composite score 
of executive functioning, it was found that executive functions were impaired in MA. All three 
groups were significantly different from one another, indicating that, in general, the MA+ group 
showed the most severe impairments on tasks of executive functioning and control participants 
showed the least. 
 
Moreover, we identified significant impairments in the domains of Response Inhibition and Set-
Shifting, Attention and Working Memory, and Verbal Fluency (for a summary of these results refer to 
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Tables 45 – 47 below). We did not however observe significant impairment in Decision-Making and 
Impulsivity (for a summary of these results refer to Table 48 below). In our sample, very specific 
impairments regarding decision making were observed. For example we noted that MA participants 
were more impulsive than controls. However, both MA groups performed similarly on this domain. 
Significant impairments were observed on Response Inhibition and Set-Shifting tasks. It was shown 
that MA+ participants showed greater impairments than the other two participant groups. MA 
participants were also considerably slower to respond on the majority of tasks compared to NCs. 
Both MA groups also performed similarly on tasks of Attention and Working Memory and both of 
these groups performed poorly compared to normal controls. Both MA groups also performed 
similarly on phonemic fluency, however, on semantic fluency, the MA+ group performed worse than 
the MA- group. Both groups showed greater impairments on verbal fluency than controls. Hence, it 
is evident that MA dependence with a history of psychosis presents similarly to MA dependence 
without a history of psychosis in terms of executive functioning deficits, except with regards to 
response inhibition and set-shifting where the largest differences between these groups were 
observed.    
 
Table 45. Summary of results for tasks of response inhibition and set-shifting 
 Between-Group Comparisons 
 MA+ > MA- MA+ > NC MA- > NC 
Affective Go/No Go task 
 Mean correct latency (positive) 
 Mean correct latency (negative) 
 Total omissions (positive) 
 Total omissions (negative) 
 
-- 
-- 
-- 
* 
 
** 
* 
* 
** 
 
** 
** 
-- 
* 
Stop signal task 
 Directions errors on stop/go trials 
 Proportion of successful stops 
 Median correct RT on go trials 
 SSD (last half) 
 SSRT (last half) 
 
-- 
-- 
-- 
-- 
-- 
 
* 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
-- 
Stroop task 
  Total time 
 Errors 
 Self corrected errors 
 
* 
-- 
-- 
 
** 
* 
** 
 
* 
-- 
* 
Wisconsin card sorting task 
 Total correct 
 Total errors 
 Perseverative responses 
 Perseverative errors 
 
-- 
-- 
* 
* 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
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Table 46. Summary of results for tasks of attention and working memory 
 Between-Group Comparisons 
 MA+ > MA- MA+ > NC MA- > NC 
Task switching 
 Errors 
 Average reaction time 
 
-- 
-- 
 
** 
-- 
 
-- 
-- 
Reaction Time 
 Five choice movement time 
 Five choice reaction time 
 
-- 
-- 
 
-- 
-- 
 
-- 
-- 
Attention network task 
Accuracy:  
 Neutral trials 
 Congruent trials 
 Incongruent trials 
Reaction time: 
 Neutral trials 
 Congruent trials 
 Incongruent trials 
 
 
-- 
-- 
* 
 
-- 
-- 
-- 
 
 
* 
* 
* 
 
* 
* 
-- 
 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
Spatial working memory 
 Between errors 
 Strategy 
 
-- 
-- 
 
** 
* 
 
-- 
-- 
Spatial Span 
 Span length 
 
-- 
 
-- 
 
-- 
 
 
Table 47. Summary of results for tasks of verbal fluency 
 Between-Group Comparisons 
 MA+ > MA- MA+ > NC MA- > NC 
Phonemic (letter) fluency 
 FAS total 
 
* 
 
** 
 
-- 
Semantic (category) fluency 
 Total Score 
 
* 
 
 
** 
 
-- 
Category switching 
 Total correct responses 
 
-- 
 
* 
 
-- 
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Table 48. Summary of results for tasks of decision-making and impulsivity 
 Between-Group Comparisons 
 MA+ > MA- MA+ > NC MA- > NC 
Delay Discounting Task 
 Number of discounts 
 
-- 
 
** 
 
** 
Balloon Analogue Risk Taking Task 
 Number of pumps 
 Average number of pumps 
 Maximum number of pumps 
 Total points earned 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
Information Sampling Task 
Win condition fixed 
 Mean no. of boxes  opened/trial 
 Mean P (correct) 
 Total correct 
 Sampling errors 
 Discrimination errors 
 Mean box opening latency 
Win condition decreasing 
 Mean no. of boxes opened/trial 
 Mean P (correct) 
 Total correct 
 Sampling errors 
 Discrimination errors 
 Mean box opening latency 
 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
* 
-- 
 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
-- 
-- 
Cambridge Gambling Task 
 Delay aversion 
 Deliberation time 
 Overall proportion bet 
 Quality of decision making 
 Risk adjustment 
 Risk taking 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
* 
-- 
 
-- 
-- 
-- 
-- 
-- 
-- 
 
 
 
Research Question 3: Were symptoms of ADHD found to be co-morbid in our MA groups and if so, 
was there a correlation between these symptoms and EFs? 
 
Chapter 10 dealt with this research question. Significant differences between our groups were only 
observed on childhood measures of ADHD rather than adulthood measures of ADHD. The MA groups 
performed similarly, but both groups were significantly different from controls. Therefore, both 
groups scored higher on symptoms of childhood ADHD than controls. The measure of adulthood 
symptoms of ADHD were also different across groups, however, this difference did not reach 
statistical significance. This indicates that the co-morbidity of symptoms of ADHD is more likely in 
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MA dependent populations. This then begs the question of whether the co-morbidity of ADHD 
symptoms in this population can account for the executive impairments observed. We ran 
correlational analyses to determine whether there was in fact a relationship between these two 
constructs. A relationship was observed between decision making and childhood symptoms of 
ADHD. The executive domain where we noted the least significant results was the only domain 
found to be associated with the childhood symptoms measured by the ADHD questionnaire. None of 
our other domains were found to relate to symptoms of ADHD. The executive dysfunction observed 
in methamphetamine dependence is therefore more likely a result of MA toxicity, rather than 
premorbid ADHD. 
 
Research Question 4: Is there a correlation between executive impairment and cortical thickness 
changes in our MA sample? 
 
Chapter 9 attempted to answer this research question. A relationship was observed between 
executive impairment and cortical thickness of frontal brain regions. Generally, these relationships 
were found in the expected regions. Decision-making was largely associated with cortical thickness 
of the OFC. Response inhibition was largely associated with cortical thickness of the ACC and the 
DLPFC. Working Memory was largely associated with cortical thickness of the DLPFC as well as the 
ACC. Verbal Fluency was largely correlated to the OFC and the ACC. We expected to find much 
overlap in our results given the overlap between these executive domains. This is exactly what we 
found.  
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CONCLUSION 
 
In concluding this thesis it is noted firstly that executive functions are impaired in methamphetamine 
dependence and particularly in methamphetamine psychosis. While response inhibition appears to 
be the most affected executive function in methamphetamine, working memory and verbal fluency 
impairments also exist. The domain that was least affected in our sample was decision-making. This 
may be due to the nature of the tests used; which may not be sensitive enough to measure such 
impairment in this population. Nonetheless, executive functions are significantly impaired in 
methamphetamine dependence, particularly methamphetamine psychosis. This not only has an 
impact on the course of the illness, but also on functional outcomes (Donaghue & Doody, 2012). 
“Cognitive impairment has been associated with poorer treatment outcomes in a range of studies” 
(Aharonovich et al., 2003; as cited in Scott et al., 2007, p. 287). Secondly, while childhood symptoms 
of ADHD were found particularly in our methamphetamine psychosis group, these scores did not 
appear to impact on executive functions in our sample, indicating that the executive dysfunction 
observed in our sample is likely due to the effects of MA toxicity. Thirdly, in general, increased 
cortical thickness was associated with impairment in our methamphetamine dependent group and 
decreased cortical thickness was associated with impairment in our methamphetamine psychosis 
group. Cortical thickening may be a compensatory response in order to maintain function in our 
sample. Executive functions were found to be correlated with regions of the frontal cortex. 
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LIMITATIONS AND DIRECTIONS FOR FUTURE RESEARCH 
 
The current study contains a number of limitations that should be addressed in future studies. 
Firstly, the relatively small sample size makes the generalisability of results challenging. Larger 
sample sizes are suggested for future studies. Small sample sizes may be attributed to the challenge 
of recruitment of MA dependent participants. This was due to various factors; namely, it is a time 
consuming process; the response rate is low; and the drop-out rate is high. In addition, the sample 
consisted of relatively pure MA users; such individuals are difficult to find, given that most drug 
users are poly-drug users. Secondly, our tasks of decision-making may have proved to be less 
sensitive to the construct being measured in this population. Future studies should explore 
alternative options when testing decision-making. For example, tasks where real rewards are offered 
may be more appealing to participants. In addition, gambling tasks where the participant believes 
they are playing against an opponent may result in more meaningful engagement in the task. Third, 
the wide range of abstinence among the sample may produce large amounts of variability in the 
data. Future studies should minimise the range of abstinence in order to reduce such variability. 
Fourth, differences between groups on level of education and IQ may impact on neuropsychological 
test results. Future studies should aim for equal levels of education and IQ scores across groups, as 
far as possible. Fifth, the focus of this thesis was executive functioning; therefore future studies 
should aim to assess other neuropsychological domains such as memory or language, but should do 
so comprehensively in order to gain a clearer understanding of neuropsychological functioning as a 
whole in methamphetamine. 
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APPENDICES 
 
APPENDIX A: PARTICIPANT SCREENING QUESTIONAIRE 
 
DATE: ____________________________ 
 
Personal Details: 
 
Full Name: _________________________________________ 
Date of Birth: _______________________________________ 
Gender:____________________________________________ 
 
 Contact Details: 
 
Address:____________________________________________ 
         ____________________________________________ 
         ____________________________________________ 
 
Tel. number (home): _____________________________________ 
                     (mobile): ____________________________________ 
     Email Address: ________________________________________ 
 
 
 Medical Details:                               Please circle  
       
1. Are you right-handed?       Yes  /  No  
 
2. Do you take any kind of medication on a regular basis?        Yes  /  No 
    If yes, please specify what kind 
____________________________________________________________________ 
 
3.  Have you ever had a head injury?           Yes  /  No 
     If yes, describe most severe: 
____________________________________________________________________ 
 
4. Were you knocked unconscious?           Yes  /  No 
    If yes, how long? 
 ___________________________________________________________________ 
 
5. Any surgery/hospitalisation as a result of your head injury?        Yes  /  No 
    If yes, please specify: 
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___________________________________________________________________ 
 
6. Have you ever had seizures or an epileptic fit?         Yes  /  No 
 
7. Has anyone in your immediate family (siblings, parents) ever        Yes  /  No 
    been diagnosed with epilepsy? 
    If yes, please specify who: 
 ____________________________________________________________________ 
 
8. Have you ever been diagnosed with a psychiatric illness?                  Yes /  No 
    If yes, please specify:  
____________________________________________________________________ 
 
9. Have you ever had any neurological condition?         Yes  /  No 
    If yes, please specify:  
____________________________________________________________________ 
  
10. Do you have a metal object in your body (eg. aneurysm clip)?       Yes  /  No 
      If yes, please specify: 
____________________________________________________________________ 
 
11. Do you wear a metal prosthesis (eg. artificial leg)?         Yes  /  No 
      If yes, please specify:  
____________________________________________________________________ 
 
12. Do you have a pace-maker?            Yes  /  No 
 
13. Have you ever been diagnosed with asthma?          Yes  /  No 
 
14. Have you ever been diagnosed with chronic bronchitis,        Yes  /  No 
     emphysema, or any other respiratory problems?                               
  
15. Have you ever been diagnosed with a hepatic (liver) problem/        Yes  /  No       
     disorder?          
 
16. Have you ever been diagnosed with a renal (kidney) problem/        Yes  /  No 
     disorder?      
 
17. Have you ever been diagnosed with an endocrine (hormonal)          Yes  /  No 
     problem/disorder? 
     
18. Have you ever had a seropositive test for HIV?                                Yes  /  No 
 
29. If you are female, are you currently pregnant?         Yes  /  No 
  
 
 
Other notes: 
_____________________________________________________________________________ 
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APPENDIX B: PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT:  
Neural correlates of deficits in affect regulation in methamphetamine abusers with a history of psychosis  
REFERENCE NUMBER: 340/2009  
PRINCIPAL INVESTIGATOR: Dr Donald Wilson 
ADDRESS: University of Cape Town, Dept of Psychiatry and Mental Health, Groote Schuur Hospital (J2), Anzio 
Road, Observatory 7925, Cape Town, South Africa 
CONTACT: E-mail:d.wilson@uct.ac.za, Phone: +27-21-404-2182, Fax: +27-21-448-8158 
 
Dear Volunteer 
 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study staff 
or doctor any questions about any part of this project that you do not fully understand. It is very 
important that you are fully satisfied that you clearly understand what this research entails and how 
you could be involved. Also, your participation is entirely voluntary and you are free to decline to 
participate. If you say no, this will not affect you negatively in any way whatsoever. You are also free 
to withdraw from the study at any point, even if you do agree to take part.  
This study has been approved by the Faculty of Health Sciences Human Research Ethics Committee 
(FHS HREC) of the University of Cape Town, and will be conducted according to the ethical guidelines 
and principles of the international Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
This project is being run at the Department of Psychiatry, University of Cape Town. We aim to recruit 
a total of 60 participants over a period of 3 years. 
What is this research study all about?  
Background: The increasing use of methamphetamine (MA, also “tik” or “meth”) is a cause for 
concern for a number of reasons. On the personal level the chronic use of MA has been associated 
with brain damages resulting in potentially long-lasting mental health effects including confusion, 
impaired concentration and memory. Imaging studies have shown that MA use is associated with 
imbalances in the neurochemistry of the brain. Thus long-term abuse of “tik” or “meth” is associated 
with the development of paranoid, often violent psychotic states accompanied by auditory, visual 
and/or tactile hallucinations. MA abuse also has profound consequences on an interpersonal level, 
due to associated impairments in emotion regulation. For instance, aggression and hostility have 
been consistently identified in chronic users of MA and such emotional disturbances have been 
associated with abnormalities in functional and structural neuroanatomy. 
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Methods: Participants will have to complete questionnaires and a series of behavioural and cognitive 
tasks. Some of these will be used to determine whether MA abuse and MA-induced psychosis is 
associated with defects in social awareness and regulation of emotions. In addition, brain imaging 
techniques will be used to determine the effect of MA abuse, with and without a history of 
psychosis, on brain structure and function. Specifically, structural magnetic resonance imaging (MRI), 
magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) will be employed to 
investigate how brain structure and metabolism change in MA abusers in comparison to healthy 
controls. DNA analyses of blood samples will be conducted to examine whether specific genes 
account for structural and functional brain abnormalities after methamphetamine abuse and for 
increased vulnerability to psychosis. 
In addition, associations between “tik” abuse and the disability of controlling emotions will be 
assessed. Participants will therefore perform a simple task (Affective Labelling task) measuring 
emotional processing as part of the functional MRI scan. This task will be used to assess differences 
in brain activation corresponding to impairments in regulating behaviour.  
 
Procedures 
If you agree to take part in the study and if you meet all of the conditions required for entering the 
study (assessed in a screening interview), you will complete the following 3 phases and procedures: 
At your first visit the study will be explained and written consent to take part will be obtained. Your 
study investigator will ask you some questions about your psychiatric and neurological history and 
you will have to fill out several questionnaires. If you are eligible and agree to participate in the 
study you will be asked to attend the second testing session at the Cape Universities Brain Imaging 
Centre (www.sun.ac.za/cubic). 
During the second testing day, you will be asked to complete behavioural tasks. Following 
completion of these tasks the brain scanning session, Magnetic Resonance Imaging (MRI) and 
Spectroscopy (MRS), will take place. 
During the third visit you will undergo neuropsychological testing including tasks about your 
memory, attention and risk taking behaviour. 
It is estimated that none of the testing sessions should take more than 3-4 hours to complete. 
The psychiatric interview will take place either at Valkenberg Hospital or in the Psychiatric 
department at Groote Schuur Hospital. Brain imaging will be conducted using a 3T Siemens 
Magnetom Allegra at CUBIC, Stellenbosch. Each scanning session will last approximately one hour. 
Structural and functional imaging data will be acquired. Stimuli for each cognitive-affective protocol 
will be computerized and displayed to you in the scanner via a screen display. The 
neuropsychological assessment, which will be computer based tests, will take place in the Psychiatric 
Department of Groote Schuur Hospital.  
Urine screens will be performed on both days of testing to verify methamphetamine abstinence and 
to determine the degree of cannabis use, as well as for a pregnancy test (if you are female). You will 
have to pee in a cup for those tests. The results of those tests are not for legal medicine or police 
purpose, and will only be used for our study. 
Blood samples will be collected for routine laboratory testing and for possible future gene and 
protein expression studies. Approximately 35ml (7 teaspoons) of blood will be drawn from your arm. 
We may need to contact you again to get another blood sample should we fail to get a DNA sample 
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from your blood. Candidate polymorphisms identified to be associated with drug dependency or 
psychosis and possibly playing a role in explaining variance in the MRI results will be investigated 
later on. This process will take place at the Division of Human Genetics at the University of Cape 
Town. 
Magnetic Resonance Imaging 
With an MRI you can obtain very detailed images of organs and tissues throughout the body, even of 
the brain, as in our study. MRS provides a tool to investigate metabolites in the living brain. Both 
MRI and MRS testing cause no pain and the magnetic fields produce no known tissue damage of any 
kind.  
The MRI and MRS examination are performed in a special room that houses the MR system or 
"scanner". You will be escorted into the room by a staff member of the MRI facility and asked to lie 
down on a comfortably padded table that gently glides you into the scanner. This is typically a large, 
tunnel magnet that is open at both ends, so you won't be completely enclosed at any time.  
As the scan is done in a relatively confined space, occasionally people feel closed-in or frightened. 
This does not happen often, and if you feel anxious, we will spend time allowing you to get used to 
the surroundings. Another side-effect might be a tingling feeling in your teeth if you have metal 
fillings. 
The most important thing for you to do is to relax and lie perfectly still during the time the imaging 
takes place. For the functional imaging you will be asked to perform some simple tasks of emotional 
processing and attention, which will enable the investigators to determine your brain function. 
During the structural and diffusion tensor imaging you will be able to close your eyes and rest. Given 
that the testing session will take one hour to complete, you might get sleepy or uncomfortable after 
a while, but you are asked to stay awake and not to move throughout the scanning.  
A radiologist will operate the scanner from behind a window, and will be able to see and hear you 
during the scan. You will be able to communicate with the radiologist or the study assistant at any 
time using an intercom system. You will also be given an alarm call button to hold during the scan, 
which you can press to get attention. 
The MR scanner may produce loud tapping or knocking noises at times during the testing, which is 
normal and should not worry you. Especially when the magnet in the machine is switched on, it will 
make some loud banging noises, but you will be clearly warned when this will take place. You will 
feel nothing and the noise is not harmful to you in any way. To minimise the possible discomfort 
associated with this, we will give you some soft earplugs to put in. 
MRI and MRS scans are commonly performed and a safe procedure if you have been screened 
correctly for the presence of any magnetic material on or inside you such as pace-makers, surgical 
clips and metal objects in the eyes. A formal screen for this will be done at the screening visit by a 
member of the study team. 
Why have you been invited to participate? 
Three groups of participants will be included in this study: methamphetamine (MA) abusers with a 
history of psychosis, MA abusers without a history of psychosis and non-substance-abusing healthy 
control subjects. Each of the groups will consist of 20 participants. You may fit into one of these 
categories as assessed during your initial screening. 
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What will your responsibilities be? 
The study investigator will be required to ask you about medications that you may be taking 
currently or that you may have taken recently. Your study investigator will explain to you which 
medications need to be stopped during the entire length of the study and how soon before you take 
part in the study these medications must be stopped. 
Your doctor will also advise you on which prescription or over-the-counter medications or any other 
remedies or foods that you will be required to either stop or restrict your consumption of during the 
entire length of the study. This will include a restriction on the amount of alcohol that can be 
consumed. 
At each visit you may be asked to complete questionnaires or tasks to check the status of your 
symptoms. These will measure your mood, emotional responses, trust, sociability and emotional 
resilience. 
Please ensure that you are punctual at all times, as we are using specialized equipment during each 
of the sessions, for which costs are incurred. If for some reason you are unable to complete a visit on 
a particular day we may reschedule to complete the assessments at another time.  
Will you benefit from taking part in this research? 
There are no direct benefits to you for participating in this study. However, you will be making an 
important contribution to this research that may benefit others in the future. We expect that the 
results of this study will help us understand the effects of methamphetamine on brain structure and 
function and how their abuse can lead to the development of psychosis. 
Are there any risks involved in your taking part in this research? 
There are no major risks involved in participation in this study. There will be several questionnaires, 
including some about past traumatic events that ask for information of a very personal and sensitive 
nature. This may cause some emotional discomfort. 
Who will have access to your medical records? 
Maintaining your confidentiality is important. Your personal information (for example your gender, 
age, the details of your medical conditions) and other information (the data collected by the 
investigators as part of the study) will be identified by a number (i.e. coded). Your name will not 
appear in any publications or reports produced from this study. The investigators will keep the 
information and the results collected about you in this study. This information about you will be kept 
in a secure place.  
By agreeing to take part in this study, you will be allowing certain persons to see the information 
about you (both personal, including your name, and other information) held by the study doctor. 
You have the right to withdraw your consent to participate in this study at any time. 
If you withdraw your consent to participate in this study no new information will be collected from 
you and added to existing data or to a database. Your information will be processed electronically 
(i.e. by a computer) or manually and analysed to determine the outcome of this study. Your 
information may/could be sent to regulatory authorities and to the Ethics Committees. You have the 
right to ask the study doctor about the data being collected on you for the study and about the 
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purpose of this data. You have the right to ask the study doctor to allow you to see your personal 
information and to have any necessary corrections made to it. 
What will happen in the unlikely event of some form of injury occurring as a direct result of your 
taking part in this research study? 
If you become ill or injured as a direct result of your participation in this clinical study, you will be 
referred for appropriate medical treatment. The University of Cape Town’s insurance policy will 
cover the costs of such treatment. If you have any questions concerning the availability of 
compensation/medical care or if you think you have experienced a research-related illness or injury, 
contact details are below. Your legal right to claim compensation for injury where you can prove 
negligence is not affected.  
If you have any questions about your rights as a research subject, you should contact the Faculty of 
Health Sciences Human Research Ethics Committee (FHS HREC), Tel: (021)4066492, Fax: 
(021)4066411. 
If you have questions about this study you should first discuss them with your study doctor or the 
Faculty of Health Sciences Human Research Ethics Committee (FHS HREC), UCT.  
Dr D. Wilson:  (021)4042182 
Dr H. Temmingh:  (021)4403185 
After you have consulted your doctor or the FHS HREC and if they have not provided you with 
answers to your satisfaction, you should write to the South African Medical Research Council at: 
Head Office Cape Town, Corporate Communications Office, Sarah Bok,  PO Box 19070, Tygerberg, 
7505, South Africa or Fax: (021)9380200. 
Will you be paid to take part in this study and are there any costs involved? 
All evaluations will be provided, hence there will be no costs involved for you or your medical aid, if 
you do take part in the study. You will be compensated for taking part in the study as your transport 
and meal costs will be covered with supermarket vouchers to exchange for food, amounting to R150.  
Is there anything else that you should know or do? 
You can contact the Committee for Human Research at (021)4066492 if you have any concerns or 
complaints that have not been adequately addressed by your study doctor. 
You will receive a copy of this information and consent form for your own records. 
Informed Consent Form for Study Participants 
Title of the Research Project: “Neural correlates of deficits in affect regulation in methamphetamine 
abusers with a history of psychosis.” 
 
Declaration by participant 
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By signing below, I …………………………………..…………. agree to be interviewed and asked personal 
information as part of the above named study and that the information I give will be correct. 
Furthermore, I declare that: 
I have read, or had read to me, the “Participant Information Leaflet and Consent Form” and it is 
written in a language with which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels it is in 
my best interests, or if I do not follow the study plan, as agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     . 
Signature of participant  
By signing below, I …………………………………..…………. agree to have my blood taken for the proposed 
genetic tests as described in the “Participant Information Leaflet and Consent Form”. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     . 
Signature of participant  
By signing below, I …………………………………..…………. agree to undergo brain scans (MRI/MRS) as 
described in the “Participant Information Leaflet and Consent Form”. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     . 
Signature of participant  
By signing below, I …………………………………..…………. agree to Neuropsychological testing as described 
in the “Participant Information Leaflet and Consent Form”. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     . 
Signature of participant  
Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed above. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     . 
Signature of investigator 
207 
 
 
 
 
 
 
APPENDIX C: SOCIO-DEMOGRAHIC QUESTIONNAIRE 
 
 
                                                                                Study ID: ----------------- 
Rater: 
Date of interview: 
Subject’s Address: 
Telephone numbers: _____________________&____________________ 
                                    ______________________&____________________ 
Collateral sources of information: 
Relationship with subject 
 
Name Contact numbers 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subject’s home language/ Mother tongue:  
i) English ii) Afrikaans iii) Xhosa iv) Other 
Language(s) that subject can communicate in fluently: 
i) English ii) Afrikaans iii) Xhosa iv) Other 
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Section A: Demographic data 
1. Gender :    Male  .............                                   Female ................. 
2. Age :  ........................ 
3. Race  :        i. Black  
                       ii. White 
                       iii. Coloured 
                        iv. Asian                                 other (specify)................. 
4. Religion........................................ 
    Would you describe yourself as a religious person?    Yes..........          No......... 
5. Marital status:        i. Single 
                                   ii. Married 
                                   iii. Co-habiting 
                                   iv. Widowed 
                                   v. Divorced 
                                   vi. Separated 
6. Do you have children?   Yes .......                                          No ......          
     If Yes, how many? ............................... 
7. Who lives with you at home? (e.g Friend, Step-father, mother,etc)...................... 
8. What is your highest level of education (highest grade completed)?  ..................... 
11. Employment status:   i. Employed 
                                         ii. Unemployed 
                                         iii. Student 
     If employed, what kind of job do you do? ............................................................... 
12. Monthly income ............................................. 
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Section B: ‘TiK’ abuse history 
13. What was your first drug of abuse? ......................................................... 
      Name the first 2 drugs in order of usage (i............................................... 
                                                                      (ii...................................................... 
14.a. How old were you when you first used Tik? ......................................... 
14.b. How old were you when you first used drug? ...................................... 
15.a. How long have you been using ‘Tik’ ? ................................................... 
15.b. When last did you use Tik? …………………………………………….... 
16. How much do you spend on ‘Tik’ on a weekly basis? ............................. 
17. What quantity of ‘Tik’ do you use on a weekly basis? ............................. 
18. Have you had any previous treatment for ‘Tik’ abuse?   Yes.......            No....... 
      If Yes, which type:              i. In-patient Rehab 
                                                 ii. Out-patient Rehab 
                                                 iii. Both in-patient and out-patient Rehab 
19. How many attempts at rehabilitation have you had in the past? ........................... 
20. What was your longest period of abstinence from ‘Tik’ as a consequence of treatment? 
.................................. 
21. What was your longest period of voluntary abstinence from ‘Tik’, not as a consequence of 
treatment? ..................................... 
22. Why do (did) you use methamphetamine (tik) …………………………………….. 
______________________________________________________________ 
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Section C: (Family and Personal history of Psychiatry illness) 
23. Have you ever been diagnosed to have a psychiatric illness in the past?           Yes............                                         
No.......... 
If Yes, when was the first time you had a psychiatric illness? (specify month and year) 
............................................................. 
24. Has anyone in your family had a psychiatric illness not related to drug abuse? 
          Yes...............                                 No.............         
If Yes, who?  (e.g. Father, Brother, Aunt, Cousin, etc) ................................... 
 
Section D: General pattern of drug abuse 
 
Name of 
drug 
 
Age 
started 
using 
Date last 
used 
Pattern of 
use in last 
12 months 
Average 
spend a 
month(R) 
Period of heavy 
use 
Quantity used 
per  week 
  
nicotine 
 
 
      
 
 
meth(tik) 
      
 
 
cannabis 
      
 
 
alcohol 
      
 
 
mandrax 
      
 
 
opiods 
      
 
 
cocaine 
      
 
 
ecstasy 
      
 
 
others 
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Section E: Living condition 
1. Do you have the following amenities at home?            
i. Tap with running water     Yes  No                                                       
ii. Electricity                                                                                Yes  No 
iii. Stove                                                                                       Yes  No 
iv. Flush toilet in house                                                            Yes  No 
v. TV                                                                                       Yes  No 
vi. Fridge                                                                                  Yes  No 
vii. Adequate clothing for child                                                  Yes  No 
viii. Enough food to eat (at least 2 meals/day)                           Yes  No 
ix. 2 people or less in bedroom.                                                Yes  No 
x. Do you read at least 1 newspaper/ magazine per week     Yes  No 
 
 
 
2. Type of dwelling:  shack/ house/ flat / boarding house/ roofless/ refugee centre/  Skilled nursing 
facility. 
 
3. Size of the dwelling where applicable (no. of bedrooms) ____ 
 
4. How many people live in the dwelling ? ___  
 
5. Are your parents married / separated / divorced?  
 
6. Do you share or do you have your own bedroom?________ 
 
7. How often do you see your extended family? ____________ 
 
8. Nationality: __________________Age immigrated to SA (if applicable) 
 
9. Parents’ nationality______________ 
 
 
Section F: Treatment history of psychiatric disorder: 
i. When was the first time you saw someone (like a social 
worker/psychologist/psychiatrist/counsellor) for emotional/psychiatric problems? 
_________________________________________ 
ii. What life changing event was associated with that 1st presentation (like divorce/death/new 
school/job loss)? ________________________________ 
iii. Were you admitted or seen as an out- patient? And what diagnosis was given? 
_____________________________________________________ 
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iv. Were you placed on medications? (If Yes, name them)  
_________________________________________________________ 
 
Definite Diagnosis SCID-I summarized 
Axis I: 
Principle: 
__________________________________________________________________________________
_____________________________________________ 
___________________________________________________________________ 
Additional diagnosis 
__________________________________________________________________________________
__________________________________________________________________________________
_____________________________________ 
Co morbid Diagnoses: 
__________________________________________________________________________________
__________________________________________________________________________________
_____________________________________ 
 
Axis (GAF score) _______________________ 
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APPENDIX D: BRIEF CHILDHOOD AND ADULTHOOD SCREENING QUESTIONNAIRE FOR ADHD 
 
 
Biographical Information 
Name (optional): _____________________ 
Age (in years & months): _______________ 
Gender: 
Female 1 
Male 2 
 
Highest Educational Level:  
Grade 7 or lower 1 
Grade 8 - Grade 11 2 
Grade 12 3 
Post-matric certificate 4 
Post-matric diploma 5 
B-degree 6 
Honours degree 7 
Masters degree 8 
Doctorate degree 9 
Post-doctorate degree 10 
 
Has anybody in your childhood years mentioned that you may be suffering from ADHD? 
No 0 
Yes 1 
 
Were you diagnosed with ADHD as a child by a Mental Health Professional (e.g. doctor, psychiatrist, 
psychologist, etc.) 
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No 0 
Yes 1 
 
Have you been diagnosed with ADHD as an adult by a Mental Health Professional (e.g. doctor, 
psychiatrist, psychologist, etc.) 
No 0 
Yes 1 
 
 
INSTRUCTIONS 
In the following part of the questionnaire you will find a list of thoughts, feelings and behaviours. For 
each item you must indicate whether or not you display or experience this thought, feeling or 
behaviour AND how often you display or experience it. 
 
SECTION A: CHILDHOOD 
Think back to your childhood years (5 – 17 years) and see if you can identify any of the following: 
Item Occurrence   Frequency    
  
Yes No Almost 
Never 
Now and 
again 
At least 
once a 
week 
At 
least 
once a 
day 
More 
than 
once 
per day 
Failed to give close attention to 
details to schoolwork, work, or 
other activities 
       
Made careless mistakes in 
schoolwork 
       
Difficulty sustaining attention in 
tasks  
       
Adults and friends often 
complained that you did not seem 
to listen when spoken to directly 
       
 In trouble for not finishing 
schoolwork, homework, chores or 
duties  
       
 Compared to other children your 
schoolwork and other activities 
were disorganized 
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You avoided, disliked, or were 
reluctant to engage in tasks that 
require sustained mental effort 
(such as schoolwork or homework) 
       
Lost things that were necessary 
for tasks or activities (eg, toys, 
school assignments, pencils, 
books, or tools) 
       
Easily distracted by sounds        
Easily distracted by movements        
Forgetful in daily activities (e.g. 
forgot about homework 
assignments, or forgot to pack for 
your extra-mural activities) 
       
Fidgeted with hands or feet         
Had difficulty sitting still        
Left your seat in classroom or in 
other situations in which remaining 
seated was expected 
       
Compared to other children you 
ran around or climbed up things 
more than they did 
       
Others complained that you were 
noisy 
       
 Compared to other children you 
were often more on the move than 
they were 
       
You had more energy than the 
other children around you 
       
 Adults and friends complained 
that you talk too much 
       
 Blurted out answers before 
questions had  been completed 
       
Difficulty awaiting your turn        
Interrupted or intruded on others 
(e.g., butts into conversations or 
games) 
       
You had difficulty reading        
You disliked reading        
Your handwriting was not neat        
You disliked writing        
Mixed “b’s” and “d’s” or “6’s” and 
“9’s” 
       
You had difficulty with 
mathematics 
       
You disliked mathematics        
Had difficulty with “learning” 
subjects (e.g. History)  
       
Disliked “learning” subjects        
Told by teachers and parents that        
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you were lazy 
Told by teachers, parents and 
other adults that you were naughty 
       
You felt that you were not as 
clever as the other children 
       
Most other children disliked you        
You had the sense that most 
adults did not like you 
       
You were teased or got into 
trouble because you were clumsy 
       
  
 
 
 
 
SECTION B: ADULTHOOD 
 
In terms of your thoughts, which, and how often of the following do you experience? 
Item Occurrence   Frequency    
  
Yes No Almost 
Never 
Now and 
again 
At least 
once a 
week 
At least 
once a 
day 
More 
than 
once per 
day 
Have difficulty falling asleep 
because my thoughts keep 
me awake 
       
I seem to be always thinking        
While listening to others my 
mind wanders 
       
While talking to others, I lose 
track of what I was going to 
say 
       
I have to consciously stop 
myself from blurting out my 
thoughts 
       
I have difficulty maintaining 
focus 
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I have difficulty relaxing 
because I’m constantly 
thinking 
       
I have difficulty organising my 
thoughts 
       
I replay situations in my mind        
I worry about becoming bored        
I have difficulty planning a 
task because my thoughts 
constantly wander 
       
Unrelated thoughts seems to 
pop into my head 
       
I am distracted by movement        
I am distracted by sounds        
Many possible outcomes to 
future scenarios run through 
my mind 
       
Once the challenge of a new 
task is over, I lose interest 
quickly 
       
Before I begin a complicated 
job/task, I fail to make careful 
plans 
       
Avoid, dislike, or am reluctant 
to engage in tasks that 
requires sustained mental 
effort 
       
Fail to give close attention to 
details  
       
Make careless mistakes in my 
work 
       
Have difficulty keeping your 
attention when you are doing 
boring or repetitive work 
       
 
In my interactions with others: 
Item Occurrence   Frequency    
 
Yes No Almost 
Never 
Now and 
again 
At least 
once a 
week 
At least 
once a 
day 
More 
than 
once per 
day 
Feel compelled to interrupt 
others during conversations 
       
Talk excessively        
Finish other people’s sentences        
Have difficulty waiting my turn        
Difficulty concentrating on what 
people say to you, even when 
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they are speaking to you 
directly 
Prefer friends who are exciting 
and unpredictable 
       
Prefer a partner who is exciting 
and unpredictable 
       
Get bored with friends easily         
Constantly making new friends        
Get bored in intimate 
relationships 
       
My partner(s) often accuse me 
of a lack of commitment in our 
relationship 
       
I enjoy the thrill of a new 
intimate relationship, but lose 
interest when the thrill is gone 
       
People describe me as 
unreliable in my relationships 
       
 
In terms of your behaviour, which, and how often of the following do you experience? 
Item Occurrence   Frequency    
 
Yes No Almost 
Never 
Now and 
again 
At least 
once a 
week 
At least 
once a 
day 
More 
than 
once per 
day 
Fidget or squirm with your 
hands or feet when you have to 
sit down for a long time 
       
New and exciting experiences 
and sensations even if they are 
a little frightening 
       
Doing things just for the thrill of 
it 
       
Do things that others may 
describe as frightening 
       
Enjoy new and unpredictable 
situations  
       
Others describe me as being 
an impulsive person 
       
Begin a new job/task without 
much advance planning on 
how I will do it 
       
Do things on impulse        
Get so carried away by new and 
exciting things and ideas that I 
never think of possible 
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complication 
Tendency to change interests 
frequently 
       
Difficulty staying within the 
speed limit when I’m driving 
       
Others say that I take 
unnecessary risks when driving 
       
 
In terms of your feelings, which, and how often of the following do you experience? 
Item Occurrence   Frequency    
 
Yes No Almost 
Never 
Now and 
again 
At least 
once a 
week 
At least 
once a 
day 
More than 
once per 
day 
Lose temper        
Am touchy or easily 
annoyed by the others 
       
Am angry or resentful        
Get frustrated in traffic        
Get irritated when things 
are not done quickly 
enough to my liking 
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APPENDIX E: TESTS OF NORMALITY 
 
  Tests of Normality: Shapiro-Wilk 
Task  Outcome Measure Group Statistic Sig. 
DDT NoDiscounts MA+ .896 .069 
 
MA- .922 .407 
 
NC .886 .152 
BART Pumps MA+ .866 .024 
 
MA- .841 .060 
 
NC .938 .527 
 
Avpumps MA+ .866 .024 
 
MA- .841 .060 
 
NC .938 .527 
 
Maxpumps MA+ .743 .001 
 
MA- .893 .212 
 
NC .895 .195 
 
Points MA+ .935 .289 
 
MA- .856 .087 
 
NC .926 .406 
IST Meanofboxesopenedpertrial MA+ .897 .073 
 
MA- .923 .415 
 
NC .911 .285 
 
MeanPcorrect MA+ .957 .600 
 
MA- .933 .512 
 
NC .938 .533 
 
TotalCorrect MA+ .853 .015 
 
MA- .863 .102 
 
NC .919 .350 
 
SamplingErrors MA+ .751 .001 
 
MA- .838 .055 
 
NC .819 .025 
 
DiscriminationErrors MA+ .749 .001 
 
MA- .844 .065 
 
NC .895 .191 
 
Meanboxopeninglatency MA+ .740 .000 
 
MA- .934 .521 
 
NC .963 .818 
 
Meanofboxesopenedpertrial MA+ .932 .261 
 
MA- .776 .011 
 
NC .964 .834 
 
MeanPcorrect MA+ .929 .233 
 
MA- .799 .020 
 
NC .863 .083 
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Totalcorrect MA+ .930 .244 
 
MA- .922 .407 
 
NC .920 .359 
 
SamplingErrors MA+ .930 .241 
 
MA- .844 .065 
 
NC .872 .105 
 
DiscriminationErrors MA+ .879 .038 
 
MA- .889 .194 
 
NC .802 .015 
 
Meanboxopeninglatency MA+ .703 .000 
 
MA- .943 .611 
 
NC .928 .425 
CGT DelayAversion MA+ .891 .057 
 
MA- .945 .633 
 
NC .971 .903 
 
DeliberationTime MA+ .894 .065 
 
MA- .924 .426 
 
NC .529 .000 
 
Overallproportionbet MA+ .943 .387 
 
MA- .962 .820 
 
NC .889 .164 
 
QualityofDecisionMaking MA+ .817 .005 
 
MA- .917 .370 
 
NC .928 .432 
 
RiskAdjustment MA+ .963 .721 
 
MA- .964 .840 
 
NC .896 .196 
 
RiskTaking MA+ .969 .824 
 
MA- .952 .714 
 
NC .928 .432 
AGN Meancorrectlatencypos MA+ .940 .347 
 
MA- .808 .025 
 
NC .937 .519 
 
Meancorrectlatencyneg MA+ .948 .465 
 
MA- .967 .871 
 
NC .967 .861 
 
TotalOmissionpos MA+ .892 .061 
 
MA- .926 .447 
 
NC .778 .008 
 
TotalOmissionsneg MA+ .919 .165 
 
MA- .964 .840 
 
NC .597 .000 
SST DirectionErrorsonstopandgotrials MA+ .815 .004 
 
MA- .883 .169 
 
NC .841 .045 
 
Proportionofsuccessfulstopslasthalf MA+ .968 .813 
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MA- .659 .000 
 
NC .939 .546 
 
MedianCorrectRTongotrials MA+ .949 .478 
 
MA- .848 .071 
 
NC .843 .048 
 
SSDlasthalf MA+ .913 .128 
 
MA- .917 .371 
 
NC .754 .004 
 
SSRTlasthalf MA+ .886 .049 
 
MA- .903 .272 
 
NC .970 .894 
Stroop Trial1 MA+ .900 .079 
 
MA- .962 .817 
 
NC .964 .832 
 
Errors MA+ .747 .001 
 
MA- .762 .000 
 
NC .366 .000 
 
SCerrors MA+ .883 .043 
 
MA- .713 .002 
 
NC .366 .000 
 
Trial2 MA+ .960 .663 
 
MA- .964 .841 
 
NC .828 .032 
 
Errors MA+ .803 .003 
 
MA- .531 .000 
 
NC .366 .000 
 
SCerrors MA+ .883 .043 
 
MA- .813 .028 
 
NC .603 .000 
 
Trial3 MA+ .946 .430 
 
MA- .880 .157 
 
NC .929 .435 
 
Errors MA+ .800 .003 
 
MA- .723 .003 
 
NC .366 .000 
 
SCerrors MA+ .903 .090 
 
MA- .898 .242 
 
NC .554 .000 
 
Trial4 MA+ .790 .002 
 
MA- .825 .040 
 
NC .865 .086 
 
Errors MA+ .696 .000 
 
MA- .710 .002 
 
NC .509 .000 
 
SCErrors MA+ .709 .000 
 
MA- .907 .294 
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NC .593 .000 
WCST Trialsadministered MA+ .649 .000 
 
MA- .788 .015 
 
NC .894 .187 
 
Totalcorrect MA+ .959 .651 
 
MA- .876 .141 
 
NC .933 .476 
 
Correct MA+ .891 .059 
 
MA- .907 .295 
 
NC .776 .007 
 
TotalErrors MA+ .898 .075 
 
MA- .909 .310 
 
NC .751 .004 
 
PerseverativeResponses MA+ .937 .310 
 
MA- .944 .621 
 
NC .737 .002 
 
PerseverativeErrors MA+ .938 .326 
 
MA- .934 .525 
 
NC .732 .002 
 
Failuretomaintainset MA+ .796 .002 
 
MA- .833 .049 
 
NC .594 .000 
TS Errors MA+ .954 .557 
 
MA- .847 .070 
 
NC .782 .009 
 
AvRT MA+ .952 .517 
 
MA- .961 .807 
 
NC .880 .130 
RT FiveChoiceMovementTime MA+ .820 .005 
 
MA- .964 .835 
 
NC .970 .892 
 
FiveChoiceReactionTime MA+ .718 .000 
 
MA- .755 .006 
 
NC .946 .617 
ANT FinalnACC MA+ .752 .001 
 
MA- .732 .003 
 
NC .731 .002 
 
FinalcACC MA+ .739 .000 
 
MA- .607 .000 
 
NC .500 .000 
 
FinaliACC MA+ .838 .009 
 
MA- .898 .243 
 
NC .892 .179 
 
FinalnRT MA+ .917 .150 
 
MA- .862 .101 
 
NC .930 .451 
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FinalcRT MA+ .875 .033 
 
MA- .871 .126 
 
NC .915 .315 
 
FinaliRT MA+ .957 .614 
 
MA- .666 .001 
 
NC .889 .164 
SWM BetweenErrors MA+ .934 .282 
 
MA- .961 .808 
 
NC .959 .777 
 
Strategy MA+ .962 .695 
 
MA- .929 .473 
 
NC .861 .079 
SSP SpanLength MA+ .961 .680 
 
MA- .971 .906 
 
NC .927 .422 
FAS F MA+ .871 .029 
 
MA- .868 .118 
 
NC .912 .294 
 
A MA+ .839 .010 
 
MA- .944 .620 
 
NC .966 .849 
 
S MA+ .901 .084 
 
MA- .914 .344 
 
3.0 .897 .202 
 
TOTAL MA+ .883 .043 
 
MA- .914 .343 
 
NC .863 .082 
 
Animals MA+ .919 .163 
 
MA- .895 .223 
 
NC .920 .360 
 
BoysNames MA+ .976 .922 
 
MA- .945 .641 
 
NC .952 .688 
 
TOTAL MA+ .948 .456 
 
MA- .944 .628 
 
NC .933 .481 
 
FruitsFurnitire MA+ .958 .633 
 
MA- .910 .313 
 
NC .912 .296 
ADHD Q Childhood185 MA+ .796 .002 
 
MA- .921 .397 
 
NC .925 .404 
 
Adulthood255 MA+ .855 .016 
 
MA- .951 .704 
 
NC .973 .915 
 
Total440 MA+ .861 .020 
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MA- .931 .493 
  NC .955 .722 
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APPENDIX F: LEVENE’S STATISTICS 
 
CHAPTER FOUR 
 
Table 1. Levene's statistic for all four composite executive domains 
 Levene’s Statistic df1 df2 Sig. 
Decision Making and Impulsivity 1.355 2 55 .266 
Response Inhibition and Set-shifting 4.515 2 55 .015 
Attention and Working Memory 21.491 2 55 .000 
Verbal Fluency 0.222 2 55 .802 
 
 
CHAPTER FIVE 
 
Table 2. Levene's statistic for the outcome measures of the BART 
 Levene’s Statistic df1 df2 Sig. 
Total pumps .702 2 56 .500 
Adjusted average .702 2 56 .500 
Maximum Pumps 2.329 2 56 .107 
Total Points .437 2 56 .648 
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Table 3. Levene's statistics for the IST outcome measures 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Win Condition Fixed     
 Mean Number of boxes 
 opened per trial 
1.826 2 54 .171 
 Mean P correct 1.038 2 54 .361 
 Total Correct 1.326 2 54 .274 
 Sampling errors 2.706 2 54 .076 
 Discrimination errors 2.339 2 54 .106 
 Mean box opening latency 1.022 2 54 .367 
Win Condition Decreasing     
 Mean Number of boxes 
 opened per trial 
2.275 2 54 .113 
 Mean P correct 3.666 2 54 .032* 
 Total correct 2.719 2 54 .075 
 Sampling errors 2.029 2 54 .141 
 Discrimination errors 2.813 2 54 .069 
 Mean box opening latency 4.463 2 54 .016* 
 
 
 
Table 4. Levene's statistics for the CGT outcome measures 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Delay aversion 
Deliberation time 
Overall proportion bet 
Quality of decision making 
Risk adjustment 
Risk taking 
3.791 
.108 
1.568 
3.167 
2.886 
.634 
2 
2 
2 
2 
2 
2 
55 
55 
55 
55 
55 
55 
.029 
.898 
.218 
.050 
.064 
.534 
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Table 5. Levene's statistics for the IST outcome measures 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Win Condition Fixed     
 Mean Number of boxes 
 opened per trial 
1.826 2 54 .171 
 Mean P correct 1.038 2 54 .361 
 Total Correct 1.326 2 54 .274 
 Sampling errors 2.706 2 54 .076 
 Discrimination errors 2.339 2 54 .106 
 Mean box opening latency 1.022 2 54 .367 
Win Condition Decreasing     
 Mean Number of boxes 
 opened per trial 
2.275 2 54 .113 
 Mean P correct 3.666 2 54 .032* 
 Total correct 2.719 2 54 .075 
 Sampling errors 2.029 2 54 .141 
 Discrimination errors 2.813 2 54 .069 
 Mean box opening latency 4.463 2 54 .016* 
 
 
Table 6. Levene's statistics for the CGT outcome measures 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Delay aversion 
Deliberation time 
Overall proportion bet 
Quality of decision making 
Risk adjustment 
Risk taking 
3.791 
.108 
1.568 
3.167 
2.886 
.634 
2 
2 
2 
2 
2 
2 
55 
55 
55 
55 
55 
55 
.029 
.898 
.218 
.050 
.064 
.534 
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CHAPTER SIX 
 
Table 7. Levene's statistics for the Stop Signal Task 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Directions errors on stop/go trials 
Proportion of successful stops 
Median correct RT on go trials 
SSD (last half) 
SSRT (last half) 
12.330 
.178 
.308 
3.953 
5.583 
2 
2 
2 
2 
2 
50 
50 
50 
50 
50 
.000 
.838 
.736 
.025 
.006 
 
Table 8. Levene's statistics for the WCST 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Trials Administered 
Total correct 
Total errors 
Perseverative responses 
Perseverative errors 
.601 
1.055 
1.725 
4.775 
5.160 
2 
2 
2 
2 
2 
39 
39 
39 
39 
39 
.553 
.358 
.192 
.014 
.010 
 
CHAPTER SEVEN 
 
Table 9. Levene's Statistics for the ANT 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
Accuracy:  
 Neutral Trials 
 Congruent Trials 
 Incongruent Trials 
 
Reaction Time: 
 Neutral Trials 
 Congruent Trials 
 Incongruent Trials 
 
17.320 
18.009 
25.607 
 
 
1.456 
.669 
1.576 
 
2 
2 
2 
 
 
2 
2 
2 
 
56 
56 
56 
 
 
56 
56 
56 
 
.000 
.000 
.000 
 
 
.242 
.516 
.216 
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CHAPTER EIGHT 
Table 10. Levene's Statistics for Verbal Fluency 
Outcome measure Levene’s 
Statistic 
df1 df2 Sig. 
F 
A 
S 
Total 
Animals 
Boy’s Names 
Total 
Category Switching 
.180 
2.339 
1.313 
1.210 
.140 
.324 
.018 
1.001 
2 
2 
2 
2 
2 
2 
2 
2 
55 
55 
55 
55 
55 
55 
55 
55 
.836 
.106 
.277 
.306 
.870 
.724 
.982 
.374 
 
 
 
 
 
 
